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Abstract 
 
Highly functionalized 5 or 6-membered nitrogen-containing heterocyclic 
moieties are highly prevalent in pharmaceuticals reagents, alkaloid natural products, 
organocatalysts, as well as useful building blocks in organic synthesis.  Novel 
approaches to synthesizing these structures are sought therefore to maximize their 
accessibility. Within the well-established organic synthesis artillery, electrocyclic 
reactions serve as the predominant strategy to construct pyrrolidine and piperidine 
analogues.  In this dissertation, the first stereocontrolled assembly of indolizidines 
from 2-allylic proline esters by aza-Prins reaction, and endo-selective synthesis of 
highly functionalized 5-vinylic pyrrolidines from benzylic and allylic azomethine 
ylide using novel [3+2] dipolar cycloaddition are described. These methodologies 
then culminate in a formal synthesis of Borreria alkaloid, borrecapine, by using an 
unprecedented sulfonyl group substituted dipolarophile. Finally, new directions in our 
laboratory to make pyrrolidine scaffolds are included in the last chapter of this thesis.  
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Chapter 1 
 
From 2-Allylic Proline Esters to Indolizidines: Development of an Aza-Prins 
Strategy 
 
1.1. Introduction of aza-Prins reaction 
1.1.1. Background and discovery 
The “Prins reaction” was first discovered by O. Kriewitz in 1899 (Scheme 1.1) 
by heating paraformaldehyde with β-pinene to produce an unsaturated primary 
alcohol.1,2 This type of reaction was not systematically investigated until two decades 
later by H.J. Prins (Scheme 1.2) who studied the reaction between several alkenes 
with paraformaldehyde catalyzed by sulfuric acid.3,4  To honor his contribution in this 
area, the acid-catalyzed condensation of alkenes with aldehydes is refered to as the 
Prins reaction.  
Scheme 1. 1. Kriewitz’s additive compounds of formaldehyde with terpene 
                                                      
                                               
1
 Kriewitz, O. Ber. 1899, 32, 57-60.  
2
 Kriewtiz, O. J. Chem. Soc. 1899, 76, 298 
3
 Prins, H.J. Chem. Weekblad, 1919, 16, 1510-1526. 
4
 Prins, H.J. Chem. Weekblad, 1919, 16, 1072-1073. 
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Scheme 1. 2. Prins’ condensation of formaldehyde with styrene 
                                      
Except for the originally developed intermolecular reaction to prepare allylic 
alcohols or 3-substituted alcohols, the intramolecular version of the Prins reaction 
between oxocarbenium ions and tethered olefinic nucleophiles is more widely 
featured in the synthesis of O-heterocycles, like tetrahydropyrans (Scheme 1.3).5,6  
Similar to this access to 6-membered oxa-heterocycles, piperidine was also 
synthesized by the nitrogen version of the reaction, known as the aza-Prins reaction.5 
This latter reaction was first studied in the 1980’s by Speckamp 5d, 7 and Overman 8, 9, 
10
 separately, the results of which were soon applied in systematic methodology 
development and natural products total syntheses.  
Scheme 1. 3. First synthesis of tetrahydropyran via Prins cyclization from 3-buten-1-
ol 
 
 
                                               
5
 For reviews of Prins and aza-Prins reaction, see: (a) Arundale, E., Mikeska, L.A., Chem. Rev., 1952, 
51, 505-555. (b) Pastor, I.M., Yus, M., Current Organic Chemistry, 2007, 11, 925-957. (c) Olier, C., 
Kaafarani, M., Gastaldi, S., Bertrand, M. P., Tetrahedron, 2000, 66, 413-445. (d) Speckamp, W.N., 
Hiemstra, H., Tetrahedron, 1985, 41, 4367-4416. 
6
  Hanscheke, E., Chem. Ber., 1955, 88, 1053-1061. 
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1.1.2. Examples for the synthesis of piperidines and indolizidines using the aza-
Prins reaction 
From 1985 to 1986, Speckamp and co-workers performed comprehensive 
pioneering studies of intramolecular reactions of N-acyliminium intermediates.5d,7  In 
their publications, various methods for generating N-acyliminium ions and the 
syntheses of their precursors were described. Aromatic π-nucleophiles (Pictet-
Spengler-type cyclization) (Scheme 1.4) and non-aromatic π-nucleophiles (aza-Prins-
type cyclization) (Scheme 1.5) were both tested with tethered N-acyliminium ions in 
the presence of protic acids.  A variety of indolizidinone (lactam) compounds, 
including Erythrina-type and harmicine-type molecules, and 2-piperidinone 
compounds were synthesized. 
Scheme 1. 4. Pictect-Spengler-type cyclization with aromatic π-nucleophiles toward 
Erythrina-type alkaloids 
 
Scheme 1. 5. Aza-Prins reactions with non-aromatic π-nucleophiles 
 
In the same decade, Overman and co-workers used iminium ion-vinylsilane 
cyclization as the key step in the total synthesis of dendrobatid toxin 251D (Scheme 
                                               
7
  (a) Hiemstra, H., Fortgens, H.P., Speckamp, W.N., Tetrahedron Letters, 1985, 26, 3155-3158. (b) 
Ent. H., Koning, H., Speckamp, W.N., J. Org. Chem., 1986, 51, 1687-1691. 
 4 
1.6).8 Distinct from Speckamp’s methods to generate N-acyliminium ion intermediate 
from aminal derivatives, Overman condensed formaldehyde with the pyrrolidine 
moiety on the building block to form a Schiff iminium ion intermediate, which was 
then attacked by an adjacent vinylsilane nucleophile in the presence of 
camphorsulfonic acid (CSA). In 1988, the research group also developed the 
nucleophile promoted iminium ion-alkyne cyclization (Scheme 1.7),9 which they then 
successfully applied in the total synthesis of allopumiliotoxin 253A (Scheme 1.8).10                              
Scheme 1. 6. Overman’s total synthesis of dendrobatid toxin 251D via iminium ion-
vinylsilane cyclization 
 
Scheme 1. 7. Nucleophile promoted iminium ion-alkyne cyclization 
                            
Scheme 1. 8. Overman’s total synthesis of allopumiliotoxin 253 A 
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The aza-Prins reaction can also be catalyzed by Lewis acids. In 2006, Martin 
and co-workers developed Fe (III) promoted aza-Prins reactions between γ,δ-
unsaturated N- tosylamines and aldehydes to provide N-tosyl piperidine scaffolds 
                                               
8
 Overman, L.E., Bell, K.L., J. Am. Chem. Soc., 1981, 103, 1851-1853 
9
 Overman, L.E., Sharp, M.J., J. Am. Chem. Soc, 1988, 110, 612-614. 
10
 Overman, L.E., Sharp, M.J., Tetrahedron Letters, 1988, 29, 901-904. 
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with the trans-2-alkyl-4-halo 6-membered N-heterocycles as the major stereoisomer 
(Scheme 1.9).11  The scope of this reaction was later broadened by the same research 
group using different γ, δ-unsaturated N-sulfonylamines.12             
Scheme 1. 9. Iron(III)-catalyzed aza-Prins cyclization 
 
In 2008, Murty and co-workers developed BiCl3 catalyzed aza-Prins 
cyclizations between N-protected homoallylic amines and epoxides. A series of trans-
piperidine derivatives were synthesized in high yields with BiCl3 as the catalyst for 
epoxide ring opening (Scheme 1.10).13                     
Scheme 1. 10. Bismuth(III)-catalyzed aza-Prins cyclization 
 
In the same year, Yadav and co-workers prepared 4-iodopiperidines in high 
yields and good diastereoselectivity by aza-Prins cyclization using a stoichiometric 
amount of iodine and catalytic amounts of gallium (III) iodide. They proved that the 
presence of gallium iodide is critical for the reaction’s success, and the induction 
                                               
11
 Carballo, R.M., Ramirez, M.A., Rodriguez, M.L., Martin, V.S., Padron, J.I., Org. Lett., 2006, 8, 
3837-3840.  
12
 (a) Miranda, P.O., Carballo, R.M., Martin, V.S., Padron, J.I., Org. Lett., 2009, 11, 357-360. (b) 
Carballo, R.M., Valdomir, G., Purino, M., Martin, V.S., Padron, J.I., Eur. J. Org. Chem., 2010, 2304-
2313. 
13
 Murty, M.S.R. Tetrahedron Letters, 2008, 49, 1141-1145. 
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effect of molecular iodine in essential for the reaction to be high-yielding (Scheme 
1.11). 14  They then carried this methodology forward to synthesize indolizidine 
molecules.15       
             
Scheme 1. 11. Gallium(III)-catalyzed aza-Prins cyclization 
 
Some research groups showed, however, that molecular iodine itself is able to 
promote aza-Prins type cyclization in some particular cases. This observation dates 
back to 1988, as mentioned earlier, when Overman and co-workers developed the 
nucleophile-induced iminium ion-alkyne cyclization. I2 was used as one of the 
nucleophiles to synthesize unsaturated 4-iodo indolizidines.8 In 2009, Silva and co-
worker used bicyclic homoallylic N-tosyl amine and benzaldehyde to furnish 
conjugated isochromene and isoquinoline derivatives with 20 mol% I2 (Scheme 
1.12)
.
16
                               
Scheme 1. 12. I2-catalyzed aza-Prins cyclization 
 
In 2010, Dobbs and co-workers used indium trichloride as a highy efficient, 
mild Lewis acid catalyst to prepare a mixture of piperidine and pyrrolidine scaffolds 
                                               
14
 Yadav, S.J. Tetrahedron Letters, 2008, 49, 3330-3334. 
15
 Reddy, B.V., Chaya, D.M., Yadav, J.S., Gree, R., Synthesis, 2012, 44, 297-303. 
16
 Silva Jr., L.F., Quintiliano, S.A., Tetrahedron Letters, 2009, 50, 2256-2260. 
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by aza-Prins cyclization (Scheme 1.13). 17  The ratio between 6-membered and 5-
membered azacycles depended on the starting aldehydes’ functionality (Table 1.1).                     
Scheme 1. 13. Indium-catalyzed aza-Prins cyclization 
              
Table 1. 1. Products ratios of indium-catalyzed aza-Prins reaction of (Z)-homoallyl 
tosylamine with different aldehydes 
Entry R Time/h Yield of piperidine (%) 
Yield of 
pyrrolidine (%) 
1 n-C7H15 17 35 35 
2 Ph 144 15 0 
3 Ph(CH2)2 17 40 36 
4 c-hex 144 26 50 
5 CO2Et 1 20 0 
  
 
Yadav and co-workers in the same year developed boron promoted aza-Prins 
cyclizations toward 4-fluoropiperidines from N-tosyl homoallylic amines and 
aldehydes. 18  The reaction was catalyzed by tetrafluoroboric acid-diethyl ether 
complex at ambient temperature, and proved to be high yielding and highly cis-
selective (Scheme 1.14).      
Scheme 1. 14. Boron-catalyzed aza-Prins reaction 
 
                                               
17
 Dobbs, A.P., Guesne, S.J.J., Parker, R.J., Skidmore, J., Stephenson, R.A., Hursthouse, M.B., 
Organic&Biomolecular Chemistry, 2010, 8, 1064-1080. 
18
 Yadav, J.S., Subba Reddy, B.V., Ramesh, K., Narayana Kumar, G.G.K.S., Gree, R., Tetrahedron 
Letters, 2010, 51, 1578-1581. 
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Several other Lewis acids, like Au,19 and Sc,20 were also demonstrated to be 
efficient catalysts for aza-Prins type reactions.  
1.1.3. Aza-Prins cyclization as key steps in cascade reactions toward alkaloids 
synthesis 
Aza-Prins cyclizations have served as a prevalent method, especially when 
combined with other C-C bond formation methodologies, to construct the piperidine 
core of natural products and synthetic therapeutic agents. This is exemplified by 
Overman’s synthesis of dendrobatid toxin 251D8 and allopumiliotoxin 253A,10 267A, 
323B, 339A,21 
In 2011, Overman and co-workers prepared trans-hydroisoquinolones 
asymmetrically using Pinacol rearrangement ([1,2]-hydride shift) terminated N-
acyliminium ion cyclizations (Scheme 1.15).22 In 2005, Armstrong and co-workers 
developed a selective methodology to access [2.2.1] or [3.2.1] azabicyclic heptanes 
using a SnCl4 catalyzed aza-Prins-Pinacol cascade strategy ([1,2]-alkyl group 
migration),23 which was then successfully applied in total syntheses of (±)-epibatidine 
and (±)-epiboxidine (Scheme 1.16).24                              
Scheme 1. 15.  Pinacol-terminated (hydride shift) cyclizations of N-acyliminium ion 
 
                                               
19
 Kim, C., Bae, H., Lee, J., Jeong, W., Kim, H., Sampath, V., Rhee, Y., J. Am.Chem. Soc. 2009, 131, 
14660-14661. 
20
 Subba Reddy, B.V., Borkar, P., Pawan Chakravarthy, P., Yadav, J.S., Gree, R., Tetrahedron Letters, 
2010, 51, 3412-3416. 
21
 Caderas, C., Lett, R., Overman, L.E., Rabinowitz, M.H., Robinson, L.A., Sharp, M.J., Zablocki, J., 
J.Am.Chem.Soc., 1996, 118, 9073-9082. 
22
 Kamatani, A., Overman, L.E., Org. Lett., 2001, 3, 1229-1232. 
23
 Armstrong, A., Shanahan S. E., Org. Lett., 2005, 7, 1335-1338. 
24
 Armstrong, A., Bhonoah, Y., Shanahan, S.E., J. Org. Chem., 2007, 72, 8019-8024. 
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Scheme 1. 16. SnCl4 catalyzed aza-Prins-pinacol cascade toward the syntheses of 
epibatidine and epiboxidine 
 
The resulting carbocation generated from an aza-Prins cyclization can also be 
trapped by aryl π-nucleophiles. In 2009, Yadav and co-workers synthesized 4-
arylpiperidines using N-tosyl homoallylic amines, aldehydes and arenes by 
intermolecular and intramolecular aza-Prins-Friedel-Crafts cascade reactions in the 
presence of stoichiometric amounts of BF3·OEt2 or catalytic amounts of scandium(III) 
triflate (Scheme 1.17)
. 
25
 
In 2010, Porco and co-workers developed an aza-Prins and 
intramolecular Friedel-Crafts tandem process to form polycyclic scaffolds using N-
phosphinylimines and styrenic olefins in the presence of La(OTf)3 and trifluoroacetic 
anhydride (TFAA) (Scheme 1.18).26  
Scheme 1. 17. Yadav’s intermolecular and intramolecular aza-Prins-Friedel-Crafts 
process 
 
                                               
25
 (a) Yadav, J.S., Subba Reddy, B.V., Ramesh, K., Narayana Kummar, G.G.K.S., Gree, R., 
Tetrahedron Letters, 2010, 51, 818-821. (b) Subbba Reddy, B.V., Borkar, P., Yadav, J.S., Sridhar, B., 
Gree, R. J. Org. Chem. 2011, 76, 7677-7690. 
26
 Kinoshita, H., Ingham, O.J. Ong, W.W., Beeler, A.B., Porco, J.A., J.Am.Chem.Soc., 2010, 132, 
6412-6418. 
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Scheme 1. 18. Porco’s intramolecular aza-Prins-Friedel-Crafts tandem process 
 
A systematic study on neighboring heteroatom-terminated aza-Prins reactions 
was carried out by Reddy and co-workers by performing an Sc(OTf)3-catalyzed N-
terminated intramolecular aza-Prins cyclizations to form heterobicyclic compounds 
(Scheme 1.19).20 Yadav and co-workers also developed a para-toluenesulfonic acid 
(p-TSA) promoted intramolecular nitrogen-terminated aza-Prins cyclization to form 
diazabicyclic molecules using (E)-hex-3-ene-1,6,-ditosylamine and styrene oxides as 
starting reagents (Scheme 1.20).27 
Scheme 1. 19. Sc(OTf)3-catalyzed aza-Prins cyclization 
NHTs
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N N
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H
H
H
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Scheme 1. 20. p-TSA-catalyzed aza-Prins cyclization 
 
Shair and co-workers completed the total synthesis of cortistatin A (Scheme 
1.21), a potent endothelial cell proliferation inhibitor in 2008 by using a highly 
                                               
27
 Yadav, J.S., Borkar, P., Chakravarthy, P.P., Subba Reddy, B.V., Sarma, A.V.S., Basha, S.J., Sridhar, 
B., Gree, R., J. Org. Chem., 2010, 75, 2081-2084. 
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diastereoselective O-terminated aza-Prins reaction after a silicate-directed 
elimination/ring expansion sequence from the Hajos-Parrish ketone. 28  In 2010, 
Overman and co-workers accomplished the first total syntheses of Lycopodium 
alkaloids (+)-nankakurines A and B29 using a Diels-Alder reaction and a nitrogen-
terminated aza-Prins cyclization as key steps to construct the skeleton of these 
alkaloids (Scheme 1.22). 
Scheme 1. 21. Aza-Prins key steps in Shair’s total synthesis of cortistatin A 
 
Scheme 1. 22. Aza-Prins key step in Overman’s total synthesis of nankakurines 
 
Aza-Prins cyclizations are also coupled with Dield-Alder reactions to produce 
one of the most powerful strategies to build up complex structures of alkaloids. In 
1988, Heathcock and co-workers published a concise total synthesis of the 
Daphniphyllum alkaloid (±)-methyl homosecodaphniphyllate in high yield. 30  Four 
rings and 5 bonds were formed in a single transformation following sequential Diels-
Alder and aza-Prins cyclizations (Scheme 1.23).  
                                               
28
 Lee, H., Nieto-Oberhuber, C., Shair, M.D., J. Am. Chem. Soc. 2008, 130, 16864-16866. 
29
 (a) Nilsson, B.L., Overman, L.E., Read de Alaniz, J., Rohde., J.M., J. Am. Chem. Soc., 2008, 130, 
11297-11299. (b) Altman, R.A., Nilsson, B.L., Overman, L.E., Read de Alaniz, J., Rohde, J.M., Taupin, 
V., J. Org. Chem. 2010, 75, 7519-7534. 
30
 Ruggeri, R.B., Hansen, M.M., Heathcock, C.H.,  J. Am. Chem. Soc., 1988, 110, 8734-8736. 
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Scheme 1. 23. Heathcock’s synthesis of (±)-methyl homosecodaphniphyllate 
 
Besides the above examples, aza-Prins cyclizations have also played a 
significant role in the total syntheses of oscillarin,31 cylindricines,32 lepadiformine,32 
(-)-solenopsin A, 33  (+)-epi-dihydropinidine,33 and lyconadins A-C, 34  all of which 
featured convenient, atom-economical, stereocontrolled methodology to construct 
their 6-membered aza-heterocyclic core. The development of more facile versions of 
the aza-Prins cyclization is continually pursued by synthetic organic chemists. In 
continuation of our interests in the synthesis of N-containing small molecules, we 
herein describe a novel methodology for constructing multi-substituted indolizidines 
from 2-allylic pyrrolidines by aza-Prins cyclization.  
1.2. Methodology development: synthesis of indolizidines from 2-allylic proline 
esters using aza-Prins cyclization 
1.2.1. Previous related work and their inspirations 
In 2010, the Waters group reported a domino 2-aza-Cope-[3+2] dipolar 
cycloaddition protocol for the synthesis of highly functionalized 2-allylpyrrolidine 
                                               
31
 Hanessian, S., Tremblay, M., Petersen J.F., J. Am. Chem. Soc., 2004, 126, 6064-6071. 
32
 Liu, J., Hsung, R.P., Peters, S.D., Org. Lett., 2004, 6, 3989-3992. 
33
 Dobbs, A.P., Sebastien, J.J., Synlett, 2005, 13, 2101-2103. 
34
 Nishimura, T., Unni, A.K., Yokoshima, S., Fukuyama, T., J. Am. Chem. Soc., 2013, 135, 3243-3247. 
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scaffolds. 35  In this sequence, the condensation of homoallylic amines with ethyl 
glyoxylate afforded an imine of type I, which after facile 2-aza-Cope rearrangement 
delivered an azomethine ylide precursor of type II. Addition of AgOAc and Et3N 
furnished a stabilized, N-metalated azomethine ylide, which in the presence of a 
dipolarophile underwent subsequent [3+2] dipolar cycloaddition to afford multi-
substituted 2-allylpyrrolidine in a one-pot process. Up to four stereogenic centers 
were created within the proline cycloadduct, and the resultant 2-allyl moiety presented 
a convenient point for additional structural advancements.                   
Scheme 1. 24. 2-aza-Cope-[3+2] dipolar cycloaddition cascade reaction 
 
1.2.2. Documented synthetic versatility of 2-allylprolines 
Such 2-allylproline scaffolds have been carried toward targets with a higher 
degree of complexity. In 2009, Santos and co-workers prepared indolizidine 
compounds from 2-allylproline esters by either ring closing metathesis or Pauson-
Khand reaction (Scheme 1.25).36 However, the preparation of indolizidines from 2-
allylprolines via aza-Prins reaction is far less developed.                         
                                               
35
 McCormack, M.P., Shalumova, T., Tanski, J.M., Waters, S.P., Org. Lett. 2010, 12, 3906-3909. 
36
 Duran-Lara, E.F., Shankaraiah, N., Geraldo, D., Santos, L.S., J. Braz. Chem. Soc., 2009, 20(5), 813-
819. 
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Scheme 1. 25. Preparation of indolizidines from 2-allyl proline ester 
 
1.2.3. Development of an aza-Prins cyclization approach to indolizidines from 2-
allyl pyrrolidines 
Drawing upon our ability to access a variety of 2-allylpyrrolidine scaffolds 
through the 2-aza-Cope-[3+2]-dipolar cycloaddition sequence, we wished to explore 
the feasibility of preparing indolizidines through the aza-Prins cyclization. We 
expected that condensation of an aldehyde onto the pyrrolidine nitrogen would furnish 
an iminium ion, which could undergo nucleophilic attack by the pendant allyl group. 
Interception of the developing carbocation by either the solvent or a tethered 
nucleophile would furnish the six-membered ring of the indolizidine and two 
additional stereocenters. In this manner, the use of tandem, multicomponent reactions 
would provide access to functionalized indolizidines in a concise and stereoselective 
fashion (Scheme 1.26).                    
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Scheme 1. 26. Proposed synthesis of indolizidines from 2-allylpyrrlidines via aza-
Prins cyclization 
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In the early planning stages, we anticipated that the condensation of an 
aldehyde onto an already sterically encumbered, neopentyl pyrrolidine nitrogen might 
present a challenge to our synthetic approach. For our initial studies, formaldehyde, 
the simplest aldehyde which is most widely used in Prins reactions, was chosen as the 
electrophilic component. Gratifyingly, treatment of 2-allylpyrrolidine 1 with aqueous 
formaldehyde and TFA (1.0 equiv) in wet acetonitrile for 24 hours at ambient 
temperature provided indolizidine 4 in 80% yield as a single observable diastereomer. 
Aza-Prins cyclizations of 2-allylpyrrolidines 2 and 3 under similar conditions gave 
indolizidines as single diastereomers in 79 and 82% yields, respectively. Conducting 
these processes in aqueous media promoted clean termination of the aza-Prins 
reaction through nucleophilic attack by water, affording hydroxyl-substituted 
indolizidines 5-6 in good overall yields (Scheme 1.27).  
Scheme 1. 27. Aza-Prins cyclization with formaldehyde 
 
The high level of diastereoselectivity observed in this cyclization may be 
attributed to a chair transition state in which the pyrrolidine ring fusions occupy 
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equatorial positions with respect to the newly forming piperidine ring, as well as axial 
approach of the incoming nucleophile (water) in a favorable antiperiplanar alignment 
with the π* orbital of the iminium ion, These stereochemical assignments were 
confirmed through 2D NMR spectroscopy as well as NOE enhancement studies.                                               
Figure 1. 1. Rationale of diastereoselectivity of the aza-Prins cyclization with 
formaldehyde 
 
Encouraged by these findings, additional aldehyde components were surveyed. 
To avoid the undesired tautomerization of the newly-formed iminium ion to an 
enamine, aldehydes with no α-hydrogens were utilized in this aza-Prins reaction. 
Therefore, glyoxylic acid, in the absence of TFA, readily underwent condensation at 
room temperature onto the pyrrolidine nitrogen. After olefin-iminium ion cyclization, 
lactone 7 emerged within 24 hours in 94% yield as one diastereomer (Scheme 1.28). 
The formation of lactone 7 may be rationalized by ring closure of the olefin onto the 
iminium ion followed by nucleophilic interception of the resulting carbocation by the 
carboxyl group in glyoxylic acid. In like manner, the reactions of 2-allylpyrrolidines 2 
and 3 under similar conditions gave indolizidine lactones 8 and 9 in excellent yields 
(97 and 83%, respectively) as single diasereomers. Spectroscopic analysis of 
indolizidine 7-9 revealed that the newly formed lactone ring adopts a syn-1,3-diaxial 
conformation with respect to the indolizidine system. These observations were later 
confirmed through X-ray analysis and chemical correlation to a related compound. 
Overall, the use of glyoxylic acid as the aldehyde component led to the formation of 
two additional rings and two new stereogenic centers in a single step.      
 17 
Scheme 1. 28. Aza-Prins cyclization with glyoxylic acid 
 
The use of glyoxal as the aldehyde component led to the formation of both 
indolizidine and lactol ring systems. Treatment of the 2-allylpyrrolidines 1-3 with 
aqueous glyoxal (10 equiv) and TFA (1.0 equiv) effected complete aza-Prins 
cyclization within 2-3 hours at room temperature to afford indolizidine products 10-
12 in 66-73% yield (Scheme 1.29). These indolizidines were observed to exist in 
solution as equilibrating mixtures of their corresponding hydroxy-aldehyde (major) 
and lactol (minor) forms. In CDCl3, the hydroxy-aldehyde forms were predominate in 
ratios shifting from 2:1 to 7:1 along with more electron-deficienct aryl rings resulting 
in increasing lactol formation as determined by 1H NMR spectroscopy.  
Scheme 1. 29. Aza-Prins cyclization with aqueous glyoxal 
 
Recrystallization of 12 from MeOH:H2O (3:2) gave colorless prisms, which 
were revealed by X-ray analysis to be the lactol form. The X-ray crystal structure 
confirmed that the newly formed six-membered ring of the indolizidine adopts a 
chairlike conformation, while the two new stereocenters of the lactol function assume 
a syn-1,3-diaxial relationship (Graph 1.2).                                 
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Figure 1. 2. X-ray crystal structure of lactol 12 
 
Aza-Prins cyclizations using ethyl glyoxylate required somewhat more forcing 
conditions, presumably due to the increased steric encumbrance of the aldehyde 
component. A variety of reaction parameters were investigated with 2-
allylpyrrolidines to identify the optimal conditions. Good conversions to the 
corresponding indolizidines were best achieved by conducting the reactions at 50 °C, 
aza-Prins cyclizations were not observed at room temperature. In this manner, 
treatment with ethyl glyoxylate (5.0 equiv) and TFA (2.0 equiv) for 1.5 hours 
delivered indolizidine 13, bearing two ester and one alcohol function, in 66% yield 
(Scheme 1.30). Although this increase in temperature allowed for shorter reaction 
times, prolonged exposure of the hydroxyl-esters to the reaction conditions for more 
extended times (3-5 hours) led to the gradual formation of lactones, presumably 
through acid-catalyzed, intramolecular transesterification. Therefore, prompt 
neutralization after consumption of 1-3 was necessary for good conversions. That the 
indolizidines could be transformed through lactonization indicated a stereochemical 
correlation between the two systems. Similar to the previously described aza-Prins 
cyclizations with aldehydes, the resulting new stereogenic centers of the indolizidine 
ring adopt a syn-1,3-diaxial relationship (Figure 1.3).  
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Scheme 1. 30. Aza-prins cyclization with ethyl glyoxylate 
 
Figure 1. 3. X-ray crystal structure of hydroxyl-ester compound 14 
N
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In addition to those α-keto aldehydes, we also attempted benzaldehyde as the 
electrophile in the aza-Prins reaction. No desired product formed after prolonged 
reaction time at elevated temperature in the presence of TFA (1 equiv). Nearly 100% 
of the starting pyrrolidine cycloadduct was recovered, presumably due to inaccessible 
approach of the aldehyde with a phenyl ring to an already sterically hindered 
pyrrolidine nitrogen.  
The use of pyrrolidine cycloadduct 16, generated from azomethine ylide and 
dimethyl maleate, in the aza-Prins reaction led to complicated results. When first 
treated with aqueous formaldehyde and TFA in wet acetonitrile, 2-allyl pyrrolidine 16 
underwent a 2-aza-Cope rearrangement to afford 2H-pyrrole 17 in 1.5 hours (Scheme 
1.31). After 24 hours stirring at room temperature, two indolizidine cycloadducts 18a 
and 18b were isolated and separated by column chromatography. By interpretation of 
the 1H-NMR spectra, these two molecules were assigned as a pair of diastereomers, of 
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which relative stereogenetic centers were not able to be fully characterized due to the 
ambiguity of the sigmatropic rearrangement-tautomerization process (Scheme 1.32).                              
Scheme 1. 31. Unexpected [3,3]-sigmatropic rearrangement under aza-Prins condition 
 
Scheme 1. 32. Aza-Prins cyclization from rearranged 2H-pyrrole 
 
In summary, we have developed a new and operationally facile method for the 
synthesis of indolizidines through aza-Prins cyclizations of 2-allyl pyrrolidines. 
Though aza-Prins cyclizations have proven to be effective for the preparation of 
piperidines, our work now expands the scope of this reaction to include indolizidine 
scaffolds. We have also demonstrated that 2-allyl pyrrolidines, now readily accessible 
through our domino 2-aza-Cope-[3+2] dipolar cycloaddition sequence, are useful 
precursors for the preparation of additional heterocyclic systems. Synthetic 
applications of the aza-Prins cyclization toward alkaloid natural products bearing 
indolizidine frameworks are now being investigated.  
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Table 1. 2. Preparations of indolizidines via aza-Prins cyclizations 
      
Entry Starting Molecules R Products compound # 
Yield 
(%)a 
1 
 
 
 
H 
 
 
 
4 80 
2 OMe 5 82 
3 CF3 6 79 
4 
 
 
 
H 
 
 
 
7 94 
5 OMe 8 83 
6 CF3 9 97 
7 
 
 
 
H 
 
 
 
10 72 
8 OMe 11 73 
9 CF3 12 66 
10 
 
 
 
H 
 
 
 
13 66 
11 OMe 14 57 
12 CF3 15 62 
a. Yields were obtained by column chromatography 
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Chapter 2 
 
New strategy to generate azomethine ylides synthesis of 5-vinyl pyrrolidines 
 
2.1.Introduction to the significance of 5-vinyl pyrrolidines 
2.1.1. Prevelance of the 5-vinyl pyrrolidinyl structure in bio-active molecules 
5-vinyl pyrrolidine moieties occur widely in natural products and synthesized 
small molecules that have promising biological activities. Cephalotaxus fortunei and 
C. drupacea alkaloids, like cephalotaxine, were isolated by Paudler and co-workers in 
the 1960’s and 1970’s. 37  Manzamine alkaloids (A-C) were firstly isolated from 
marine sponge Haliclona by Higa and co-workers in the 1980’s.38 Those molecules 
exhibit highly potent biological properties, including anti-bacterial, anti-inflammatory, 
and anti-tumor activities.39  Securinine, the first alkaloid recognized in its family, was 
first isolated by Muraveva and Bankovakii in 1956.40 Its structure and the structure of 
one of its stereoisomers, allosecurinine, were not identified until 1962 by Yoshii and 
co-workers in Japan.41  In recent decades, more alkaloids in this family were isolated, 
characterized and studied using modern technologies. Most of them show interesting 
                                               
37
 (a) Paudler, W.W., Kerley, G.I., McKay, J.B., J. Org. Chem., 1963, 28, 2194-2197. (b) Powell, R.G., 
Weisleder, D., Smith Jr., C.R., Wolff, I.A., Tetrahedron Letters, 1969, 10, 4081-4084.  
38
 (a) Sakai, R., Higa, T., Jefford, C.W., Bernardinelli, G.J., J. Am. Chem. Soc., 1986, 108, 6404-6405. 
(b) Sakai, R., Kohmoto, S., Higa, T., Tetrahedron Letters, 1987, 28, 5493-5496.  
39
 Zhang, B., Higuchi, R., Miyamoto, T., Soest, R.W.M.V., Chem. Pharm. Bull., 2008, 56, 866-869.  
40
 Muraveva, V.I., Bankovski, A.I., Dokl. Acad. Nauk. SSSR, 1956, 110, 998-1000.  
41
 Satoda, I., Murayama, M., Tsuji, J., Yoshii, E., Tetrahedron Letters, 1962, 3, 1199-1206.  
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anti-bacterial, anti-malarial, and anti-cancer activities, 42  as well as effects on the 
central nervous system (CNS).43  A unique Streptomyces species natural product: 
cyclizidine was first obtained as a crystalline levorotatory substance under aerobic 
fermentation conditions by Poyser and co-workers in 1982.44 Its absolute structural 
information was unambiguously collected by X-ray crystallography and NMR 
spectroscopy by the same research group.44 Spirotryprostatins are indolic alkaloids 
found in Aspergillus fumigatus fungus BM939 by Osada and co-workers, most of 
which have been found to possess anti-mitotic properties.45 Both spirotryprostatin A 
and B are able to inhibit the mammalian cell cycle in G2/M phase.45b Spirotryprostatin 
B shows cytotoxicity on human leukemia cell lines. 45b Those promising biological 
activities suggest these molecules’ potential as anti-cancer therapeutics.                     
Figure 2. 1. Vinylpyrrolidine moiety-containing natural products 
 
                                               
42
 Qin, S., Liang, J., Guo, Y., Helv. Chim. Acta., 2009, 92, 399-403.  
43
 (a) Liras, S., Davoren, J.E., Bordner, J., Org. Lett., 2001, 3, 703-706. (b) Bentler, J.A., Karbon, E.W., 
Brubaker, A.N., Malik, R., Curtis, D.R., Enna, S.J., J. Brain Res., 1985, 330, 135-140.  
44
 (a) Freer, A.A., Gardner, D., Greatbanks, D., Poyser, J.P., Sim, G.A., J. Chem. Soc., Chem. Commun., 
1982, 20, 1160-1162. (b) Gomi, S., Ikeda, D., Nakamura, H., Naganawa, H., Yamashita, F., Hotta, K., 
Kondo, S., Okami, Y., Umezawa, H., Iitaka, Y., J. Antibiot., 1984, 37, 1491-1493. 
45
 (a) Cui, C., Kakeya, H., Osada, H., Tetrahedron, 1996, 52, 12651-12666. (b) Cui, C., Kakeya, H., 
Osada, H., J. Antibiot., 1996, 49, 832-835. 
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2.1.2. Documented syntheses of 5-vinyl pyrrolidines 
Because of their frequent existence in bio-active natural products and 
therapeutic agents, 5-vinyl pyrrolidines are a major pursuit of synthetic organic 
chemists. So far, a variety of different syntheses toward this structure, including 
systematic methodology development and key transformations in total synthesis, have 
been published. 
Historically, assembly of 5-vinyl pyrrolidines by nucleophilic addition to 
pyrrolinyl iminium ions by π-nucleophiles was the most common strategy. Pyrrolinyl 
iminium ions are usually generated from α-methoxy amides or carbamates by anodic 
oxidations (Scheme 2.1) following either the Ross-Eberson-Nyberg procedure46 or the 
Kolbe-like anodic decarboxylation of N-acylated prolines. 47  This strategy was 
adopted by several research groups to synthesize vinylic pyrrolidines. In 1990, 
Wistrand and Skrinjar prepared trans-2,5-disubsituted pyrrolidines by stereoselective 
addition of organocopper reagents to N-acyliminium ion in the presence of BF3·Et2O 
(Scheme 2.2).48 Pedregal and co-workers then expanded the scope of these reactions, 
and explained the stereoselective outcome by proposing an N-acyliminium ions-
copper complex (Figure 2.2).49 In 1992, Biellmann and co-workers synthesized 5-
vinyl-L-prolines, which acted as potential proline dehydrogenase inhibitors from N-
methylcarbamate L-proline esters. In 2000, Moeller and co-workers used anodic 
amide oxidation combined with intramolecular reductive amination or ring-closure 
                                               
46
 (a) Shono, T., Tetrahedron, 1984, 40, 811-850. (b) Eberson, L., Malmberg, M., Nyberg, K., Acta 
Chem., Scand., 1983, B37, 555-566. (c) Shono, T., Matsumura, Y., Tsubata, K., J. Am. Chem. Soc., 
1981, 103, 1172-1176.  
47
 Horikawa, H., Iwasaki, T., Matsumoto, K., Miyoshi, M., J. Org. Chem., 1978, 43, 335-337. 
48
 Wistrand, L., Skrinjar, M., Tetrahedron, 1991, 47, 573-582.  
49
 Collado, I., Ezquerra, J., Pedregal, C., J. Org. Chem., 1995, 60, 5011-5015. 
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metathesis strategies to prepare lactam peptidomimetics via 5-vinyl proline methyl 
ester as the key intermediate (Scheme 2.3).50               
Scheme 2.1. Anodic oxidation of amide- or carbamate-protected pyrrolidines and 
prolines 
 
 
Scheme 2.2. Synthesis of trans-2,5-disubstituted pyrrolidines via organocopper 
reagents to N-acyliminium ions 
                                 
Figure 2. 2. Models of stereoselective addition of organocopper reagents 
 
                                               
50
 (a) Beal, L.M., Liu, B., Chu, W., Moeller, K.D., Tetrahedron, 2000, 56, 10113-10125. (b) Tong, Y., 
Fobian, Y.M., Wu, M., Boyd, N.D., Moeller, K.D., J. Org. Chem. 2000, 65, 2484-2493.  
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Scheme 2. 3. Moeller’s anodic oxidation of amide/ring closing metathesis sequence 
 
Transition metal-catalyzed amination reactions are another methodology to 
prepare vinylpyrrolidines. ⑴Pd-catalyzed amination/cyclizations: In 1981, Godleski 
and co-workers synthesized several vinylic 1-azaspirocyclic compounds from 
cyclohexenone using π-allyl palladium catalyzed spirocyclization (Scheme 2.4).51 In 
1990, Gallagher and co-workers developed a Pd(II)-mediated asymmetric sythesis of 
N-heterocyclic-substituted acrylates in the presence of CO in MeOH (Scheme 2.5).52  
In 1991, they successfully applied this methodology in an enantioselective synthesis 
of pumiliotoxin 251D,53  in which the indolizidine core with an exocyclic alkene 
moiety was efficiently constructed by the electrophilic palladium-mediated 
cyclization. Unlike Gallagher’s methods, in which nucleophilic amines added to 
metal-activated allenes, Yamamoto and co-worker developed a palladium-catalyzed 
intramolecular hydroamination of allenes (Scheme 2.5). Instead of Pd activation of 
the π-bonds, the metal complex coordinated with nitrogen before insertion to the 
                                               
51
 Godleski, S.A., Meinhart, J.D., Miller, D.J., Wallendael, S.V., Tetrahedron Letters, 1981, 22, 2247-
2500. 
52
 Fox, D.N.A., Gallagher, T., Tetrahedron, 1990, 46, 4697-4710. 
53
 Fox, D.N.A., Lathbury, D., Mahon, M.F., Molloy, K.C., Gallagher, T., J. Am. Chem. Soc., 1991, 113, 
2652-2656.  
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allenic double bonds.54 In 1992, Katritzky and co-workers developed a palladium-
catalyzed allylic substitution reaction using benzotriazole as a leaving group to 
prepare vinyl pyrrolidine scaffolds (Scheme 2.7). 55  The regioselectivity of this 
transformation is regulated by the favorable entropy of formation of 5-membered 
heterocycles. In 2005, Yamamoto and co-workers developed a palladium-catalyzed 
intramolecular N-alkylation to allylic halide or alcohol to make cis-5-vinyl proline 
esters (Scheme 2.8).56 In 2013, Zawisza and co-workers reported an enantioselective 
synthesis of vinyl pyrrolidines via Pd(0)-catalyzed intramolecular amination to allylic 
carbonates (Scheme 2.9).57                 
Scheme 2. 4. Godleski’s synthesis of 6.7-unsaturated 1-azaspirocycles 
                   
Scheme 2. 5. Gallagher’s Pd(II)-mediated cyclization toward vinyl pyrrolidines 
      
Scheme 2. 6. Yamamoto’s palladium catalyzed intramolecular hydroamination of 
allenes 
 
                                               
54
 Meguro, M., Yamamoto, Y., Tetrahedron Letters, 1998, 39, 5421-5424.  
55
 Katrizky, A.R., Yao, J., Yang, B., J. Org. Chem., 1999, 64, 6066-6070. 
56
 Eustaache, J., Van de Weghe, P., Le Nouen, D., Uyehara, H., Kabuto, C., Yamamoto, Y., J. Org. 
Chem. 2005, 70, 4043-4053. 
57
 Olszewska, B., Kryczka, B., Zawisza, A., Tetrahedron, 2013, 69, 9551-9556. 
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Scheme 2. 7. Palladium-catalyzed preparation of vinylpyrrolidines from N-
allylbenzotriazoles 
 
                    
Scheme 2. 8. Palladium and silver-catalyzed hydroamination of allylic halidse or 
alcohols 
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Scheme 2. 9. Pd(0)-catalyzed allylic amination of allyl carbonates 
 
⑵ Ag-catalyzed amination of allenes: In 1983, Arseniyadis and Gore reported 
the selective formation of E-vinyl pyrrolidine from γ-allenic secondary amines by 
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AgNO3-promoted cyclization (Scheme 2.10).58 From 1987, Gallagher and co-workers 
reported comprehensive studies on Ag(I) catalyzed stereoselective synthesis of 
functionalized 5-membered azacycles from protected allenic amines (Scheme 2.11).52, 
59
 AgBF4 was found to be the most efficient catalyst. cis-2,5-disubstitued pyrrolidines 
were the predominant  products due to the bulk of the N-protecting groups. They then 
extended the research to asymmetric preparation of vinyl pyrrolidines by electrophile-
mediated cyclization from allenic amines with chiral protecting groups. In 1991, they 
reported this methodology in a synthesis toward anatoxin A. In 2005, Yamamoto and 
co-workers also developed a silver-catalyzed intramolecular allylic amination to form 
trans-5-vinyl proline esters selectively.56  
Scheme 2. 10. Silver-catalyzed intramolecular hydroamination of allenes 
NHR3
AgNO3
R1
R2 N
R3
R2
R1
R1=R2=H, R3=C3H7, 95%
R1=R2=H, R3=CH2Ph, 79%
R1=R2=H, R3=Ph, 82%
R1=R2=Ch3, R3=C3H7 71%
R1=R2=CH3, R3=CH2Ph, 79%
 
Scheme 2. 11. Gallagher’s development of silver catalyzed intramolecular amination 
to allenes 
 
⑶  Other transition metal-catalyzed hydroamination/cyclization: In 1997, 
Marks and co-workers developed an organolanthanide-mediated hydroamination and 
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 Arseniyadis, S., Gore, J., Tetrahedron Letters, 1983, 24, 3997-4000. 
59
 (a) Kinsman, R., Lathbury, D., Vernon, P., Gallagher, T., J. Chem. Soc., Chem. Commun., 1987, 
243-244. (b) Huby, N.J.S., Kinsman, R.G., Lathbury, D., Vernon, P.G., Gallagher, T.,  J. Chem. Soc., 
Chem. Commun., 1991, 145-155.(c) Davies, I.W., Gallagher, T., Lamont, R.B., Scopes, D.I.C., J. Chem. 
Soc., Chem. Commun., 1992, 335-337.  
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cyclization strategy to synthesize Z-vinyl pyrrolidines as the major products using 
aminoallenes as starting materials (Scheme 2.12).60 The reaction proceeded through 
insertion of the N-lanthanoid metal bond into the internal allenic C-C double bond. 
Diastereoselectivity arises from minimization of steric interaction between the 
methylenes of the amino allene and the bulky Cp* ligands. In 2005, Helmchen and 
co-workers published a highly enantioselective syntheses of trans-2,5-divinyl 
pyrrolidines by intramolecular allylic amination catalyzed by a complex of 
phosphorus amidites and [Ir(COD)Cl]2 (Scheme 2.13).61 In 2008, Okamoto and co-
workers found that intramolecular hydroamination to allenes can also be promoted by 
copper salts, such as CuCl, CuCl2, and Cu(OTf)2 (Scheme 2.14). 62  In 2011, 
Widenhoefer and co-worker developed a AuCl and AgSbF6 co-catalyzed 
intramolecular amination of chiral allylic alcohol with alkylamines and carbamates 
(Scheme 2.15).63                        
Scheme 2. 12. Organolanthanide-catalyzed intramolecular hydroamination 
 
                                               
60
 Arredondo, V.M., McDonald, F.E., Marks, T.J., J. Am. Chem. Soc., 1998, 120, 4871-4872. 
61
 Welter, C., Dahnz, A., Brunner, B., Streiff, S., Dubon, P., Helmchen. G. Org. Lett., 2005, 7, 1239-
1242. 
62
 Tsuhako, A., Oikawa, D., Sakai, K., Okamoto, S., Tetrahedron Letters, 2008, 49, 6529-6532. 
63
 (a) Mukherjee, P., Widenhoefer, R. Org. Lett., 2011, 13, 1334-1337. (b) Mukherjuee, P., 
Widenhoefer, R. Angew. Chem. Int. Ed., 2012, 51, 1405-1407. 
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Scheme 2. 13. Intramolecular Ir-catalyzed allylic amination 
 
                             
Scheme 2. 14. Copper-catalyzed intramolecular hydroamination of allenylamines 
              
Scheme 2. 15. Gold (I)-catalyzed intramolecular amination of allylic alcohol 
 
In addition to nucleophilic addition to pyrrolidinyl iminium ions and transition 
metal-catalyzed intramolecular aminations, several other protocols have also been 
documented make vinyl pyrrolidine compounds. In 1985, Oshima and co-workers 
reported a synthesis of vinyl prolines via palladium-promoted rearrangement of 
dienylaziridine (Scheme 2.16).64 In 1990, Bernotas developed a one-pot strategy for 
the formation of polyhydroxylated vinyl pyrrolidines via a reductive elimination-
reductive amination tandem reaction from bromopyraoside (Scheme 2.17).65 In 2012, 
Stahl and co-workers reported chiral synthesis of N-sulfinyl vinyl pyrrolidines via 
                                               
64
 Fugami, K, Morizawa, Y., Oshima, K., Nozaki, H., Tetrahedron Letters, 1985, 26, 857-860. 
65
 (a). Bernotas, R.C., Ganem, B., Tetrahedron Letters, 1985, 26, 1123. (b) Bernotes, R.C., 
Tetrahedron Letters, 1990, 31, 469-472. 
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palladium-catalyzed aerobic oxidative cyclization of tethered olefins under an O2 
atmosphere (Scheme 2,18).66 The reaction was used to construct common precursors 
of tropane alkaloids. In 2005, Carreira and co-worker reported a total synthesis of 
spirotryprostatin B, in which a vinylic-pyrrolidinyl-spirooxindole core was contructed 
by ring expansion of vinylic cyclopropane (Scheme 2.19).67 In 2008, Avenoza and 
Buston developed a ring-opening-closing metathesis strategy to prepare a various of 
2.5-divinylic prolines (Scheme 2.20).68  [3+2] dipolar cycloaddition of azomethine 
ylides was also used to prepare vinyl pyrrolidine scaffolds. Those reactions were 
promoted either by protic acid or organocatalysts (Scheme 2.21),69 which afforded 
mixtures of stereoisomers. 
Scheme 2. 16. Pd(0) promoted rearrangement of 1,3-butadienyl aziridine to vinyl 2H-
pyrrole 
        
Scheme 2. 17. Synthesis of polyhydroxylated pyrrolidines via reductive elimination-
reductive amination as key steps 
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 Redford, J.E., McDonald, R.I., Rigsby, M.L., Wiensch, J.D., Stahl, S.S. Org. Lett., 2012, 14, 1242-
1245.  
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 Marti, C., Careira, E.E., J. Am. Chem. Soc., 2005, 127, 11505-11515. 
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 Carreras, J., Avenoza, A., Buston, A.H., Peregrina, J.M., J. Org. Chem. 2009, 74, 1736-1739.  
69
 Vicario, J.L. Reboredo, S., Badia, D., Carrillo, L., Angew. Chem. Int. Ed., 2007, 46, 5168-5170. 
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Scheme 2. 18. Synthesis of vinyl pyrrolidines via aerobic oxidative cyclization of 
alkenes 
 
 
Scheme 2. 19. Construction of vinyl pyrrolidine core by ring expansion of 
cyclopropanes 
    
Scheme 2. 20. Avenoza & Buston’s ROCM process to make 2,5-divinylic prolines 
 
Scheme 2. 21. Synthesis of vinyl pyrrolidine by organocatalyzed dipolar 
cycloaddition 
 
2.2.Inspirations from previous research in the Waters group 
During our development of the 2-aza-Cope-rearrangement-[3+2] dipolar 
cycloaddition protocol, we discovered that treating the initial imines generated from 
homoallylic amines and ethyl glyoxylate with AgOAc and Et3N led to the formation 
 34 
of metallated azomethine ylides, which could be trapped by electron-deficient olefins 
to form pyrrolidine products via a [3+2] dipolar cycloaddition (Scheme 2.22). The 
formation of azomethine ylides from unrearranged imines was attributed to the 
increased acidity of the benzylic protons upon coordination of the imine with the 
Lewis acid. The activated benzylic protons became easier to remove by mild organic 
bases, like Et3N.  
Scheme 2. 22. [3+2] dipolar cycloaddition with azomethine ylides formed from 
unrearranged imines 
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2.3.Development of a new entry to azomethine ylides from benzylic and allylic 
amine and glyoxals 
Drawing on those previous discoveries, we realized that this method would 
circumvent the reliance on α-amino esters as ylide precursors, and we decided to 
investigate this methodology for ylide formation more comprehensively. Bearing 
acidic α-carbonyl protons, amino esters are classically employed in the formation of 
ester-stabilized azomethine ylides via 1,2-prototropy or metallation/deprotonation 
process. We postulated that benzylic and allylic amines, which also have acidic 
hydrogens, would also condense with α-dicarbonyl compounds to form azomethine 
ylide precursors. Chelation established by Lewis acid coordination between the ester 
and imine moieties would lower the pKa of the benzylic or allylic protons, which 
without coordination are beyond the reach of most organic bases. A mild amine base 
would therefore be sufficient to permit deprotonation and formation of the azomethine 
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ylide. Subsequent dipolar cycloaddition with a dipolarophile would afford pyrrolidine 
scaffolds bearing an alkenyl moiety for further structural advancement (Scheme 2.23).  
Scheme 2. 23. Proposed [3+2] dipolar cycloaddition with azomethine ylide 
 
Control experiments to access azomethine ylides through classical 
metallation/deprotonation process were also attempted.70  Glycine methyl ester, 
acrolein, AgOAc, Et3N, and phenyl maleimide were reacted, but resulted in a complex 
mixture with no observable cycloadduct. In addition, attempts to preform the imine by 
condensing glycine methyl ester with acrolein failed, only leading to intractable 
mixtures. These observations may be attributed to competitive reactions, such as 1,4-
conjugate addition of the amine to the α,β-unsaturated aldehyde. The labile imine 
arising from glycine methyl ester and acrolein would also undergo decomposition and 
polymerization (Scheme 2.24). 
Scheme 2. 24. Competing processes with the use of α-amino esters and α,β-
unsaturated aldehydes toward azomethine ylides 
 
Therefore, the feasibility of reaching ylide through the new logic was 
investigated. The enhanced electrophilicity of the aldehyde on α-dicarbonyl 
compounds, such as ethyl glyoxylate would promote rapid imine formation, thereby 
satisfying the first criterion for azomethine ylide formation. Pre-formation of the 
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imine was proved by a NMR-tube control reaction with allylamine and ethyl 
glyoxylate in CDCl3, which revealed that clean glyoxylimine formation was achieved 
within 10 minutes. Gratifyingly, addition of Et3N, a catalytic amount of AgOAc, and 
phenyl maleimide into the imine solution effected azomethine ylide formation and 
cycloaddition within 24 hours at room temperature. The desired 5-vinyl proline ester 
was delivered as one diastereomer. The reactivity of benzylamine, which possesses 
acidic protons, was also examined in a same manner. Indeed, azomethine ylide 
generation and [3+2] dipolar cycloaddition provided the expected pyrrolidine 
product.70 Prior to our work, azomethine ylides were generated via the imines of 
secondary benzylic amines and glyoxylates under only thermal, prototropic condition, 
which provided mixtures of stereoisomers with poor selectivity.71  
The reaction conditions were then optimized by using two equivalents of 
glyoxylimine relative to the dipolarophile to avoid the unfavorable conjugate addition 
of pyrrolidine nitrogen onto phenyl maleimide.70 Reactions in different solvents, such 
as MeCN, THF, and PhMe gave comparable yields, so they were selected according 
to substrate solubility. The rationale for the high levels of stereocontrol is threefold: a. 
an energetically favorable ylide conformation in which allylic 1,3-strain is minimized, 
thereby situating the vinyl or aryl groups as depicted (Scheme 2.25), b. a 
conformationally rigid, W-shaped ylide geometry through metal chelation, c. 
favorable endo transition state established between the azomethine ylide and 
dipolarophile.  
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8679-8690. 
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Scheme 2. 25. Origins of stereoselectivity in azomethine ylide formation and 
cycloaddition 
 
To further understand the generality of this reaction which can access 
pyrrolidines beyond the reach of classical protocols, we next investigated the scope of 
the electrophilic component with a variety of allylic and benzylic amines. Based on 
our success with ethyl glyoxylate, we hypothesized that additional α-dicarbonyl 
systems such as arylglyoxaldehydes and heteroarylglyoxaldehydes, each bearing 
functional groups available for both imine condensation and metal coordination, 
should meet the criteria for azomethine ylide formation and would react accordingly. 
Phenyl glyoxal was first selected, which was synthesized via a known procedure from 
acetophenone. Gratifyingly, its ability to furnish azomethine ylides upon condensation 
with amines was successfully demonstrated. Good to excellent yields were obtained 
for phenyl glyoxal as electrophile with all allylic and benzylic amines. The desired 
cycloadducts were isolated as one observable diastereomer.  
Indole glyoxal was next investigated as our specific interest in this electrophile 
centers on its anticipated utility in alkaloid total synthesis. In either MeCN or THF, 
good to excellent yields were again achieved for all entries. Absolute endo-selectivity 
was again observed for each substrate. N-methyl indole glyoxal was used to generate 
the azomethine ylide with prenyl amine due to insolubility of its des-methyl analog.   
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Table 2. 1. Substrate survey of phenyl glyoxal as the α-dicarbonyl electrophile 
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Table 2. 2. Substrate survey of indole glyoxal as the α-dicarbonyl electrophile 
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Isatin was also tested as an electrophile with allylic or benzylic amines and 
phenyl maleimide for the [3+2] dipolar cycloaddition. Unfortunately, a mixture of 
these three substrates in dry toluene did not afford the desired cycloadduct (Scheme 
2.26). We also tried to preform the imines between isatin and amines at either room or 
elevated temperature, into which AgOAc/Et3N and phenyl maleimide were added 
after a certain amount of time (5-24 hours). These reactions also failed to yield any 
pyrrolidine products.  
To increase the solubility and activity of isatin derived azomethine ylides, 
different protecting groups were attached to the isatin nitrogen to afford N-tosyl, N-
benzyl, and N-methyl isatin derivatives (Scheme 2.26).72 These compounds were then 
treated with allylic or benzylic amines to form azomethine ylide precursors. No 
fruitful results were obtained in formation of imines from N-protected isatins or 
following ylide generation and [3+2] dipolar cycloaddition.              
Scheme 2. 26. [3+2] dipolar cycloaddition of isatin-derived azomethine ylide with N-
phenyl maleimide 
 
 
In summary, we presented the first examples of generating azomethine ylides 
from benzylic and allylic amines with glyoxylates and glyoxals, which relieved the 
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reliance on amino acid esters for the formation of such important ylide intermediates. 
We also demonstrated that these 5-vinylpyrrolidines were not readily accessible from 
classical methods of generating azomethine ylides. 18 examples provided good to 
excellent yield of product as single diastereomers. Efforts toward catalytic, 
asymmetric variants and applications in alkaloid total synthesis are currently 
underway. 
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Chapter 3 
 
Application of novel azomethine ylide dipolar cycloaddition: study toward total 
synthesis of borrecapine 
 
3.1.Isolation of borrecapine 
Borrecapine (Figure 3.1) was isolated and characterized in 1977 by Jacquemin 
and co-workers from Guyanese Borreria species as a yellow crystal,73 the melting 
point of which was 203-205 °C. It possesses biologically activities such as anti-tumor 
properties. There is no reported total synthesis route to date.                                            
Figure 3. 1. Borrecapine 
 
3.2.Proposed retrosynthetic route #1 toward borrecapine 
We envisaged that borrecapine could be prepared from 3-acyl pyrrolidine 43 
via a Wittig-like olefination reaction. In turn, compound 43 could be accessed from 3-
acyl-4-tosyl-pyrrolidine by reductive desulfonylation reactions. The key intermediate 
would be assembled using our recently developed azomethine ylide generation and 
[3+2] dipolar cycloaddition from imine 46 and (E)-sulfonyl methacrolein 45.  Imine 
component 46 can easily be obtained from the indole glyoxal 47 and 3-methylbut-2-
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en-1-amine (prenyl amine). The indole glyoxal can be synthesized through an 
established procedure of Friedel-Crafts reaction and nBu3SnH reduction.  
Scheme 3. 1. Proposed retrosynthetic route #1 toward borrecapine 
 
3.3.Forward Synthesis #1 toward borrecapine 
3.3.1. Synthesis of indole glyoxal 47 
To a solution of indole in anhydrous diethyl ether was added freshly distilled 
oxalyl chloride (1.2 equiv.) The resulting yellow crystalline solid acid chloride 50 was 
isolated by filtration, and washed with cold diethyl ether. Acid chloride 50 was treated 
with 1 equivalent of tributyltin hydride in ethyl acetate to provide aldehyde 47 as a 
light yellow solid (Scheme 3.2).          
Scheme 3. 2. Synthesis of N-H indole glyoxal 
 
3.3.2. Sulfonyl dipolarophiles in dipolar cycloadditions 
3.3.2.1. [3+2] dipolar cycloaddition of azomethine ylide with sulfonyl 
dipolarphiles 
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Sulfonyl substituted dipolarophiles have drawn recent attention due to their 
high electron deficiency and functional transformation versatility. Moreover, being a 
stronger electron-withdrawing and a more easily removable substituent compared to 
carbonyl groups, sulfonyl moieties can direct the regioselectivity of [3+2] dipolar 
cycloadditions of azomethine ylides with sulfonyl acrylates which lead to formation 
of 2,3-dicarboxylic ester pyrrolidine molecules.  
In 1988, Kobayashi and co-workers prepared a trifluoromethylated pyrrolidine 
from N-benzylideneglycinate and 1-phenylsulfonyl-3,3,3-trifluoropropene via [3+2] 
dipolar cycloaddition in the presence of LDA at -78 °C (Scheme 3.3).74 In 1989, 
Grigg and co-workers used vinyl sulfones to react with glycine imino esters catalyzed 
by LiBr or AgOAc in the presence of Et3N in DMSO (Scheme 3.4).75  In 2008, 
Fukuzawa and co-workers developed a highly exo-selective and enantioselective [3+2] 
dipolar cycloaddition of azomethine ylides with vinyl sulfones using a 
CuOAc/ClickFerrophos complex as a chiral catalyst (Scheme 3.5).76 Shortly after, 
Wang and co-workers developed an endo-selective asymmetric synthesis of 
pyrrolidine scaffolds through [3+2] dipolar cycloaddition using AgOAc and chiral 
ligand TF-BiphamPhos (Scheme 3.6).77 In 2012, Sansano and co-workers developed 
another enantioselective azomethine ylide dipolar cycloaddition with disulfonyl 
olefins using BINAP-silver salts as chiral catalysts (Scheme 3.7).78 They then applied 
this methodology to the synthesis of key precursors of crispine and harmicine, as well 
as GSK 2nd generation inhibitors of hepatitis C virus. In 2012, Kudryavtsev and co-
                                               
74
 Taguchi, T., Tomizawa, G., Kawara, A., Nakajima, M., Kobayashi, Y., Journal of Fluorine 
Chemistry, 1988, 40, 171-182.  
75
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workers developed a facile aromatization to convert 4-bromo-4-phenylsulfonyl 
proline esters, which were made from phenyl α-bromovinyl sulfones and azomethine 
ylides, into corresponding pyrroles (Scheme 3.8).79           
Scheme 3. 3. Kobayashi’s [3+2] dipolar cycloaddition of azomethine ylide with 
trifluoromethyl phenylsulfonyl dipolarophile 
 
Scheme 3. 4. Grigg’s tandem Michael addition-[3+2] dipolar cycloaddition with 
divinyl sulphone 
 
Scheme 3. 5. Fukuzawa’s enantioselective synthesis of 4-phenylsulfonyl pyrrolidines 
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Scheme 3. 6. Wang’s asymmetric [3+2] dipolar cycloadditions of azomethine ylide 
with β-sulfonyl acrylates 
             
Scheme 3. 7. Sansano’s enantioselective [3+2] dipolar cycloaddition of azomethine 
ylides with disulfonyl olefin 
 
Scheme 3. 8. [3+2] dipolar cycloaddition of azomethine ylide with phenyl α-
bromovinyl sulfone 
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Carretero and co-workers did a comprehensive study of vinyl sulfone 
dipolarophiles in [3+2] dipolar cycloadditions with azomethine ylides, and subsequent 
phenylsulfonyl group transformations. In 2006, they described a general protocol for 
enantioselective [3+2] dipolar cycloaddition of azomethine ylides and vinyl sulfones 
promoted by Cu(CH3CN)4ClO4/Taniaphos as the catalyst system (Scheme 3.9).80 The 
resulting cycloadducts were then converted into 2,5-disubstituted pyrrolidines by 
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reductive desulfonylation. In 2008, they described using bis-sulfonyl ethylene as a 
masked acetylene equivalent in enantioselective [3+2] dipolar cycloaddition catalyzed 
by a Cu(I)/Fesulphos system (Scheme 3.10). 81  The chiral Cu(CH3CN)4PF6/(R)-
Segphos chiral ligands catalyst was also demonstrated by the research group to 
efficiently provide  4-phenylsulfonyl pyrrolidines in excellent exo-diastereoselectivity 
and enantiocontrol. 82   They were able to selectively access exo- or endo- 
multisubstituted pyrrolidines using Segphos-based ligand-controlled Cu(I)-catalyzed 
asymmetric [3+2] dipolar cycloaddition of azomethine ylides with β-phenylsulfonyl 
enones (Scheme 3.11).83 In the same year, they reported a pyrrole and oligopyrrole 
synthesis via sequential [3+2] dipolar cycloaddition of azomethine ylides with 
sulfonyl dipolarophiles/basic elimination/oxidation strategy.84  
Scheme 3. 9. Cu(I)/Taniaphos-catalyzed [3+2] dipolar cycloaddition with vinyl 
sulfones 
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Scheme 3. 10. Cu(I)/Fesulphos-catalyzed [3+2] dipolar cycloaddition with bis-
sulfonyl ethylene 
 
Scheme 3. 11. Cu(I)-catalyzed, ligands-dependant diastereoselective [3+2] dipolar 
cycloaddition with β-phenylsulfonyl enones 
 
 The [3+2] dipolar cycloaddition of azomethine ylides with sulfonyl olefins 
has also served as key steps in the synthesis of the pyrrolidine core of natural products 
and bioactive small molecules. In 2006, Gin and co-workers constructed the 
pyrrolidine moiety of the anti-leukemia alkaloid (-)-deoxyharringtonine by the [3+2] 
dipolar cycloaddition of phenyl vinyl sulfone with an unstabilized azomthine ylide 
generated from O-acylation and C-desilylation (Scheme 3.12). 85  In 2010, Laha 
reported a total synthesis of tropinone which featured the formation of its 8-
azabicyclo[3.2.1]octane skeleton by [3+2] dipolar cycloaddition of an endocyclic non-
stabilized azomethine ylide with phenyl vinyl sulfone (Scheme 3.13).86  
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Scheme 3. 12. Key steps in Gin’s total synthesis of (-)-deoxyharringtonine 
                     
Scheme 3. 13. Key steps in Laha’s total synthesis of tropinone alkaloids 
 
 
3.3.2.2.Synthesis of sulfonyl methacrolein dipolarophile 
According to literature procedures,87 sulfonyl methacrolein was synthesized 
originally from 2-methyl allylbromide 51, which was converted to 2-methyl allylic 
tosylate 52 via SN2 substitution with sodium para-toluenesulfinate. The alkene 
moiety was then epoxidized using mCPBA to form epoxide 53. The epoxide then 
underwent a base-mediated ring opening followed by hydrolysis to form allylic 
alcohol 54, which was then cleanly oxidized to the sulfonyl methacrolein 55 using 
MnO2 (Scheme 3.14).        
Scheme 3. 14. Synthesis of sulfonyl methacrolein dipolarophile 
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3.3.4. Model studies of [3+2] dipolar cycloaddition of allylic imino esters with 
sulfonyl methacrolein 
With the sulfonyl methacrolein 55 in hand as dipolarophile, model studies for 
[3+2] dipolar cycloadditions of azomethine ylides were next explored. Initially, 
allylamine 21 and ethyl glyoxylate 56 were chosen based on commercial availability 
to form the azomethine ylide 58 after chelation with a catalytic amount of 
AgOAc/PPh3 and deprotonation by Et3N. Unfortunately, no cycloadducts were found 
after 24 hour stirring at room temperature and subsequent standard aqueous work-up 
and concentration.  
Indole glyoxal 47 was then used instead of ethyl glyoxylate to form 
azomethine ylide 60 with allylamine under the same reaction conditions. Attempted 
[3+2] dipolar cycloaddtion with sulfonyl methacrolein still did not produce any 
desired pyrrolidine products (Scheme 3.15).  
Scheme 3. 15. [3+2] dipolar cycloaddition of azomethine ylide 58 & 60 with sulfonyl 
methacrolein dipolarophile 55 
 
At this stage, we attributed the lack of reactivity of our allylic azomethine 
ylide with sulfonyl methacrolein to either the incompatibility of the aldehyde 
functionality to the basic reaction conditions (no aldehyde peaks were noticed in 1H-
NMR of crude products) or the lability of the sulfonyl methacrolein compound in the 
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presence of AgOAc and Et3N, or a lack of electron-deficiency in the designed 
dipolarophile.  
3.3.5. Synthesis and application of acetal protected sulfonyl methacrolein 
In order to preserve the aldehyde function for later manipulations, we 
protected the group by converting it to the corresponding acetal with ethylene glycol 
(Scheme 3.16). The desired product was isolated in quantitative yield with no further 
purification necessary.                          
Scheme 3. 16. Protection of aldehyde functionality with ethylene glycol 
 
We next used the protected dipolarophile 61 in the [3+2] dipolar cycloaddition 
with azomethine ylide 58 under the same conditions. Still no desired cycloadduct was 
found and 61 was recovered quantitatively (Scheme 3.17).  
Scheme 3. 17. [3+2] dipolar cycloaddition of azomethine ylide 58 with acetal-
protected sulfonyl methacrolein. 
 
3.3.6. Synthesis of sulfonyl methyl methacrylate dipolarophile 
In order to increase the reactivity of the sulfonyl dipolarophile and mask the 
aldehyde functionality, we decided to further oxidize the aldehyde substituent to an 
ester. We first used previously synthesized sulfonyl methacrolein 55 as starting 
material which was treated again with MnO2 in the presence of NaCN in AcOH and 
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MeOH.88 A mixture of starting aldehyde compound and resulting methyl ester product 
was isolated even after an extended period of time and elevated reaction temperature 
(Scheme 3.18).  
Scheme 3. 18. Oxidation of sulfonyl methacrolein with MnO2/NaCN 
 
With this in mind, we adopted another route 89  to 62 which started from 
methyl methacrylate 63. After stirring with sodium para-toluenesulfinate and iodine 
for 3 days at room temperature, methyl methacrylate was transformed to quaternary 
iodo-intermediate 64 via iodosulphonylation. Compound 64 was then efficiently 
converted to the desired tri-substituted trans-olefin 62 via dehydroiodination under 
basic conditions (Scheme 3.19).   
Scheme 3. 19. Synthesis of sulfonyl methyl methacrylate via 
iodosulphonylation/dehydroiodination 
 
3.3.7. Model study of [3+2] dipolar cycloaddition of allylic imino esters with 
sulfonyl methyl methacrylate 
Sulfonyl methyl methacrylate 62 was then used as the dipolarophile in the 
[3+2] dipolar cycloaddition of allylic azomethine ylide 58 generated from allyl amine 
and ethyl glyoxylate under same reaction conditions described previously 
(AgOAc/PPh3/Et3N). Pyrrolidine cycloadduct 65 was isolated after 24 hours stirring 
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at room temperature (Scheme 3.20), the structure of which was confirmed by 1H, 13C, 
2D-COSY NMR studies (Figure 3.2).  
Scheme 3. 20. [3+2] dipolar cycloaddition of azomethine ylide 58 with sulfonyl 
methyl methacrylate 62 
 
Scheme 3. 21. Competitive isomerization of sulfonyl methyl methacrylate. 
                                                       
Figure 3. 2. 2D-COSY interaction between α-carbonyl and methylene protons 
 
To form the observed isolated product 65 by [3+2] dipolar cycloaddition, 
dipolarophile 66 must have been involved instead of the sulfonyl methyl methacrylate 
62.  Review of the literature revealed that sulfonyl methyl methacrylate 62 is prone to 
base-promoted isomerization to form the more stabilized geminal di-substituted 
alkene 66 (Scheme 3.21).90  
This evidence indicated that the initially-added sulfonyl methacrolein 62 most 
likely isomerized to the di-substituted olefin 66 before engaging in the [3+2] dipolar 
cycloaddition with allylic azomethine ylide 58. It also suggested that the expected 
reaction between the azomethine ylide and sulfonyl methyl methacrylate 62 must be 
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too sluggish compared to the competitive isomerization process and subsequent 
cycloaddition. Therefore, the sulfonyl methyl methacrylate 62 would prefer to 
undergo this alternative route to form the observed product 65.  
3.3.8. Synthesis of sulfonyl ethyl acrylate dipolarophile  
To avoid the unwanted isomerizaton, we decided to utilize a 1,2-disubstituted 
alkene such as 69, as a potential solution. We anticipated that the [3+2] dipolar 
cycloaddition of our azomethine ylide and disubstituted sulfonyl acrylate would 
deliver the desired regioisomer, in which the quaternary center of borrecapine could 
be generated by an enolate methylation in a separate step. To these ends, we then 
attempted the synthesis of sulfonyl ethyl acrylate 69. A similar strategy was adopted 
using ethyl acrylate as starting material.89 The desired 1,2-disubstituted sulfonyl 
acrylate 69 was successfully obtained via an iodosulphonylation-dehydroiodination 
reaction (Scheme 3.22). 
Scheme 3. 22. Synthesis of sulfonyl ethyl acrylate 69 
 
3.3.9. Model Studies of [3+2] dipolar cycloaddition of allylic imino esters with 
sulfonyl ethyl acrylate 
The model study of dipolar cycloaddtion was first carried out using the same 
azomethine ylide 58 formed by condensation of allylamine with ethyl glyoxylate and 
the sulfonyl ethyl acrylate under the previously described conditions. A mixture of 3 
stereoisomers was isolated with a total of 90% yield, one of which was isolated by 
flash column chromatography.   
 55 
Scheme 3. 23. [3+2] dipolar cycloaddition of azomethine ylide 58 with sulfonyl ethyl 
acrylate 69 
 
To determine the regioselectivity of this [3+2] dipolar cycloaddition with an 
asymmetric dipolarophile, we designed a base-promoted elimination reaction which 
would be able to convert sulfonyl pyrrolidines to 2H-pyrroles or even fully 
aromatized pyrroles. Such molecules can be utilized to identify  the regioselectivity of 
the original [3+2] dipolar cycloaddition by 2D-COSY or NOE NMR studies.  
Three stereoisomeric pyrrolidine products were divided into two groups, one 
of which contained two inseparable isomers. Both groups of compounds in 
chloroform were treated with 1 equivalent of DBU, and then heated at reflux for 4 
hours (Scheme 3.24). The resulting crude material was purified by column 
chromatography. Only one 2H-pyrrole product 70 was isolated and characterized 
from the group containing two inseparable isomers. The results from NMR analysis of 
the elimination product proved that the two starting isomeric compounds are 
diastereomers, each bearing ethyl esters on the 4th position of the pyrrolidine ring. 
From the other reaction was isolated 2H-pyrrole 71 with the ethyl ester functionality 
on the 3rd position, which must have originated from pyrrolidine with reversed 
regioselective cycloaddition.              
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Scheme 3. 24. Base-promoted elimination of sulfonyl group: conversion of 
pyrrolidines to 2H-pyrroles 
                             
Figure 3. 3. 1D-NOE enhancements of compound 72 
 
Using the purified pyrrolidine compounds from [3+2] dipolar cycloaddition, 
we next assigned the 4 stereocenters on the ring by NOE studies. Previous 
assignments of the relative diastereoselective outcome of 2-aza-Cope-[3+2] dipolar 
cycloadducts were compared. The allylic protons displayed a 3% NOE enhancement 
with the α-sulfonyl proton, which is much stronger than the known trans-pair of 
protons (shown as 1% enhancement on NOE spectrum). These results indicated that 
Ha and Hb were positioned on the same face of the pyrrolidine ring (Figure 3.3). To 
reach this product, the dipolar cycloaddition went through the desired endo-transition 
state.                   
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Figure 3. 4. Stereo-outcome of the [3+2] dipolar cycloaddition of azomethine ylide 
58 with sulfonyl ethyl acrylate 69 
 
We also reacted sulfonyl ethyl acrylate 69 with the azomethine ylide 60 
generated from indole glyoxal and allylamine under the same reaction conditions. 
After stirring at room temperature for 24 hours, two pyrrolidine products were 
isolated in a total of 96% yield (Scheme 3.25). We next utilized a similiar strategy to 
identify the regioselectivity of the [3+2] dipolar cycloaddition. Each compound in 
toluene was treated with 2 equivalents of DBU, at 70 °C for 4 hours (Scheme 3.26).  
Fully aromatized pyrrole molecules were isolated. NOE studies were performed on 
each compound. The key through-space NOE enhancement between the 2-H of the 
indole moiety and the 2-H of the pyrrole was observed on compound 75 (Figure 3.5). 
This interaction was not seen on compound 76. These NMR structural analyses 
indicated that the pyrrolidines were formed as 2 regio-isomers with a ratio of 0.9:1.  
Scheme 3. 25. [3+2] dipolar cycloaddition with azomethine ylide 59 and sulfonyl 
ethyl acrylate 69 
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Scheme 3. 26. Base-promoted elimination of sulfonyl group and oxidation: 
conversion of pyrrolidine to pyrrole 
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Figure 3. 5. 1D-NOE enhancement of pyrrole product 75 
                          
Figure 3. 6. Stereo-outcome of [3+2] dipolar cycloaddition of azomethine ylide 60 
with sulfonyl ethyl acrylate 69 
 
3.4. Proposed retrosynthetic route #2 toward borrecapine 
The low reactivity or regioselectivity of sulfonyl acrolein and acrylates with 
azomethine ylides formed from allylamine and glyoxals or glyoxylates prompted us to 
develop more effective dipolarophiles with stronger directing groups. Nitro olefins 
have one of the most electron-withdrawing groups and can be used as dipolarophiles 
in [3+2] dipolar cycloaddition with azomethine ylides, though the concertedness of 
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the cycloaddition remains uncertain. Based on these considerations, we elected to 
install a nitro group in the dipolarophile to replace the sulfonyl functionality. With the 
nitro group on the alkene, increased electron-deficiency and thus regioselectivity were 
expected. 
Our retrosynthetic plan for using nitro olefins was approximately the same to 
the one with sulfonyl dipolarophile, except that the methylene moiety on the 
pyrrolidine ring would be installed by removal of the –NO2 group using nBu3SnH 
(Scheme 3.27).             
Scheme 3. 27. Proposed retrosynthetic route #2 toward borrecapine 
 
3.5. Forward synthesis #2 toward borrecapine 
3.5.1. Synthesis of the nitro methyl methacrylate dipolarophile 
Tri-substituted nitro olefin synthesis was first attempted using a traditional 
addition/elimination strategy.91 To a solution of methyl pyruvate 81 in nitromethane 
was added triethylamine. The desired nitro alcohol 82 was isolated in quantitative 
yield, which was then mesylated followed by base-promoted elimination. Two 
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conformational isomers were isolated with a 9:1 ratio (Scheme 3.28). Unfortunately, 
the major isomer was found by NOE studies to be the unwanted cis product 83.  
Scheme 3. 28. Preparation of nitro methyl methacrylate by addition/elimination 
process 
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We then started from methyl methacrylate following a radical nitration 
process.92  This one-pot method allowed stirring methyl methacrylate with sodium 
nitrite in AcOH/H2O/PhH co-solvent (Scheme 3.29). However, this reaction never 
went to completion even after prolonged time with a substantial excess of 
NaNO2/AcOH. We attributed this incompletion to the volatility and instability of the 
HNO2 generated from NaNO2 with acid. Gratifyingly, though in low conversion, the 
only tri-substituted nitro olefin was the desired trans product.                            
Scheme 3. 29. Preparation of nitro methyl methacrylate 57 from methyl methacrylate 
 
3.5.2. Model study of [3+2] dipolar cycloaddition of allylic imino ester with nitro 
methyl methacrylate 
With the nitro dipolarophile in hand, we soon applied it in the [3+2] dipolar 
cycloaddition with azomethine ylide 58, generated from allylamine and ethyl 
glyoxylate, in the presence of AgOAc, PPh3, and Et3N. No indication of the desired 
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cycloadducts was observed by crude 1H-NMR spectroscopy after stirring for 24 hours 
at room temperature (Scheme 3.30). This result is due to a similar reason: the tri-
substituted nitro methyl acrylate 84 underwent base-promoted isomerization to form 
the more stable di-substituted olefin 85 (Scheme 3.31).93  This molecule not only 
possesses an electron-deficient C-C double bond, but also a highly acidic methylene 
H-atoms which are easily deprotonated by Et3N. These active protons would increase 
the likelihood of side reactions.  
Scheme 3. 30. [3+2] dipolar cycloaddition of azomethine ylide 58 with nitro methyl 
methacrylate 84 
                                   
Scheme 3. 31. Competitive isomerization of nitro methyl methacrylate 84 
 
Surprisingly, when switching to inorganic bases, such as K2CO3, KOH, and 
KOtBu, some desired cycloadducts were observed in crude 1H-NMRs, and purified by 
flash column chromatography with low yields (up to 18%). Yields of this reaction 
were slightly increased corresponding to the increase of basicity from K2CO3 to 
KOtBu (Table 3.1). The reason for this trend is uncertain. One possible explanation 
could be that the [3+2] dipolar cycloaddition was accelerated with a stronger base like 
KOtBu, which made the reaction faster to compete with isomerization of the 
dipolarophile.            
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Table 3. 1. [3+2] dipolar cycloaddtion of azomethine ylide 58 and nitro methyl 
methacrylate 84 with different bases 
 
Although low yielding, this material was carried forward utilizing azomethine 
ylide 60 generated from allylamine and indole glyoxal under the same reaction 
condition. This reaction did not to provide any expected cycloadducts. Instead, 
Michael addition product 87 between allylamine and nitro methyl methacrylate was 
isolated as the major product (Scheme 3.32). As the same equivalents of allylamine 
and indole glyoxal were added to pre-form the imine by stirring at room temperature 
for 0.5 hour (sufficient time proved by control reaction in NMR tube), no allylamine 
should remain in the mixture. Therefore, we proposed a plausible mechanism of 
formation for the  Michael product. The imine nitrogen, as the Michael donor, 
attacked the highly activated Michael acceptor, which was the nitro methyl acrylate, 
to form an iminium ion intermediate. This intermediate could easily be hydrolyzed to 
give the observed product.  
 63 
Scheme 3. 32. Michael addition of allylamine to nitro methyl methacrylate 
 
3.5.3. Synthesis of nitro ethyl acrylate dipolarophile 
To prevent the occurrence of competitive isomerization, we also synthesized 
di-substituted nitro olefin 90 (Scheme 3.33). Starting from ethyl acrylate, 
nitromecuration product 88 was isolated after treatment with mercury (II) chloride 
and sodium nitrite. The mercury chloride functionality was then replaced by bromide 
using bromine in H2O/Et2O. Dehydrobromination of compound 89 gave rise to the 
nitro ethyl acrylate 90 in 63% yield after recrystalization.  
Scheme 3. 33. Synthesis of nitro ethyl acrylate 
 
3.5.4. Model study of [3+2] dipolar cycloaddition of allylic imino glyoxal with 
nitro ethyl acrylate 
When we used the nitro ethyl acrylate 90 as the dipolarophile in [3+2] dipolar 
cycloaddition with azomethine ylide 60 generated from allylamine and indole glyoxal, 
the Michael adduct 91 between allylamine and nitro olefin was again isolated 
(Scheme 3.34). We concluded that the engagement of indole glyoxal-derived 
azomethine ylide 59 in [3+2] dipolar cycloaddition with nitro olefins was not as 
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efficient as it acting as a nucleophile in the Michael addition. Hence the reaction went 
through the preferred Michael pathway to solely form the observed product 91.  
Scheme 3. 34. Michael addition of allyl amine to nitro ethyl acrylate 90 
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3.6. Proposed retrosynthetic route #3 toward borrecapine 
As we were not able to selectively synthesize good amounts of the key 
pyrrolidine intermediate by [3+2] dipolar cycloaddition using sulfonyl or nitro olefins 
as the dipolarophile, we next elected to explore the activity of the azomethine ylide. It 
is well known that stabilized azomethine ylides can be generated from α-imino esters 
by coordination with Lewis acid followed by base-promoted deprotonation. The 
acidity of the α-hydrogen atom is a key parameter in terms of whether or not this 
process occurs, or how efficient this process will be. To facilitate deprotonation of the 
α-proton, one could employ stronger bases than Et3N, like LDA or Li-HMDS. 
However, this can also cause problems afterwards, such as epimerization of syn-
proline esters into anti-cycloadducts. According to the unique structure of our 
azomethine ylide precursors, we envisioned that by adding an electron-withdrawing 
group on indole nitrogen, the resulting negative charge created by deprotonation could 
be better stabilized, which in turn would make the α-proton easier to be removed by 
mild bases.  
To fulfill this goal, we elected to use N-tosyl indole glyoxal as one of the 
building blocks. We expected that the generation of the azomethine ylide should be 
more facile, so sulfonyl methacrolein 55 was still our primary option for the 
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dipolarophile, because C-sulfonyl and N-sulfonyl groups could be removed by 
reductive conditions. 
3.6.1. Synthesis of N-tosyl indole glyoxal 
The synthesis of N-tosyl indole glyoxal was no precedent. Therefore, we 
designed a route starting from indole, which was converted to N-tosylated indole 92 
in the presence of TsCl and KOH. Toluene and H2O were used as co-solvent, and 
tetrabutylammonium sulfate was added as phase transfer catalyst. A quantitative 
amount of N-tosyl indole 92 was isolated by recrystalization from 100% ethanol as a 
white powder, which was then treated with acetic anhydride and anhydrous AlCl3 in 
DCM. N-tosyl-3-acetyl indole 93 was obtained by Friedel-Crafts acylation. The 
purified product was isolated in 85% yield by recrystalization from 95% ethanol. The 
acetyl group was then oxidized to the desired α-keto aldehyde by SeO2 under Riley’s 
condition. The final product 94 was isolated as a mixture of the expected glyoxal and 
its monohydrate after flash column chromatography (Scheme 3.35). We demonstrated 
that this isolated mixture did not effect the formation of imine with allylamines by 
running control reactions in an NMR-tube.  
Scheme 3. 35. Synthesis of N-Tosyl indole glyoxal 
 
3.6.2. Model study of [3+2] dipolar cycloaddition of allylic imino N-tosyl glyoxal 
with sulfonyl methacrolein and sulfonyl methyl methacrylate 
Tosylation of the nitrogen on indole glyoxal not only facilitated the formation 
of its azomethine ylides, but also increased its solubility in toluene. In the presence of 
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AgOAc/PPh3 and Et3N, these ylides were successfully coupled with both sulfonyl 
methacrolein 55 and sulfonyl methyl methacrylate 62 dipolarophiles to yield highly 
functionalized 5-vinyl porrolidines 96 and 97, which were purified as single 
stereoisomers by column chromatography (Scheme 3.36). 
Scheme 3. 36. [3+2] dipolar cycloaddition of azomethine ylide 95 with sulfonyl 
methacrolein 55 and sulfonyl methyl methacrylate 62.  
  
We next attempted to identify the regioselective outcome of this [3+2] dipolar 
cycloaddition. By alkylation of the pyrrolidine nitrogen on 96 with benzyl bromide 
(Scheme 3.37), two separate spin systems could be created, which made the structural 
analysis much easier by 2D-TOCSY NMRs. From the information provided by 2D-
NMR spectroscopy we noticed that 3 olefinic protons and 1 allylic proton coupled to 
each other, and the α-carbonyl and α-sulfonyl protons also interacted with each other. 
Therefore, the 3-acetyl indole substituent and the sulfonyl group should reside on the 
same side of the pyrrolidine ring of 98, and the vinyl group was connected to the α-
carbon adjacent to the quaternary center. Unfortunately, the structure of these isolated 
regioisomers is opposite to the outcomes we predicted.  
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Scheme 3. 37. Alkylation of pyrrolidine nitrogen and spin systems by 2D-Tocsy 
NMR 
 
To rationalize this regioselective outcome, we postulated hypothesized that the 
azomethine ylide 95 formed from N-tosyl indole glyoxal and allylamines is possibly 
electronically different from the ones generated from amino acid esters and aromatic 
aldehydes. Allylic hydrogens are deprotonated to create negative charge in the former 
case, while for the latter ylide, α-carbonyl protons are removed to install the negative 
charge. Therefore, reversed electron affinity patterns can be drawn for each 
azomethine ylide, which will lead to opposite regioselective outcomes.   
Scheme 3. 38. Comparison of methods of generating azomethine ylides 
 
The two ylides’ precursors (imines) are interchangeable through base-
catalyzed 1,3-proton shift. Similar examples were reported by Soloshonok and co-
workers for transformation of fluoro-substituted ketones to corresponding amino 
derivatives (Scheme 3.39). We proposed that when initial imine 99 is formed, it can 
either undergo the [3+2] dipolar cycloaddition with sulfonyl dipolarophile in the 
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presence of AgOAc/PPh3 and Et3N to form the observed regioisomer 96, or go 
through 1,3-proton transfer toward the secondary imine 100, which is also able to 
couple with the same dipolarophile under the same condition to furnish another 
regioisomer 101 (Scheme 3.40).                  
Scheme 3. 39. Amination by 1,3-proton shift 
 
 
Scheme 3. 40. Hypothesis to rationalize the regioselective outcome of [3+2] dipolar 
cycloaddition of azomethine ylides and sufonyl methacrolein 55 
 
3.6.3. Model study of [3+2] dipolar cycloaddition of allylic imino N-tosyl glyoxal 
with methacrolein and methyl methacrylate 
Providing that the reaction proceeds through the pathway we assumed, 
methacrolein or methyl methacrylate can be utilized to replace the sulfonyl 
dipolarophiles toward the total synthesis of borrecapine. Under the same reaction 
conditions, both of these two dipolarophiles were successfully incorporated in [3+2] 
 69 
dipolar cycloaddition with N-tosyl indole glyoxal derived azomethine ylide to yield 
2H-pyrrole products 102 and 103 (Scheme 3.41).  
Scheme 3. 41. [3+2] dipolar cycloaddition of azomethine ylide 95 with methyl 
methacrylate and methacrolein 
 
What we also isolated, though in less amount, was imidazole adduct 104 
formed by a competitive self-dipolar cycloaddition of azomethine ylide and further 
oxidation (Scheme 3.42). Therefore, we used a large excess amount of methacrolein, 
and added the imine solution dropwise into the mixture of methacrolein, AgOAc/PPh3 
and Et3N in toluene via syringe pump. The side reaction was then mostly prohibited 
by following this strategy. The desired cycloadducts were isolated by column 
chromatography in 45% yield.                       
Scheme 3. 42. Competitive formation of imidazole via dimerization of the azomethine 
ylide 
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We next performed NMR studies to identify the regioselective and 
diastereoselective outcomes (Figure 3.7). From 2D-COSY NMR spectrum we 
observed a strong coupling between the allylic proton and one of the methylene 
protons. We initially attributed this abnormal coupling pattern to the structural rigidity 
of 2H-pyrrole ring, and concluded that we arrived at the desired regioisomer.  1D-
NOE NMR results confirmed the that allylic proton, the methyl group, and one of the 
methylene hydrogens resided on the same face of 2H-pyrrole ring, which implied the 
reaction went through an endo-transition state as expected.             
Figure 3. 7. Initial 1D-NOE and 2D-COSY NMR studies of cycloadduct 103 
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3.6.4. Forward synthesis toward borrecapine #1 
Encouraged by those results, we elected to begin our investigation on  the first 
total synthesis of borrecapine (Scheme 3.43). We used prenylamine 48, N-tosyl indole 
glyoxal 94, and methacrolein as building blocks to contruct key 5-memberd aza-cyclic 
intermediate 105. The N-tosyl group was then cleanly removed in the sponification 
condition using KOH in methanol. Wittig reaction was next utilized to install the 
terminal alkene moiety from aldehyde. Five equivalents of phosphorus ylide was 
generated from nBuLi and triphenylphosphine methylbromide, into which the starting 
aldehyde was added and stirred overnight. Desired 3,5-divinyl 2H-pyrrole 107 was 
isolated in 85% yield, which was then reduced to saturated the pyrrolidine by NaBH4 
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to afford a mixture of diastereomers 108 and 109 in 99% overall yield. These two 
compounds could be separated using column chromatography, and shown as 1:1 ratio.            
Scheme 3. 43. Forward synthesis #1 toward borrecapine 
 
However, when we attempted to confirm the stereochemistry of the final 
pyrrolidine products 108, the allylic proton was found to couple with neither of the 
two methylene protons by 2D-COSY NMR spectroscopy. This observation was not 
corresponding to our initial assignment of regioselective outcome using 2H-pyrrole 
cycloadduct 105. This new identification was further demonstrated by 2D-HMBC 
NMR studies. By extensive study of 2D-COSY NMR spectroscopy (Figure 3.8), we 
ascribed the correlation of the allylic proton with one of the methylene protons in the 
starting 2H-pyrrole to an unusual W-shaped coupling, which is also sometimes 
observable by 2D-COSY NMRs. By drawing the 2H-pyrrole in three dimensions, we 
could clearly see that the allylic proton was perfectly aligned with one of the 
methylene protons in W-shape. These also rationalized why we only saw that the 
allylic proton coupled to only one of the methylene protons, but not to the other. The 
synthetic route (Scheme 3.43), therefore, needs to be corrected (Scheme 3.44).  
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Scheme 3. 44. Corrected synthetic route toward borrecapine-like molecules 
 
Figure 3. 8. 2D-COSY NMR studies of pyrrolidine product 108 and corrections of the 
structure 2H-pyrrole 105 to 105’ 
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Though discouraged by the misleading assignments, this stereochemical 
outcome challenged our hypothesis in the following aspects: a) In the [3+2] dipolar 
cycloadditions with sulfonyl methacrolein and sulfonyl methyl methacrylate 
dipolarophiles, the aldehyde and methyl ester groups act as regioselective directors 
instead of the sulfonyl functionalities. b) Though being created by removal of 
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different protons (allylic or α-carbonyl), the negative charge should still be able to 
delocalize through the 1,3-allylic system to form similar azomethine ylides with 
identical electron affinity pattern.  
3.7. Proposed retrosynthetic route #4 toward borrecapine 
Because of the ineffectiveness of sulfonyl functional groups as regioselective 
directors, we elected to start with [3+2] dipolar cycloaddition with different 
azomethine ylides and methacrolein to form pyrrolidine intermediate 111, which 
would be treated with KOH in methanol to remove the tosyl group on the indole 
nitrogen, and further oxidized using OsO4/NaIO4 to convert the alkene to ketone 112. 
Quaternary vinyl group 113 would be accessed through Wittig reaction from the 
aldehyde 112, the feasibility of which has been proved by previous results.  The 
prenyl moiety would then be constructed from the ethyl ester group on 113 by a redox 
process and Wittig olefination, which would then afford the alkaloid (Scheme 3.44).          
Scheme 3. 45. Proposed retrosynthetic route #3 toward borrecapine 
 
3.7.1. Synthesis of 2-(N-tosyl indolyl)-allylamine 
There are reliable report of preparation of 2-(N-tosyl indolyl)-allylamine 110. 
We designed a route featuring separated synthesis of two building blocks, which are 
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then connected by Suzuki coupling reaction. Gabriel synthesis conditions were 
utilized to prepare the first block from potassium phthalimide 116 and 2,3-dibromo-1-
propene 117. 95% of purified product 118 was isolated by column chromatography. 
The second building block was synthesized from indole, which was converted to N-
tosyl indole using previously described conditions. The N-tosyl indole was then 
treated with mercury (II) acetate and percholoric acid in a solution of acetic acid. 
Desired product 119 was isolated as a white powder by aqueous trituration and 
vacuum filtration. The solid was then stirred with borane in THF at room temperature 
to afford the desired N-tosyl indole boric acid 120 in 45% over two steps (Scheme 
3.45).  
Scheme 3. 46. Synthesis of Suzuki coupling building blocks 
 
 
With two essential subunits in hand, we next applied them in a Suzuki reaction 
catalyzed by Pd(PPh3)4. The cross coupling reaction proved to be highly efficient to 
prepare phthalimide protected allylic amine 121 in 90% yield which was then 
deprotected by hydrazine hydrate in 100% ethanol to afford the 2-(N-tosyl indolyl)-
allylamine 110 in 60% yield as a yellowish thick oil (Scheme 3.46).  
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Scheme 3. 47. Synthesis of N-tosyl indole allylic amine by Suzuki coupling and 
deprotection 
 
3.7.2. Model study of [3+2] dipolar cycloaddition of azomethine ylide derived 
from 2-(N-tosyl indolyl)-allylamine 
After successful preparation of 2-(N-tosyl indolyl)-allylamine, this compound 
was immediately used to condense with ethyl glyoxylate to form the imine, which was 
then corrdinated with AgOAc/PPh3, and deprotonated by Et3N to afford the 
azomethine ylide. This ylide then coupled with methacrolein in [3+2] dipolar 
cycloaddition, out of which endo cycloadduct 122 with desired regioselective 
outcome was isolated. This pyrrolidine product with 3-formyl functionality was 
reported to be labile at ambient environment as we observed. Several solvent systems 
for chromatography were attempted, none of which provided the isolated product with 
acceptable purity. We, therefore, constructed a solution to solve this problem: reduce 
the aldehyde group to primary alcohol. The collected product after column 
chromatography was treated with NaBH4 in ethanol. The desired pyrrolidine 123 with 
a primary alcohol group was isolated in 30% yield over two steps (Scheme 3.47). This 
compound was then utilized to assign the stereochemical centers by 2D-COSY and 
1D-NOE studies, the results of which showed that the desired stereoisomer was 
finally synthesized.  
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Scheme 3. 48. [3+2] dipolar cycloaddition of azomethine ylide with methacrolein 
 
3.7.3. Forward synthesis of borrecapine #2 
Having the correct diastereo- and regio-isomer in hand, we next carried it 
forward to investigate another key transformation: oxidation of the alkene to a ketone. 
Except for compound 123, several other pyrroldines with protecting groups on 
nitrogen or hydroxyl oxygen were also prepared as starting alternatives (Scheme 3.48). 
A variety of combinations of oxidative reagents were tested on these starting materials. 
For example, compound 123 was firstly treated with OsO4/NMO in THF/tBuOH/H2O, 
and then Pb(OAc)2 in EtOAc. No desired ketone products were observed by crude 1H-
NMR. When applying similar conditions to the protected pyrroldines, mostly starting 
materials were recovered. We attributed this inactivity to the steric hindrance created 
by the Boc-protecting group on the pyrrolidine nitrogen. Stronger oxidants, like RuCl3, 
will not improve the reaction, but led to decomposition of starting material. 
Ozonolysis conditions were again proved to be incompatible with molecules bearing 
indole moieties. When compound 127 was used to be oxidized by OsO4/NaIO4 with 
the presence of 2 equivalents of 2,6-lutidine, oxidation was likely to occur on 
unprotected primary alcohol to form a lactam.  
Scheme 3. 49. Protecting groups attachement and functional groups manipulation 
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3.8. Future directions 
The results from oxidation reactions indicate that: a) Mild oxidative conditions 
must be used due to the fragility of pyrrolidine starting material. b) A Boc-protecting 
group is too large for the OsO4 to approach the alkene. Smaller N-protecting groups 
need to be considered. c. The ethyl ester on the 2nd position of pyrrolidine ring cannot 
be reduced to a primary alcohol before the OsO4 oxidation.  
Based on these conclusions, we will in the future work on the revised route 
toward borrecapine, in which the pyrroldine nitrogen will be protected by smaller 
methyl carbamate. We expect that the smaller protecting group will be able to provide 
space for OsO4 to reach the alkene, and then furnish the ketone functionality. 
Reduction and re-oxidation of ethyl ester will be preformed after removal of the N-
tosyl group. Wittig reactions will be utilized to construct two olefin moieties, which 
will conclude the total synthesis of borrecapine.  
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Chapter 4 
Additional Investigations of 2-Aza-Cope Rearrangement and [3+2] Dipolar 
Cycloaddition 
4.1.Decarboxylative generation of azomethine ylides: synthesis of pyrrolidine 
scaffolds via 2-aza-Cope-rearrangement-[3+2] dipolar cycloaddition 
Based on the successful utilities of the aza-Cope rearrangement and [3+2] dipolar 
cycloaddition in the formation of carbon bonds, we initially desired to develop a new 
methodology with secondary homoallylic amines involving the two reactions 
sequentially. The cascade reaction featured three major steps: the condensation of 
secondary homoallylic amine (Scheme 4.1) with ethyl glyoxylate first affords an 
initial iminium ion, which would immediately undergo aza-Cope rearrangement to 
provide a second iminium ion. In the presence of a mild base, the resultant iminium 
ion is readily deprotonated to provide azomethine ylide tautomers, which is then 
trapped by electron-deficient olefins to furnish pyrrolidine products. Unfortunately, 
we were unable to isolate the desired product due to the inability to generate 
azomethine ylides with these secondary amines.          
Scheme 4. 1. Synthesis of N-benzyl-2-phenyl homoallylic amine 
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Scheme 4. 2 Attempted 2-aza-Cope-[3+2] dipolar cycloaddition from N-benzyl-2-
phenyl homoallylic amine 
//
 
These results prompted us to investigated alternative methods of azomethine ylide 
formation. Condensation of the 2-phenyl homoallylic amine and glyoxylic acid 
resulted in oxazolidone intermediate after cationic 2-aza-Cope rearrangement. The 
oxazolidone then lost a molecule of CO2 to generated an unstabilized azomethine 
ylide, which was then trapped by N-phenyl maleimide to form the tetra-substituted 
pyrrolidine in 28% percent yield. Further optimization of this reaction was not 
performed. 
Scheme 4. 3. Decarboxylative 2-aza-Cope-rearrangement-[3+2] dipolar cycloaddition 
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4.2.Formation of azomethine ylide from amino acid esters and aqueous 
formaldehyde catalyzed by AgOAc/Et3N at room temperature 
Though more functional groups on our pyrrolidine scaffolds could present 
convenient points for further structural advancements, 5-unsubstituted-2-quantenary 
pyrrolidine moieties are also found in the structures of numerous pharmaceutical 
reagents and natural products. Lewis acid catalyzed [3+2] dipolar cycloaddition of 
azomethine ylides can be considered one of the most powerful and reliable methods 
for the geometrically selective synthesis of 5-membered N-heterocyclic systems. 
Therefore, when construction of 5-unsubstituted proline esters is required, [3+2] 
dipolar cycloaddition remains the primary choice in most cases, in which 
paraformaldehyde is used to form the imine via condensation with amino esters at 
raised temperatures. Azomethine ylides are then generated through thermally 
promoted 1,2-prototropy, and trapped by electron deficient dipolarophiles to yield 5-
unsubstituted pyrrolidines as a mixture of diastereomers. External heat is necessary 
for the generation of azomethine ylide, but can also erode the stereoselectivity of [3+2] 
dipolar cycloaddition. Hence the development of a stereo-controlled reaction which 
can be efficient under mild conditions is in demand.  
We found that in the presence of AgOAc/PPh3 and Et3N, aqueous formaldehyde 
could be used instead of paraformaldehyde to condense efficiently with a variety of 
amino acid esters at ambient temperature. The presence of water did not interfere with 
the formation of imine or the following generation of the azomethine ylide. Excellent 
yields and diastereoselectivity were obtained.  
 
 
 
 81 
 
Table 4. 1.  [3+2] dipolar cycloaddition with amino acid esters and aqueous 
formaldehyde 
 
Entry Amino acid esters Solvent Products Yield (%)a 
1 
 
 
 
THF 
 
 
 
87 
2 
 
 
 
THF 
 
 
 
78 
3 
 
 
 
THF 
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a. isolated yield by flash column chromatography 
 
4.3.Development of camphorsulfonic acid catalyzed 2-aza-Cope rearrangement 
and [3+2] dipolar cycloaddition 
Though the 2-aza-Cope rearrangement-[3+2] dipolar cycloaddition one-pot 
protocol had been realized by thermally promoted sigmatropic rearrangement and 
subsequent metallated azomethine ylide generation at ambient temperature,35 this 
process cannot be defined as a cascade reaction in the strict sense due to their distinct 
requirements of separate reaction conditions. AgOAc was demonstrated as a highly 
NH2
CO2Et
134
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efficient Lewis acid to catalyze azomethine ylide formation and [3+2] dipolar 
cycloaddition, but inert to promote 2-aza-Cope rearrangement at room temperature. 
The equilibrium of the [3,3]-sigmatropic rearrangement shifted to the 
thermodynamically more favorable product due to better conjugate interaction 
between the phenyl group and imine π bond, not because of the trapping of 
azomethine ylide generated from rearranged imine by subsequent [3+2] dipolar 
cycloaddition.  
To our knowledge, the activation energy of the 2-aza-Cope rearrangement can be 
substantially lowered by installation of a cationic charge on the nitrogen atom within 
the framework. In the traditional cationic 2-aza-Cope mode, the iminium ion is 
obained by condensation of a secondary homoallylic amine with an aldehyde, or by 
ionization of corresponded imine by Brønsted or Lewis acids. One of the well-known 
examples of cascade process involving cationic 2-aza-Cope rearrangement is 
Overman’s aza-Cope-Mannich cascade reaction highlighting the creation of 
intramolecular Mannich reaction couterparts by 2-aza-Cope rearrangement from 
inactive homoallylic imines or iminium ions.94 This sigmatropic process shows little 
preference of the equilibrium, which is solely driven by formation of 3-formyl 
pyrrolidines via Mannich cyclization between iminium ions and tethered enols. The 
usefulness of this process has been abundantly demonstrated by Overman and others 
in various elegant total syntheses.95  
                                               
94
 (a) Overman, L.E., Tetrahedron, 2009, 65, 6432-6446. (b) Overman, L.E., Account of Chemical 
Research, 1992, 25, 352-359. (c) Jacobsen, E.J., Levin, J., Overman, L.E., J. Am. Chem. Soc., 1988, 
110, 4329-4336.  
95
 (a) Martin, C.L., Overman, L.E., Rohde, J.M., J. Am. Chem. Soc., 2008, 130, 7568-7569. (b) Dunn, 
T.B., Ellis, J.M., Kofink, C.C., Manning, J.R., Overman, L.E., Org. Lett., 2009, 11, 5658-5661. (c) 
Knight, S.D., Overman, L.E., Pairaudeau, G., J. Am. Chem. Soc., 1995, 117, 5776-5788. (d) Brummond, 
K.M., Hong, S., J. Org. Chem., 2005, 70, 907-916. (e) Agami, C., Cases, M., Couty, F., J. Org. Chem., 
1994, 59, 7937-7940. 
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Inspired by Overman’s aza-Cope Mannich cascade reaction, we next attempted to 
develop a cascade 2-aza-Cope rearrangement-[3+2] dipolar cycloaddition linear 
process. Rather than direct the sigmatropic rearrangement by a favorable conjugate 
effect, we sought to utilize the inherent reactivity of the rearranged imine to generate 
an azomethine ylide which is not accessible from the initial imine. The resulting ylide 
could then be trapped by electron deficient olefins through a [3+2] dipolar 
cycloaddition to yield pyrrolidine products as the thermodynamic sink of the process.  
We began our investigations by synthesizing homoallylic amine by reduction of 
allyl nitrile. The isolation of the homoallylic amine free base was first problematic 
due to its high volatility. Therefore, we next treated a diethyl ether solution of the 
homoallylic amine with anhydrous HCl in diethyl ether, which provided the 
homoallylic amine HCl salt as a white hydroscopic powder. Condensation of this 
homoallylic amine with ethyl glyoxylate afforded imine 140 quantitatively after 2 
hours at 40°C in the presence of Et3N.         
Scheme 4. 4. Synthesis of homoallylic amine HCl and condensation with ethyl 
glyoxylate 
 
We next attempted to define reaction conditions which could catalyze both the 2-
aza-Cope rearrangement and [3+2] dipolar cycloaddition. Realizing that sigmatropic 
rearrangement would not be detected due to the instability of resultant imine, 2-
phenyl homoallylic amine and ethyl glyoxylate were used to explore the optimal 
catalyzed condition. After extensive investigation, camphorsulfonic acid (CSA) was 
found to be an efficient catalyst at 50 °C which could promote both chemical 
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transformations. Use of scrupulously dry solvents and a dry inert atmosphere were 
necessary for the completion of the cationic 2-aza-Cope rearrangement. After addition 
of N-phenyl maleimide as the dipolarphile, 52% of desired 2-allyl proline ethyl ester 
was isolated after 48 hours stirring at 50 °C and purification by column 
chromatography as a single diastereomer. CSA was also able to promote [3+2] dipolar 
cycloaddition of azomethine ylides generated from imino esters with N-phenyl 
maleimide, out of which the pyrrolidine compound was isolated in 52% yield.  
Scheme 4. 5. CSA-catalyzed 2-aza-Cope-[3+2] dipolar cycloaddition reaction 
 
Drawing on those results, we went back to homoallylic amine, intending 
implement the cascade process by mixing homoallylic amine, ethyl glyoxylate, and 
phenyl maleimide together. With the aid of a catalytic amount of CSA, pyrroldine 
product was isolated in 45% yield. Structural analysis of the compound indicated that 
both 2-aza-Cope rearrangement and [3+2] dipolar cycloaddition were achieved under 
this mild, charge accelerated condition. However, the rearranged imine was too labile 
to survive until being converted to azomethine ylide. Instead, it was hydrolyzed to 
allylic glycine ethyl ester which then condensed with another ethyl glyoxylate to form 
the imine with two ester functionalities. The imine was then transformed to 
azomethine ylide in acidic condition which was then trapped by phenyl maleimide to 
produce the observed pyrrolidine in 45% yield.  
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Scheme 4. 6. 2-aza-Cope rearrangement-[3+2] dipolar cycloaddition with homoallylic 
amine 
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Chapter 5 
 
Experimental Procedures 
 
5.1. Material and Methods 
Unless otherwise stated, all non-aqueous reactions were carried out under an 
atmosphere of dry nitrogen in dried glassware. When necessary, solvents and reagents 
were dried prior to use. Acetonitrile was dried using a Glass Contour solvent 
purification system by SG Water USA, LLC when necessary. 2-Allylpyrrolidines 1-3 
were prepared according to the published procedure followed by purification using 
silica column chromatography. Commerially available starting materials and reagent 
were purchased from Acros, Alfa Aesar, Mallinckrodt, and TCI Chemicals. Flash 
column chromatography was performed using a forced flow of the indicated solvent 
system on EM Reagents Silica Gel 60 (230-400 mesh). TLC analysis was carried 
using Whatman Partisil K6F silica gel (60 Å, 250 µm thickness). TLC plates were 
visualized by irradiation under a 254 nm UV lamp or iodine.  
1H NMR and 2D NMR spectra were recorded on a Varian Unity Inova 500 
(500MHz) spectrometer or Bruker ARX 500 (500MHz) in CDCl3 at 298K using 
CDCl3 as internal reference (δ7.24 for CDCl3). 13C was recorded Bruker ARX 500 
(125MHz) in CDCl3 or DMSO-d6 at 298K or elvated temperature using solvent as 
internal references (δ77.0 for CDCl3, δ45.0 for DMSO-d6). Data are reported as 
follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, 
bp = broad peak, m = multiplet, app = apparent), coupling constants (Hz), and number 
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of protons. IR spectra were recorded on a Thermo Nicolet FT200 FT-IR spectrometer 
with an attenuated total reflectance ATR) head. High-resolution mass spectra (HRMS) 
in positive ESI mode were obtained on a QTof Premier mass spectrometer. X-ray 
crystallography data was collected using a Bruker APEX II single crystal 
diffractometer.  
5.2. Experimental Procedures of aza-Prins cyclizations 
5.2.1. General procedure for aza-Prins reaction with formaldehyde: 
To a stirring solution of 2-allylpyrrolidine (1-3) (1.0 mmol) in MeCN (4 mL) 
was added 37% aqueous formaldehyde (0.8 mL, 10.0 mmol), TFA (0.072 mL, 1.0 
mmol), and H2O (4 mL) and the reaction mixture was stirred at rt for 24 h. The 
reaction mixture was diluted with DCM (4 mL), washed with saturated NaHCO3 (2 x 
25 mL). The combined aqueous layer was extracted with DCM (2 x 20 mL), and the 
combined organic layer was washed with brine (2 x 20 mL), then the combined 
organics were dried (Na2SO4), filtered, concentrated, and the was residue further 
purified by silica column chromatography (40:10:0.5 EtOAc:hexanes:Et3N) to afford 
indolizidines 4-6. 
NNPh
O
O EtO2C
OH
 
4. (80%) white solid: Rf = 0.44 (EtOAc); IR (neat): 3500.7, 1719.8, 1696.6, 1329.8, 
1220.6, 1188.5cm-1; 1H NMR (500 MHz, CDCl3) δ 7.44 (bs, 2H), 7.35 (m, 6H), 7.03 
(dd, J = 1.4, 8.6 Hz, 2H), 4.65 (d, J = 9.9 Hz, 1H), 4.29 (m, 2H), 3.70 (bs, 1H), 3.63 
(dd, J = 8.2, 9.8 Hz, 1H), 3.40 (d, J = 3.4 Hz, 1H), 3.08 (m, 1H), 2.78 (ddd, J = 2.0, 
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4.2, 14.2 Hz, 1H), 2.64 (ddd, J = 1.2, 3.7, 12.3 Hz, 1H), 1.65 (d, J = 3.6 Hz, 1H), 1.59 
(dd, J = 11.8, 12.1 Hz, 1H), 1.52 (m, 2H), 1.32 (t, J = 7.2 Hz, 3H); 13C NMR (125 
MHz, CDCl3): δ 174.1, 173.6, 170.6, 137.0, 131.6, 129.0, 128.6 (2C), 128.4, 126.1, 
70.7, 66.7, 64.6, 61.7, 53.9, 47.8, 41.7, 37.1, 26.9, 14.1; high-resolution mass 
spectrum (ESI) m/z 435.1921 [(M+H)+; calcd for C25H27N2O5+: 435.1920].  
NNPh
O
O EtO2C
OH
OMe
 
5. (82%) white solid; m.p.: 201-203°C, Rf = 0.35 (4:1 EtOAc:Hexanes); IR (neat): 
3506.6, 1725.5, 1696.8, 1322.7, 1180.1, 1105.9, 1031.6 cm-1; 1H NMR (500 MHz, 
CDCl3) δ 7.35 (m, 4H), 7.29 (m, 1H), 7.07 (m, 2H), 6.86 (dd, J=1.4, 7.5Hz, 2H), 4.59 
(d, J = 9.8 Hz, 1H), 4.28 (m, 2H), 3.77 (s, 3H), 3.68 (m, 1H), 3.58 (dd, J = 8.2, 9.7 Hz, 
1H), 3.37 (d, J = 8.2 Hz, 1H), 3.04 (m, 1H), 2.76 (m, 1H), 2.62 (dd, J = 3.6, 11.7 Hz, 
1H), 1.57 (t, J = 11.9 Hz, 1H), 1.50 (m, 2H), 1.32 (t, J = 7.2 Hz, 3H); 13C NMR (125 
MHz, CDCl3) δ 174.3, 173.8, 170.9, 159,6, 131.9, 129.2, 128.8, 128.3, 126.4, 126.2, 
113.9, 70.0, 66.5, 64.1, 61.5, 55.1, 53.9, 47.8, 41.7, 37.0, 26.9, 14.0; high-resolution 
mass spectrum (ESI) m/z 465.2024 [(M+H)+; calcd for C26H29N2O6+: 465.2026].  
NNPh
O
O EtO2C
OH
CF3
 
6. (79%) white solid: Rf = 0.35 (4:1 EtOAc:Hexanes); IR (neat): 3507.1, 1703.4, 
1323.5, 1107.0, 1066.5 cm-1; 1H NMR (500 MHz, CDCl3) δ7.59 (m, 4H), 7.36 (m, 
 89 
2H), 7.30 (m, 1H), 7.00 (m, 2H), 4.69 (d, J = 9.7 Hz, 1H), 4.29 (m, 2H), 3.71 (m, 1H), 
3.67 (dd, J = 8.2, 9.7 Hz, 1H), 3.41 (d, J = 8.2 Hz, 1H), 3.07 (m, 1H), 2.69 (m, 2H), 
1.59 (t, J = 12.0 Hz, 1H), 1.52 (m, 2H), 1.33 (t, J = 7.2 Hz, 3H); 13C NMR (125 MHz, 
DMSO-d6) δ 173.5, 172.9, 169.5, 142.5, 131.5, 128.2, 127.9, 127.7 (J = 21 Hz), 127.3, 
125.7, 124.1, 123.5 (J = 272 Hz), 69.9, 64.5, 62.5, 59.8, 53.3, 47.1, 41.0, 36.8, 26.3, 
13.0); high-resolution mass spectrum (ESI) m/z 503.1812 [(M+H)+; calcd for 
C26H26N2O5F3+: 503.1794]. 
5.2.2. General procedure of aza-Prins reaction with glyoxylic acid monohydrate: 
To a solution of 2-allylpyrrolidine 5a-5c (0.5 mmol) and 4Å molecular sieves 
(200 mg) in MeCN (6 mL) was added a solution of glyoxylic acid monohydrate (54 
mg, 0.6 mmol) in MeCN (2 mL) dropwise and the reaction mixture was stirred at rt 
for 24 h. The mixture was then diluted with DCM (4 mL), decanted into a separatory 
funnel, washed with saturated NaHCO3 (2 x 25 mL) and the combined aqueous layer 
was extracted with DCM (2 x 20 mL). The combined organic phase was washed with 
brine (2 x 20 mL), dried over anhydrous sodium sulfate, filtered and concentrated and 
the residue purified by flash chromatography (40:10:0.5 EtOAc:hexanes:Et3N) to 
afford indolizidines 7a-7c. 
NNPh
O
O EtO2C O
O
 
7. (94%) white solid; m.p.: above 260°C; Rf = 0.34 (4:1 EtOAc:Hexanes); IR (neat): 
1727.1, 1697.6, 1323.0, 1103.9, 1066.9, 1019.7 cm-1; 1H NMR (500 MHz, CDCl3) δ 
7.33 (m, 8H), 6.87 (m, 2H), 4.98 (t, J = 5.3 Hz, 1H), 4.76 (d, J = 9.3Hz, 1H), 4.20 (m, 
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2H), 3.84 (t, J = 9.5 Hz, 1H), 3.49 (dd, J = 4.9, 13.9 Hz, 1H), 3.46 (d, J = 8.7 Hz, 1H), 
3.42 (d, J = 3.0 Hz, 1H), 2.27 (d, J = 12.5 Hz, 1H), 1.98 (m, 1H), 1.85 (d, J = 13.9 Hz, 
1H), 1.29 (t, J = 7.2 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 173.1, 172.5, 172.2, 
170.8, 137.9, 131.7, 128.2, 127.8, 127.6, 127.5,127.3, 125.9, 76.9, 68.9, 66.0, 60.6, 
55.7, 54.7, 48.4, 35.4, 29.9, 12.9; high-resolution mass spectrum (ESI) m/z 483.1539 
[(M+Na)+; calcd for C26H24N2O6Na+: 483.1532].  
NNPh
O
O EtO2C O
O
OMe
 
8. (97%) white solid; m.p.: 218-220°C; Rf = 0.32 (4:1 EtOAc:Hexanes); IR (neat): 
1787.3, 1713.7, 1384.4, 1185.0, 1102.8, 1089.2, 1023.6 cm-1; 1H NMR (500 MHz, 
CDCl3) δ 7.48 (m, 2H), 7.34 (m, 3H), 6.94 (m, 2H), 6.89 (m, 2H), 4.96 (t, J = 5.2 Hz, 
1H), 4.72 (d, J = 9.8 Hz, 1H), 4.21 (m, 2H), 3.81 (t, J = 9.5 Hz, 1H), 3.78 (s, 3H), 3.45 
(d, J = 8.7 Hz, 1H), 3.40 (m,1H), 3.38 (d, J = 2.9 Hz, 1H), 2.27 (d, J = 12.5 Hz, 1H), 
1.93 (m, 1H), 1.89 (d, J = 14.0 Hz, 1H), 1.30 (t, J = 7.2 Hz, 3H); 13C NMR (125 MHz, 
CDCl3) δ 173.3, 172.8, 172.6, 171.4, 159.9, 131.7, 129.4, 128.8, 128.6, 128.4, 126.3, 
77.1, 69.8, 66.7, 62.2, 55.9, 55.2, 54.7, 48.3, 36.1, 30.6, 13.6; high-resolution mass 
spectrum (ESI) m/z 513.1634 [(M+Na)+; calcd for C27H26N2O7Na+: 513.1638].  
NNPh
O
O EtO2C O
O
CF3
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9. (83%) white solid; m.p.: 247-248°C; Rf = 0.43 (4:1 EtOAc:Hexanes); IR (neat): 
1710.6, 1325.4, 1104.8, 1053.8, 1015.5 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.71 (m, 
2H), 7.61 (m, 2H), 7.30 (m, 3H), 6.81 (d, J = 7.5 Hz, 2H), 4.98 (t, J = 5.2 Hz, 1H), 
4.81 (d, J = 9.8 Hz, 1H), 4.21 (m, 2H), 3.90 (t, J = 9.1 Hz, 1H), 3.53 (d, J = 8.7 Hz, 
1H), 3.47 (dd, J = 4.4, 13.8 Hz, 1H), 3.35 (d, J = 2.7 Hz, 1H), 2.26 (d, J = 12.5 Hz, 
1H), 1.98 (m, 1H), 1.91 (d, J = 14.0 Hz, 1H), 1.32 (t, J = 7.2 Hz, 3H); 13C NMR (125 
MHz, DMSO-d6) δ 172.7, 172.2, 171.6, 170.4, 142.6, 131.2, 128.2, 128.1 (q, J = 
32Hz), 127.8, 127.5, 125.6, 124.0, 123.5 (q, J = 272 Hz), 76.5, 68.8, 65.2, 60.4, 55.4, 
54.4, 48.2, 35.2, 29.6, 12.6); high-resolution mass spectrum (ESI) m/z 529.1596 
[(M+Na)+; calcd for C27H24N2O6F3Na+: 529.1586].  
5.2.3. General procedure of aza-Prins reaction with glyoxal solution:  
40% aqueous solution of glyoxal (0.72 mL, 5 mmol), TFA (0.036 mL, 0.5 
mmol), and H2O (1-2 mL) was stirred for 30 minutes. Then the mixture was added 
into the solution of cycloadducts (0.5 mmol) in MeCN (2-3mL). The mixture was 
stirred for 2-3 hours at rt, then diluted with DCM (4 mL), washed with saturated 
NaHCO3 (2 x 25 mL) and the combined aqueous layer was extracted with DCM (2 x 
20 mL). The combined organic phase was washed with brine (2 x 25 mL), dried 
(Na2SO4), filtered and concentrated and the residue purified by flash chromatography 
(40:10:0.5 EtOAc:hexanes:Et3N) to afford indolizidines 8a-8c. 
NNPh
O
O EtO2C O
OH
 
10. (72%) white solid: Rf = 0.33 (4:1 EtOAc:Hexanes); IR (neat): 3476.9, 1713.5, 
1387.8, 1289.9, 1192.4, 1105.3, 1054.7, 1020.3 cm-1; 1H-NMR (500 MHz, CDCl3) δ 
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9.89 (s, 1H), 7.34 (m, 9H), 7.01 (m, 2H), 6.80 (m, 0.4H), 5.64 (d, J=3.2Hz, 0.2H), 
4.74 (d, J = 10.4Hz, 1H), 4.73 (d, J=9.6Hz, 0.2H), 4.64 (t, J=5.8Hz, 0.2H), 4.24 (m, 
3.6H), 3.77 (dd, J = 8.4, 10.4Hz, 0.2H), 3.69 (dd, J=8.4, 10.3Hz, 1H), 3.46 (d, J = 
8.3Hz, 1H), 3.37 (d, J=8.5Hz, 0.2H), 3.26 (m, 1H), 3.20 (ddd, J=4.9, 5.8, 13.0Hz, 
0.2H), 2.62 (m, 1H), 2.50 (m, 0.2H), 2.22 (m, 1H), 1.87 (m, 1.2H), 1.81 (m, 1H), 1.55 
(d, J=13.2Hz, 0.2H), 1.33 (t, J=7.1Hz, 0.6H), 1.30 (t, J = 7.1 Hz, 3H); 13C NMR (125 
MHz, DMSO-d6) δ 202.5, 174.0, 173.8, 173.3, 173.1, 172.2, 171.5, 139.4, 138.2, 
131.9, 128.5, 128.4, 128.1, 127.9, 127.8, 127.6, 127.3, 126.2, 97.1, 72.9, 68.8, 67.4, 
66.9, 65.4, 62.1, 62.0, 60.9, 60.3, 59.9, 54.8, 54.4, 48.3, 46.9, 38.8, 34.7, 27.4, 23.6, 
13.6, 13.4; high-resolution mass spectrum (ESI) m/z 463.1878 [(M+H)+; calcd for 
C26H27N2O6+: 463.1869].  
NNPh
O
O EtO2C O
OH
OMe
 
11. (73%) white solid: Rf = 0.33 (4:1 EtOAc:Hexanes); IR (neat): 3479.4, 1713.1, 
1385.5, 1289.7, 1185.9, 1166.8, 1104.8, 1052.9, 1020.3 cm-1; 1H NMR (500 MHz, 
CDCl3) δ9.86 (s, 1H), 7.36 (m, 6H), 7.06 (m, 2H), 6.90 (m, 3H), 5.61(s, 0.15H), 4.68 
(d, J = 10.4 Hz, 1H), 4.67 (d, J=10.1Hz, 0.15H), 4.62(t, J=5.8Hz, 0.15H), 4.25 (m, 
3.45H), 3.78 (s, 3H), 3.76(s, 0.45H), 3.65 (dd, J = 8.3, 10.3 Hz, 1.15H), 3.44 (d, J = 
8.3 Hz, 1H), 3.35 (d, J=8.6Hz, 0.15H), 3.25 (d, J = 6.6 Hz, 1H), 3.23(d, J=2.7Hz, 
0.15H), 3.17 (dd, J=5.5, 13.7Hz, 0.15H), 2.59 (m, 1H), 2.19 (m, 1H), 1.84 (m, 1.15H), 
1.78 (dd, J = 2.1, 13.9 Hz, 1H), 1.55 (d, J=13.5Hz, 0.15H), 1.30 (m, 3.45H); 13C NMR 
(125 MHz, CDCl3) δ 201.8, 173.5, 172.9, 172.8, 172.6, 172.4, 171.1, 160.2, 131.8, 
129.6, 129.4, 128.9, 128.8, 128.7, 128.2, 126.2, 126.0, 114.5, 113.9, 98.3, 74.3, 69.6, 
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67.8, 67.7, 65.6, 64.1, 63.9, 62.2, 61.6, 61.3, 60.8, 55.2, 54.9, 54.2, 48.8, 47.2, 39.4, 
34.5, 28.2, 21.8, 21.6, 13.8, 13.7; high-resolution mass spectrum (ESI) m/z 493.1972 
[(M+H)+; calcd for C27H29N2O7+: 493.1975]. 
NNPh
O
O EtO2C O
OH
CF3
 
12. (66%) crystalline solid: mp 135–140 °C (2:3 H2O:MeOH); Rf = 0.35 (4:1 
EtOAc:Hexanes); IR (neat): 1716.6, 1381.0, 1323.2, 1165.0, 1107.2, 1064.7, 1018.4 
cm-1; 1H NMR (500 MHz, CDCl3) δ9.89 (s, 1H), 7.63 (m, 5.5H), 7.33(m. 5.0H), 6.95 
(m, 2H), 6.73 (m, 1H), 5.63(s, 0.5H), 4.80 (d, J=10.5Hz, 1H), 4.78 (d, J=10.1Hz, 
0.5H), 4.64 (t, J=5.9Hz, 0.5H), 4.26 (m, 4.5H), 3.82 (dd, J=8.8, 9.7Hz, 0.5H), 3.74 (dd, 
J = 8.3, 10.4Hz, 1H), 3.48 (d, J=8.3Hz, 1H), 3.40 (d, J=8.6Hz, 0.5H), 3.21 (dd, J=5.1, 
13.4Hz, 0.5H), 3.16 (m, 1.5H), 2.65 (m, 1H), 2.24 (m, 1H), 1.84 (m, 1.5H), 1.79 (dd, 
J=1.9, 13.9 Hz, 1H), 1.55 (d, J=13.5Hz, 0.5H), 1.30 (m, 4.5H); 13C NMR (125 MHz, 
CDCl3) δ 201.3, 173.2, 173.1, 172.6, 172.5, 172.3, 171.5, 142.5, 141.4, 131.4, 131.2 
(q, J=23Hz), 128.9, 128.8, 128.5, 125.9, 125.9, 125.8, 125.8, 125.3, 125.3, 123.8 (q, 
J=272Hz), 98.1, 74.2, 69.7, 67.8, 67.7, 65.7, 63.8, 62.3, 61.9, 61.6, 60.9, 55.0, 54.2, 
48.7, 47.1, 39.5, 34.6, 28.4, 21.8, 13.9, 13.7; high-resolution mass spectrum (ESI) m/z 
531.1746 [(M+H)+; calcd for C27H26N2O6F3+: 531.1743]. 
5.2.4. General procedure of aza-Prins cyclization with ethyl glyoxylate:  
A solution of 2-allylpyrolidine (5a-5c) (0.5 mmol), ethyl glyoxylate (0.5 mL, 
2.5 mmol) and TFA (0.072 mL, 1.0 mmol) in MeCN (4 mL) was stirred for 1h at 
50 °C. The reaction mixture was then quenched with saturated NaHCO3 (2 mL). The 
 94 
reaction mixture was then diluted with DCM (4 mL), washed with saturated NaHCO3 
(2 x 25 mL) and the combined aqueous phase was extracted with DCM (3 x 20 mL). 
The combined organic phase was washed with brine (2 x 25 mL), dried (Na2SO4), 
filtered and concentrated and the residue purified by flash chromatography (40:10:0.5 
EtOAc:Hexanes:Et3N) to afford indolizidines 9a-9c. 
NNPh
O
O EtO2C
OH
CO2Et
 
13. (66%) white solid; m.p.: 220-225°C; Rf = 0.45 (4:1 EtOAc:hexanes); IR (neat): 
3450.2, 1735.2, 1711.7, 1388.4, 1194.5, 1117.7, 1103.2 cm-1; 1H NMR (500 MHz, 
CDCl3) δ7.34 (m, 8H), 6.96 (m, 2H), 4.65 (d, J = 10.4 Hz, 1H), 4.45 (d, J = 4.4 Hz, 
1H), 4.24 (m, 4H), 3.62 (dd, J = 8.3, 10.4 Hz, 1H), 3.52 (t, J = 4.3 Hz, 1H), 3.42 (d, J 
= 8.2 Hz, 1H), 2.67 (dd, J = 3.3, 13.8 Hz, 1H), 1.99 (m, 2H), 1.76 (dd, J = 2.3, 13.8 
Hz, 1H), 1.31 (t, J = 7.1 Hz, 6H); 13C NMR (125 MHz, CDCl3) δ 175.1, 173.5, 172.9, 
170.9, 136.9, 131.7, 128.8, 128.7, 128.7, 128.3, 128.2, 126.0, 68.7, 65.9, 63.2, 61.7, 
61.0, 54.5, 54.4 47.0, 35.0, 23.8, 13.9, 13.8); high-resolution mass spectrum (ESI) m/z 
529.1944 [(M+Na)+; calcd for C28H30N2O7Na+: 529.1951].  
NNPh
O
O EtO2C
OH
OMe
CO2Et
 
14. (54%) clear crystalline solid: mp 207–209 °C (2:1 EtOAc:Hexanes) Rf = 0.44 (4:1 
EtOAc:hexanes); IR (neat): 3419.2, 1740.2, 1709.4, 1372.4, 1328.8, 1197.2, 1151.5, 
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1105.9, 1066.7 cm-1; 1H NMR (500 MHz, CDCl3) δ7.50 (m, 2H), 7.30 (m, 3H), 7.00 
(d, J = 7.7 Hz, 2H), 6.86 (d, J = 8.6 Hz, 2H), 4.69 (d, J = 10.3 Hz, 1H), 4.42 (d, J = 4.3 
Hz, 1H), 4.23 (m, 4H), 3.77 (s, 3H), 3.57 (dd, J = 8.5, 9.8 Hz, 1H), 3.50 (t, J = 4.0 Hz, 
1H), 3.39 (d, J = 8.2 Hz, 1H), 2.64 (dd, J = 2.9, 13.8 Hz, 1H), 1.96 (m, 2H), 1.73 (d, J 
= 14.3 Hz, 1H), 1.30 (t, J = 7.2 Hz, 6H); 13C NMR (125 MHz, CDCl3) δ 175.6, 173.8, 
173.3, 171.0, 159.9, 131.5, 129.8, 128.9, 128.5, 128.3, 126.0, 113.7, 67.9, 65.7, 63.2, 
61.8, 61.0, 55.1, 54.1, 54.0, 46.8, 34.6, 23.4, 13.9 (2C)); high-resolution mass 
spectrum (ESI) m/z 559.2059 [(M+Na)+; calcd for C29H32N2O8Na+: 559.2056].  
NNPh
O
O EtO2C
OH
CF3
CO2Et
 
15. (62%) white solid; m.p.: 180-182°C; Rf = 0.44 (4:1 EtOAc:hexanes); IR (neat): 
3417.9, 1740.6, 1721.3, 1708.2, 1370.8, 1327.8, 1196.8, 1119.2, 1106.0, 1066.1. cm-1; 
1H NMR (500 MHz, CDCl3) δ 7.77 (m, 2H), 7.60 (d, J = 8.4 Hz, 2H), 7.30 (m, 3H), 
6.90 (m, 2H), 4.71 (d, J = 10.4 Hz, 1H), 4.40 (d, J = 4.3Hz, 1H), 4.25 (m, 4H), 3.67 
(dd, J = 8.3, 10.4 Hz, 1H), 3.44 (m, 2H), 2.70 (dd, J = 2.1, 13.9 Hz, 1H), 1.99 (m, 2H), 
1.75 (dd, J = 2.3, 13.9 Hz, 1H), 1.30 (t, J = 7.1 Hz, 6H) 13C NMR (125 MHz, CDCl3) 
δ 175.0, 173.4, 172.9, 170.8, 141.0, 131.2, 130.9 (q, J = 32 Hz), 129.2, 129.0, 128.5, 
125.8, 125.3, 125.3, 123.9 (q, J = 272 Hz), 68.0, 65.9, 63.0, 62.0, 61.2, 54.4, 54.2, 
46.8, 35.0, 23.7, 13.9 (2C)); high-resolution mass spectrum (ESI) m/z 597.1831  
[(M+Na)+; calcd for C29H29N2O7F3Na+: 529.1825]. 
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5.2.5. Procedure for formation of 17:  
To a stirring solution of 2-allylpyrrolidine 16 (0.25 mmol) in MeCN (1 mL) 
was added 37% aqueous formaldehyde (0.2 mL, 2.5 mmol), TFA (0.018 mL, 0.25 
mmol), and H2O (1 mL) and the reaction mixture was stirred at r.t. for 1.5 h. The 
reaction mixture was diluted with DCM (4 mL), washed with saturated NaHCO3 (2 x 
15 mL). The combined aqueous layer was extracted with DCM (2 x 15 mL), and the 
combined organic layer was washed with brine (15 mL), then the combined organics 
were dried (Na2SO4), filtered, concentrated, and the was residue further purified by 
silica column chromatography (EtOAc:hexanes: 1:10 to 1:6) to afford compound 17 
as the major product. 
 
17. 60% as a yellow solid; 1H NMR (500 MHz, CDCl3) δ 7.37 (m, 2H), 7.33 (m, 1H), 
7.31 (m, 2H), 5.64 (tdd, J=6.8, 9.7, 16.7Hz, 1H), 5.18 (d, J=12.8Hz, 1H), 5.05 (m, 
2H), 4.48 (q, J=7.1Hz, 2H), 4.31 (d, J=12.8Hz, 1H), 3.65 (s, 3H), 3.16 (s, 3H), 3.14 
(ddd, J=6.6, 8.7, 15.2Hz, 1H), 2.97 (ddd, J=5.8, 8.6, 14.6Hz, 1H), 2.21 (m, 2H), 1.45 
(t, J=7,1Hz, 3H) 13C NMR (125 MHz, CDCl3) δ 170.4, 164.6, 162.8, 154.9, 134.9, 
134.3, 128.6, 128.4, 128.1, 117.4, 97.5, 68.4, 62.5, 52.8, 51.4, 50.9, 45.3, 32.0, 14.1. 
5.2.6. Procedure for formation of indolizidines 18 a&b:  
To a stirring solution of 2-allylpyrrolidine 16 (1.0 mmol) in MeCN (4 mL) was 
added 37% aqueous formaldehyde (0.8 mL, 10.0 mmol), TFA (0.072 mL, 1.0 mmol), 
and H2O (4 mL) and the reaction mixture was stirred at r.t. for 24 h. The reaction 
mixture was diluted with DCM, washed with saturated NaHCO3 (2 x 20 mL). The 
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combined aqueous layer was extracted with DCM (2 x 20 mL), and the combined 
organic layer was washed with brine (2 x 20 mL), then the combined organics were 
dried (Na2SO4), filtered, concentrated, and the was residue further purified by silica 
column chromatography (EtOAc:hexanes: 1:1 with 1% Et3N) to afford compound 18 
a&b as a mixture of diastereomers, which were then separated by silica column 
chromatography (1 % MeOH in DCM). 
 
18a. Yellow oil; 1H NMR (500 MHz, CDCl3) δ 7.38 (m, 2H), 7.25 (m, 2H), 7.21 (m, 
1H), 4.53 (d, J=10.9Hz, 1H), 4.35 (q, J=7.1Hz, 2H), 4.20 (bp, 1H), 4.13 (d, J=11.2, 
1H), 3.78 (m, 2H), 3.64 (s, 3H), 3.10 (s, 3H), 3.06 (t, J=14.0Hz, 1H), 2.41 (d, 
J=14.9Hz, 1H), 2.06 (d, J=14.8Hz, 1H), 1.80 (m, 1H), 1.66 (dd, J=3.3, 14.8Hz, 1H), 
1.37 (t, J=7.1Hz, 3H) 1.31 (d, J=14.0Hz, 1H) 13C NMR (125 MHz, CDCl3) δ 175.5, 
170.7, 170.4, 140.1, 128.4, 127.9, 66.9, 64.6, 63.7, 62.2, 53.2, 52.2, 51.5, 49.5, 37.9, 
30.3, 24.6, 14.1.  
 
18b. White solid; 1H NMR (500 MHz, CDCl3) δ 7.40 (m, 2H), 7.25 (m, 2H), 7.19 (m, 
1H), 4.51 (d, J=11.0Hz, 1H), 4.29 (q, J=7.1Hz, 2H), 4.17 (d, J=11.0Hz, 1H), 3.97 (m, 
1H), 3.84 (t, J=11.0Hz, 1H), 3.65 (s, 3H), 3.08 (s, 3H), 2.65 (m, 2H), 2.19 (dd, J=4.3, 
12.5Hz, 1H), 2.12 (bp, 1H), 1.51 (m, 2H), 1.34 (t, J=7.1Hz, 3H), 1.21 (t, J=11.4Hz, 
1H) 13C NMR (125 MHz, CDCl3) δ 172.7, 170.9, 170.3, 140.1, 128.5, 127.9, 69.6, 
66.7, 64.3, 61.6, 53.4, 52.2, 51.5, 49.3, 42.6, 33.8, 27.9, 14.2. 
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5.3. Experimental procedures for generation of azomethine ylides with benzylic 
or allylic amines with glyoxals and subsequent [3+2] dipolar cycloadditions 
5.3.1 General procedure for preparation of phenylglyoxal cycloadducts:  
To a stirred solution of amines 21-26 (2.0 mmol) in MeCN (3 mL) at rt was 
added phenylglyoxal monohydrate (304 mg, 2.0 mmol). After 1.5 h, AgOAc (16 mg, 
0.10 mmol), Et3N (0.28 mL, 2.0 mmol) and phenyl maleimide (174 mg, 1.0 mmol) 
were added. After 24 h, the reaction mixture was partitioned between CH2Cl2 (20 mL) 
and saturated NaHCO3 (25 mL) and extracted with CH2Cl2 (3 x 20 mL). The 
combined organic layers were washed with brine (50 mL), dried (Na2SO4), 
concentrated, and the residue purified by trituration (Et2O) or flash column 
chromatography to afford pyrrolidine products 27-32.  
 
27. 86% as a tan solid; mp 158–160 °C; Rf = 0.41 (70:30 CH2Cl2:EtOAc); IR (neat) 
3579, 3299, 3221, 3056, 2863, 2505, 1780, 1704, 1676, 1600, 1495, 1369, 1178, 920, 
756, 688 cm-1; 1H NMR (500 MHz, CDCl3) δ 8.02 (d, J = 8.1 Hz, 2H), 7.62 (t, J = 7.4, 
1H), 7.52 (t, J = 7.7 Hz, 2H), 7.41 (t, J = 7.6 Hz, 2H), 7.34 (t, J = 7.4 Hz, 2H), 7.19 (d, 
J = 7.2 Hz, 1H), 6.18 (ddd, J = 17.0, 10.7, 6.3 Hz, 1H), 5.48 (dt, J = 17.2, 1.2 Hz, 1H), 
5.35 (dt, J = 10.6, 1.1 Hz, 1H), 5.02 (d, J = 7.7 Hz, 3H), 4.14 (t, J = 6.8 Hz, 1H), 3.89 
(t, J = 7.7 Hz, 1H), 3.59 (t, J = 8.0 Hz, 1H), 2.73 (s, 1H); 13C NMR (125 MHz, CDCl3) 
δ 196.1, 174.5, 174.2, 136.4, 133.9, 133.5, 131.6, 129.2, 129.0, 128.8, 128.3, 126.5, 
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117.7, 65.5, 63.4, 51.4, 51.0; high resolution mass spectrum (ESI) m/z 347.1392 [(M 
+ H)+; calcd for C21H19N2O3+: 347.1390]. 
 
28. 65% as a white solid: mp 182–184 °C; Rf = 0.28 (50:50 EtOAc:hexanes); IR (neat) 
3371, 1713, 1647, 1381, 1188, 748 cm-1; 1H NMR (500 MHz, CDCl3) δ 8.07 (d, J = 
7.5 Hz, 2H), 7.63 (t, J = 7.3 Hz, 1H), 7.54 (t, J = 7.7 Hz, 2H), 7.49 (m, 2H), 7.41 (t, J 
= 7.2 Hz, 2H), 7.34 (m, 3H), 7.31 (m, 1H), 7.11 (m, 2H), 5.03 (t, J = 6.7 Hz, 1H), 
4.76 (t, J = 7.9 Hz, 1H), 3.96 (t, J = 7.3 Hz, 1H), 3.71 (d, J = 8.1 Hz, 1H), 2.92 (t, J = 
6.7 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 194.8, 173.5, 172.6, 135.5, 135.4, 132.4, 
130.4, 127.9, 127.8, 127.5, 127.4, 127.3, 126.9, 125.9, 125.0, 64.3, 63.4, 50.0, 49.5; 
high resolution mass spectrum (ESI) m/z 397.1548 [(M + H)+; calcd for C25H21N2O3+: 
397.1547]. 
N
H
N
O O
Ph
O
29
 
29. 72% as a yellow solid: mp 138–141 °C; Rf = 0.53 (70:30 CH2Cl2:EtOAc); IR 
(neat) 1708, 1685, 1597, 1496, 1381, 1172, 759, 690 cm-1; 1H NMR (500 MHz, 
CDCl3) δ 8.01 (d, J = 7.2 Hz, 2H), 7.61 (t, J = 7.4 Hz, 1H), 7.50 (t, J = 7.7 Hz, 2H), 
7.41 (t, J = 7.6 Hz, 2H), 7.34 (t, J = 7.4 Hz, 1H), 7.20 (d, J = 7.2 Hz, 2H), 5.91 (dq, J 
= 14.6, 7.0 Hz, 1H), 5.71 (ddd, J = 15.9, 7.2, 1.6 Hz, 1H), 4.98 (d, J = 7.7 Hz, 1H), 
4.07 (t, J = 7.7 Hz, 1H), 3.86 (t, J = 7.7 Hz, 1H), 3.52 (t, J = 8.0 Hz, 1H), 1.78 (d, J = 
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6.4 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 196.2, 174.6, 174.3, 136.4, 133.8, 131.6, 
130.0, 129.2, 129.0, 128.8, 128.3, 126.5, 126.2, 65.5, 63.3, 51.5, 51.2, 18.1; high 
resolution mass spectrum (ESI) m/z 361.1547 [(M + H)+; calcd for C22H21N2O3+: 
361.1547]. 
 
30. 74% as a light yellow solid: mp 160–163 °C; Rf = 0.20 (50:50 EtOAc:hexanes); IR 
(neat) 3302, 2924, 1705, 1681, 1373, 1165, 756 cm-1; 1H NMR (500 MHz, CDCl3) δ 
8.02 (d, J = 7.6 Hz, 2H), 7.62 (m, 1H), 7.52 (m, 2H), 7.39 (m, 2H), 7.33 (m, 1H), 7.17 
(d, J = 7.6 Hz, 2H), 5.19 (s, 1H), 5.07 (s, 1H), 4.95 (t, J = 7.8 Hz, 1H), 3.99 (t, J = 8.5 
Hz, 1H), 3.88 (t, J = 7.4 Hz, 1H), 3.65 (t, J = 7.7 Hz, 1H), 2.76 (t, J = 9.1 Hz, 1H), 
2.03 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 196.0, 174.4, 173.8, 141.1, 136.3, 133.5, 
131.4, 128.9, 128.7, 128.5, 127.9, 126.3, 111.1, 65.4, 65.0, 50.7, 49.5, 21.6; high 
resolution mass spectrum (ESI) m/z 361.1548 [(M + H)+; calcd for C22H21N2O3+: 
361.1547]. 
 
31. 82% yield as a light yellow solid: mp 155–157  °C; Rf = 0.20 (50:50 
EtOAc:hexanes); IR (neat) 1710, 1673, 1375, 1170, 768, 688 cm-1; 1H NMR (500 
MHz, CDCl3) δ 8.02 (d, J = 7.6 Hz, 2H), 7.62 (m, 1H), 7.52 (m, 2H), 7.43 (m, 2H), 
7.35 (m, 1H), 7.23 (d, J = 7.6 Hz, 2H), 5.32 (d, J = 8.7Hz, 1H), 5.00 (d, J = 7.6 Hz, 
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1H), 4.33 (t, J = 8.4 Hz, 1H), 3.87 (t, J = 7.7 Hz, 1H), 3.51 (t, J = 7.9 Hz, 1H), 2.59 (s, 
1H), 1.83 (s, 3H), 1.81 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 196.1, 174.5, 174.0, 
138.1, 136.0, 133.4, 131.4, 128.8, 128.6, 128.3, 127.9, 126.2, 119.3, 65.0, 58.8, 51.3, 
50.5, 25.7, 18.4; high resolution mass spectrum (ESI) m/z 375.1702 [(M + H)+; calcd 
for C23H23N2O3+: 375.1703]. 
 
32. 67% yield as a brown solid: mp 155–160 °C; Rf = 0.27 (70:30 CH2Cl2:EtOAc); IR 
(neat) 1711, 1389, 1189, 1177, 967, 751, 691 cm-1; 1H NMR (500 MHz, CDCl3) δ 
8.09 (d, J = 7.3 Hz, 2H), 7.67 (t, J = 7.4, 1H), 7.57 (t, J = 11.4, 7.6 Hz, 2H), 7.45 (d, J 
= 7.6 Hz, 2H), 7.37 (d, J = 7.4 Hz, 3H), 7.33 (dd, J = 15.8, 7.5 Hz, 4H), 7.20 (d, J = 
7.3 Hz, 2H), 6.81 (d, J = 16.0 Hz, 1H), 6.52 (dd, J = 15.7, 6.6 Hz, 1H), 5.09 (d, J = 
7.7 Hz, 1H), 4.32 (t, J = 7.2 Hz, 1H), 3.93 (t, J = 7.8 Hz, 1H), 3.67 (t, J = 7.8 Hz, 1H); 
13C NMR (125 MHz, CDCl3) δ 196.9, 175.1, 174.4, 136.5, 133.9, 133.5, 131.5, 129.1, 
129.0, 128.8, 128.3, 126.5, 117.7, 64.9, 61.7, 50.5; high resolution mass spectrum 
(ESI) m/z 423.1706 [(M + H)+; calcd for C27H23N3O3+: 423.1703]. 
5.3.2. General procedure of formation of indole glyoxal cycloadducts:   
To a stirred solution of indole glyoxal (173 mg, 1.0 mmol) in THF or MeCN (5 
mL) at rt was added amines 21-26 (75 µL, 1.0 mmol). After 30 min, AgOAc (16 mg, 
0.10 mmol), Et3N (0.28 mL, 2.0 mmol) and phenyl maleimide (207 mg, 1.2 mmol) 
were added. After 24 h, the reaction mixture was diluted with CH2Cl2 (100 mL), 
washed with saturated NaHCO3 (2 x 25 mL), and extracted with CH2Cl2 (2 x 25 mL). 
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The combined organic layers were washed with brine (50 mL), dried (Na2SO4), 
concentrated, and the residue purified by trituration (Et2O) to afford pyrrolidine 
products 33-38.  
 
33. 84% as an off-white solid: Rf = 0.16 (EtOAc); IR (neat) 3502, 1705, 1496, 1056, 
763 cm-1; 1H NMR (500 MHz, DMSO-d6) δ 12.06 (s, 1H), 8.59 (d, J = 3.0 Hz, 1H), 
8.18 (d, J = 7.7 Hz, 1H), 7.49 (d, J = 7.9, 1H), 7.46 (t, J = 7.5 Hz, 2H), 7.34 (m, 1H), 
7.24 (t, J = 7.8 Hz, 1H), 7.18 (m, 3H), 6.15 (ddd, J = 17.1, 10.4, 6.5 Hz, 1H), 5.34 (d, 
J = 17.2 Hz, 1H), 5.19 (d, J = 10.5 Hz, 1H), 4.83 (d, J = 8.2 Hz, 1H), 3.93 (t, J = 6.6 
Hz, 1H), 3.89 (t, J = 7.9 Hz, 1H), 3.57 (t, J = 7.7 Hz, 1H), 2.96 (s, 1H); 13C NMR 
(125 MHz, DMSO-d6) δ 191.2, 175.6, 175.2, 137.1, 136.3, 134.7, 132.3, 132.2, 128.6, 
127.4, 126.1, 123.4, 122.3, 122.0, 116.6, 116.3, 112.6, 66.4, 63.3, 51.7, 51.5; high 
resolution mass spectrum (ESI) m/z 386.1500 [(M + H)+; calcd for C23H20N3O3+: 
386.1499]. 
 
34. 75% as an off-white solid: Rf = 0.40 (EtOAc); IR (neat) 3147, 2924, 1712, 1627, 
1427, 1373, 748 cm-1; 1H NMR (500 MHz, DMSO-d6) δ 12.05 (s, 1H), 8.67 (s, 1H), 
8.27 (d, J = 7.6 Hz, 1H), 7.50 (m, 3H), 7.40 (m, 5H), 7.28 (m, 3H), 7.10 (m, 2H), 7.10 
(d, J = 7.7 Hz, 2H), 4.84 (t, J = 5.6 Hz, 1H), 4.58 (t, J = 6.6 Hz, 1H), 4.00 (t, J = 7.5 
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Hz, 1H), 3.72 (t, J = 7.9 Hz, 1H); 13C NMR (125 MHz, DMSO-d6) δ 192.3, 176.4, 
175.6, 139.4, 137.6, 134.9, 133.4, 129.9, 129.4, 129.1, 128.5, 128.4, 127.9, 126.8, 
124.2, 123.1, 122.7, 117.2, 113.3, 67.1, 64.9, 52.0, 51.8; high resolution mass 
spectrum (ESI) m/z 436.1655 [(M + H)+; calcd for C27H22N3O3+: 436.1656]. 
N
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35. 92% as an off-white solid: Rf = 0.17 (EtOAc); IR (neat) 3178, 2924, 1705, 1635, 
1381, 1203, 748 cm-1; 1H NMR (500 MHz, DMSO-d6) δ 12.02 (s, 1H), 8.57 (d, J = 
2.2 Hz, 1H), 8.17 (d, J = 7.6 Hz, 1H), 7.47 (m, 3H), 7.37 (m, 1H), 7.22 (m, 1H), 7.18 
(m, 3H), 5.73 (m, 2H), 4.78 (t, J = 7.6 Hz, 1H), 3.85 (m, 2H), 3.49 (t, J = 7.7 Hz, 1H), 
2.85 (t, J = 7.9 Hz, 1H), 1.70 (d, J = 5.1 Hz, 3H); 13C NMR (125 MHz, DMSO-d6) δ 
191.9, 176.4, 176.0, 137.7, 135.3, 133.5, 129.9, 129.5, 129.3, 128.2, 128.1, 126.7, 
124.1, 123.0, 122.7, 117.3, 113.3, 67.1, 63.7, 52.3 (2C), 18.9; high resolution mass 
spectrum (ESI) m/z 400.1655 [(M + H)+; calcd for C24H22N3O3+: 400.1656]. 
 
36. 93% as an off-white solid: Rf = 0.26 (EtOAc); IR (neat) 3178, 1705, 1643, 1419, 
1381, 1203, 756 cm-1; 1H NMR (500 MHz, DMSO-d6) δ 12.03 (s, 1H), 8.61 (S, 1H), 
8.23 (d, J = 7.5 Hz, 1H), 7.51 (d, J = 7.8 Hz, 1H), 7.44 (m, 2H), 7.36 (m, 1H), 7.23 
(m, 2H), 7.13 (m, 2H), 5.06 (s, 1H), 4.92 (s, 1H), 4.78 (t, J = 8.2 Hz, 1H), 3.89 (t, J = 
7.7 Hz, 1H), 3.82 (t, J = 8.0 Hz, 1H), 3.67 (t, J = 7.6 Hz, 1H), 2.98 (t, J = 8.9 Hz, 1H), 
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1.95 (s, 3H); 13C NMR (125 MHz, DMSO-d6) δ 191.0, 175.1, 174.6, 142.5, 136.5, 
134.1, 132.3, 128.8, 128.2, 126.8, 125.7, 122.9, 121.8, 121.6, 116.1, 112.1, 109.9, 
65.8, 64.9, 50.7, 49.5, 21.5; high resolution mass spectrum (ESI) m/z 400.1655 [(M + 
H)+; calcd for C24H23N3O3+: 400.1656]. 
 
37. 94% as a white solid: Rf = 0.26 (EtOAc); IR (neat) 1712, 1643, 1373, 1180, 748, 
617 cm-1; 1H NMR (500 MHz, CDCl3) δ 8.34 (m, 1H), 7.87 (s, 1H), 7.39 (m, 2H), 
7.30 (m, 1H), 7.28 (m, 3H), 7.26 (m, 1H), 7.24 (m, 1H), 5.38 (d, J = 8.9 Hz, 1H), 4.75 
(d, J = 8.4 Hz, 1H), 4.23 (t, J = 8.4 Hz, 1H), 3.76 (s, 3H), 3.71 (t, J = 8.0 Hz, 1H), 
3.42 (t, J = 7.7 Hz, 1H), 1.80 (s, 3H), 1.78 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 
189.6, 174.8, 174.4, 138.4, 137.7, 136.2, 131.9, 129.1, 128.6, 126.6, 126.4, 123.9, 
123.2, 122.7, 119.5, 116.1, 109.9, 66.7, 59.8, 51.4, 51.1, 33.7, 26.1, 18.8; high 
resolution mass spectrum (ESI) m/z 428.1969 [(M + H)+; calcd for C26H26N3O3+: 
428.1969]. 
 
38. 65% as an off-white solid: Rf = 0.36 (EtOAc); IR (neat) 3148, 2924, 1705, 1635, 
1361, 748 cm-1; 1H NMR (500 MHz, DMSO-d6) δ 12.05 (s, 1H), 8.61 (s, 1H), 8.20 (d, 
J = 7.5, 1H), 7.47 (m, 5H), 7.36 (m, 3H), 7.24 (m, 5H), 6.70 (d, J = 15.9 Hz, 1H), 
6.57 (dd, J = 15.9, 7.1 Hz, 1H), 4.88 (t, J = 6.4 Hz, 1H), 4.09 (d, J = 6.8 Hz, 1H), 3.93 
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(t, J = 7.8 Hz, 1H), 3.64 (t, J = 7.6 Hz, 1H), 3.12 (t, J = 6.8 Hz, 1H); 13C NMR (125 
MHz, DMSO-d6) δ 190.7, 175.2, 174.8, 136.8, 136.6, 134.2, 132.4, 130.2, 128.7, 
128.6, 128.1, 127.7, 127.5, 126.9, 126.3, 125.6, 122.9, 121.8, 121.6, 116.2, 112.1, 
66.1, 62.5, 51.6, 51.1; high resolution mass spectrum (ESI) m/z 462.1812 [(M + H)+; 
calcd for C29H24N3O3+: 462.1812]. 
5.4. Experimental procedures for study toward total synthesis of borrecapine 
5.4.1. Procedure for formation of 65 
Allylamine 21 (1.0 mmol) and ethyl glyoxylate (1.0mmol) was added into 1 mL 
MeCN, stir for 0.5h at r.t. to preform the imine. Into the solution was next added 
AgOAc/PPh3 (0.1 mmol) (stirred for 1h at r.t. in 2mL MeCN), Et3N (1.0 mmol), and 
dipolarophile 62. The mixture was stirred at r.t. for 24h, which was then diluted with 
DCM. The organic solution was washed with sat. NH4Cl aqueous solution (2×20mL). 
The aqueous layer was then extracted with DCM (2×20mL). Combined organic layers 
was dried over anhydrous MgSO4, then filtered and concentrated under reduced 
pressure to afford crude material, which was purified by silica flash column 
chromatography (EtOAc:hexanes=2:1).  
 
65. 38% as a yellow foam: 1H NMR (500 MHz, CDCl3) δ 7.81 (d, J=8.3Hz, 2H), 7.38 
(d, J=8.1Hz, 2H), 5.58 (ddd, J=7.5, 10.3, 17.2Hz, 1H), 5.24(d, J=17.0Hz, 1H), 5.19 (d, 
J=10.3Hz, 1H), 4.28 (q, J=7.1Hz, 2H), 4.01(dd, J=5.9, 10.0Hz, 1H), 3.98 (d, 
J=14.0Hz, 1H), 3.60 (s, 3H), 3.46 (d, J=7.4Hz, 1H), 3.24 (d, J=14.1Hz, 1H), 2.88 (dd, 
J=5.9, 14.1Hz), 2.77 (dd, J=10.0, 14.1Hz, 1H), 2.48 (s, 3H), 1.35 (t, J=7.1Hz, 3H) 13C 
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NMR (125 MHz, CDCl3) δ 173.5, 171.3, 144.9, 137.7, 133.4, 129.3, 127.9, 118.8, 
72.1, 61.4, 61.3, 58.9, 54.9, 52.2, 36.3, 21.6, 14.2. 
5.4.2. Procedure for formation of 72, 73 and 74 
Allylamine 21 (1.0 mmol) and ethyl glyoxylate (1.0mmol) was added into 1mL 
MeCN, stir for 0.5h at r.t. to preform the imine. Into the solution was next added 
AgOAc/PPh3 (0.1 mmol) (stirred for 1h at r.t. in 2mL MeCN), Et3N (1.0 mmol), and 
dipolarophile 69 (0.5mmol). The mixture was stirred at r.t. for 5h, which was then 
diluted with DCM. The organic solution was washed with sat. NH4Cl aqueous 
solution (2×20mL). The aqueous layer was then extracted with DCM (2×20mL). 
Combined organic layers was dried over anhydrous MgSO4, then filtered and 
concentrated under reduced pressure to afford crude material. Mixture of 3 
diastereomers 72, 73 and 74 was first isolated by silica flash column chromatography 
(EtOAc:hexanes=1:1). Compound 72 was further separated from the mixture by silica 
flash column chromatography (DCM:EtOAc=15:1 to 10:1 to 5:1). 
 
72. 45% as a yellow foam: 1H NMR (500 MHz, CDCl3) δ 7.80 (d, J=8.3Hz, 2H), 7.39 
(d, J=8.2Hz, 2H), 5.79 (ddd, J=6.8, 10.3, 17.2Hz, 1H), 5.10 (d, J=17.2Hz, 1H), 5.06 (d, 
J=10.3Hz, 1H), 4.23 (dd, J=7.2, 10.7Hz, 1H), 4.17 (dd, J=7.2, 10.8Hz), 4.12 (m, 2H), 
4.02 (m, 2H), 3.77 (m, 2H), 2.48 (s, 3H), 1.30 (t, J=7.2Hz, 3H), 1.18 (t, J=7.2Hz, 3H) 
13C NMR (125 MHz, CDCl3) δ 170.5, 169.7, 145.3, 135.7, 135.0, 130.0, 128.8, 117.9, 
71.5, 63.7, 62.3, 61.8, 61.5, 50.1, 21.7, 14.0, 13.9 
 107 
 
73+74. 45% as a yellow foam: 1H NMR (500 MHz, CDCl3) δ 7.81 (d, J=8.3Hz, 2H), 
7.38 (d, J=8.1Hz, 2H), 5.72 (ddd, J=6.9, 10.5, 17.2Hz, 1H), 5.28 (d, J=17.2Hz, 1H), 
5.18 (d, J=10.5Hz, 1H), 4.30 (dd, J=4.6, 5.8Hz, 1H), 4.21 (d, J=5.8Hz, 1H), 4.04 (m, 
4H), 3.65 (dd, J=4.5, 7.3Hz), 4.13 (m, 1H), 2.46 (s, 3H), 1.18 (t, J=7.2Hz, 3H), 1.11 (t, 
J=7.2Hz, 3H) 13C NMR (125 MHz, CDCl3) δ 170.5, 170.3, 145.3, 134.9, 133.4, 129.9, 
128.9, 118.1, 69.7, 64.9, 61.9, 61.6, 61.3, 50.5, 21.6, 14.1, 13.9 
5.4.3. Procedure for converstion of 72, 73 and 74 to their corresponding 2H-
pyrroles 
Pyrrolidine compound 72 or mixture of 73 and 74 (0.1mmol) was dissolved in 
0.78mL of chloroform. Into the solution was added 1 equivalent of DBU. The mixture 
was heated at reflux for 4h before cooled down to r.t. The solution was diluted with 
10mL DCM, and then washed with sat. NH4Cl aqueous solution (2×10mL). 
Combined aqueous layers was extracted with DCM (2×10mL). Combined organic 
layers was washed with brine, dried over MgSO4, filtered and concentrated under 
reduced pressure to afford crude products, which was purified by silica flash column 
chromatography (EtOAc:hexanes=1:2).  
 
70. Yellow foam. 1H NMR (500 MHz, CDCl3) δ 6.71 (dd, J=10.9, 17.8Hz, 1H), 5.79 
(d, J=10.8Hz, 1H), 5.77 (d, J=17.9Hz, 1H), 4.26 (m, 4H), 3.53 (dd, J=7.2, 9.8Hz, 1H), 
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3.18 (dd, J=10.1, 17.2Hz, 1H), 3.11 (dd, J=7.4, 17.2Hz, 1H), 1.35 (t, J=7.1Hz, 3H), 
1.31 (t, J=7.1Hz, 3H)  
 
71. off-white foam. 1H NMR (500 MHz, CDCl3) δ 6.03 (ddd, J=6.2, 10.4, 16.9Hz, 
1H), 5.33 (d, J=17.2Hz, 1H), 5.24 (d, J=10.4Hz, 1H), 4.99 (m, 1H),  4.37 (q, J=7.1Hz, 
2H), 4.21 (q, J=7.1Hz, 2H), 3.22 (m, 2H), 1.39 (t, J=7.1Hz, 3H), 1.29 (t, J=7.1Hz, 3H) 
13C NMR (125 MHz, CDCl3) δ 166.2, 162.2, 136.9, 136.8, 116.7, 79.2, 62.2, 61.3, 
39.4, 14.2, 14.1 
5.4.4. Procedure for formation of 77 and 78 
Allylamine 21 (0.5mmmol) and indole glyoxal 47 (0.5mmol) were stirred in 
4mL THF at r.t. for 0.5h. Into the solution was next added AgOAc/PPh3 (0.05 mmol) 
(stirred for 1h at r.t. in 1mL THF), Et3N (0.5 mmol), and dipolarophile 69 (0.25mmol). 
The mixture was stirred at r.t. for 4h, which was then diluted with DCM. The organic 
solution was washed with sat. NH4Cl aqueous solution (2×20mL). The aqueous layer 
was then extracted with DCM (2×20mL). Combined organic layers was dried over 
anhydrous MgSO4, then filtered and concentrated under reduced pressure to afford 
crude material. 2 diastereomers 77 and 78 were separated by silica flash column 
chromatography (EtOAc:hexanes=1:1). 
 
77. 48% as a yellow foam. 1H NMR (500 MHz, CDCl3) δ 9.54 (b.p. 1H), 8.31 (d, 
J=7.3Hz, 1H), 8.16 (d, J=3.2Hz, 1H), 7.70 (d, J=8.3Hz, 2H), 7.37 (d, J=7.4Hz, 1H), 
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7.26 (m, 2H), 7.16 (d, J=8.0Hz, 2H), 5.80 (ddd, J=6.9, 10.5, 17.3Hz, 1H), 5.28 (d, 
J=17.2Hz, 1H), 5.19 (d, J=10.5Hz, 1H), 4.92 (d, J=7.0Hz, 1H), 4.73 (dd, J=5.5, 
6.9Hz, 1H), 4.18 (dd, 1H), 4.00 (q, J=7.1Hz, 2H), 3.61 (dd, J=5.4, 7.9Hz, 1H), 2.25 (s, 
3H), 1.14 (t, J=7.1Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 189.8, 170.5, 145.5, 136.6, 
135.1, 134.6, 133.4, 130.1, 128.5, 126.0, 124.1, 123.1, 122.5, 118.8, 115.9, 111.9, 
69.7, 65.6, 64.5, 61.4, 51.9, 21.8, 14.4. 
 
78. 48% as a white solid. 1H NMR (500 MHz, CDCl3) δ 8.99 (b.p., 1H), 8.35 (m, 1H), 
8.06 (d, J=3.0Hz, 1H), 7.80 (d, J=8.3Hz, 2H), 7.45 (m, 1H), 7.38 (d, J=8.0Hz, 2H), 
5.81 (ddd, J=7.0, 10.5, 17.2Hz, 1H), 5.03 (d, J=10.4Hz, 1H), 5.01 (d, J=17.1Hz, 1H), 
4.88 (d, J=6.9Hz, 1H), 4.16 (dd, J=7.0, 13.4Hz, 1H), 3.90 (m, 2H), 3.80 (q, J=7.2Hz, 
2H), 2.47 (s, 3H), 0.80 (t, J=7.2Hz, 3H) 13C NMR (125 MHz, CDCl3) δ 189.4, 170.6, 
145.4, 136.5, 135.4, 134.9, 132.7, 130.0, 128.7, 125.5, 124.1, 123.0, 122.2, 118.1, 
116.5, 117.8, 71.8, 66.9, 63.1, 61.7, 51.8, 21.7, 13.5. 
5.4.5. Procedure for converstion of 77 and 78 to their corresponding pyrroles 75 
and 76 
Pyrrolidine compound 77 or 78 (0.038mmol) was dissolved in 3mL of toluene. 
Into the solution was added 2 equivalent of DBU. The mixture was heated at 70 °C 
over night before cooled down to r.t. The solution was diluted with 10mL DCM, and 
then washed with sat. NH4Cl aqueous solution (2×10mL). Combined aqueous layers 
was extracted with DCM (2×10mL). Combined organic layers was washed with brine, 
dried over MgSO4, filtered and concentrated under reduced pressure to afford crude 
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products, which was purified by silica flash column chromatography 
(EtOAc:hexanes=1:2 to 1:1 to 2:1).  
 
75. Yellow foam. 1H NMR (500 MHz, CDCl3) δ 10.16 (b.p. 1H), 9.26 (b.p. 1H), 8.37 
(m, 1H), 7.90 (d, J=2.7Hz, 1H), 7.47 (m, 1H), 7.42 (dd, J=11.4, 18.4Hz, 1H), 7.33 (m, 
3H), 5.79 (d, J=18.1Hz, 1H), 5.49 (d, J=11.4Hz, 1H), 4.37 (q, J=7.1Hz, 2H), 1.41 (t, 
J=7.1Hz, 3H) 13C NMR (125 MHz, CDCl3) δ 179.0, 164.6, 137.8, 136.2, 131.2, 
131.1, 126.3, 125.8, 124.0, 122.7, 122.2, 117.2, 116.6, 116.1, 115.0, 111.5, 60.3, 14.5.  
 
76. Yellow foam. 1H NMR (500 MHz, CDCl3) δ 13C NMR (125 MHz, CDCl3) δ 
181.2, 165.6, 137.5, 136.2, 132.8, 131.9, 125.9, 123.8, 122.5, 121.9, 119.3, 118.6, 
111.3, 109.3, 60.2, 20.7, 13.6, 13.1. 
5.4.6. Procedure for formation of 86 
Allylamine 21 (1.0mmmol) and ethyl glyoxylate (1.0mmol) were stirred in 2mL 
THF at r.t. for 1.5h. Into the solution was next added AgOAc/PPh3 (0.1 mmol) (stirred 
for 1h at r.t. in 2mL THF), bases (1.0 mmol), and dipolarophile 84 (1.2mmol). The 
mixture was stirred at r.t. for 5h, which was then diluted with DCM. The organic 
solution was washed with sat. NH4Cl aqueous solution (2×20mL). The aqueous layer 
was then extracted with DCM (2×20mL). Combined organic layers was dried over 
anhydrous MgSO4, then filtered and concentrated under reduced pressure to afford 
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crude material 86, which were then purified by silica flash column chromatography 
(EtOAc:DCM=1:15). 
 
86. 18% as a brown solid 1H NMR (500 MHz, CDCl3) δ 5.95 (ddd, J=6.9, 10.4, 
17.2Hz, 1H), 5.41 (d, J=17.2Hz, 1H), 5.32 (d, J=10.3Hz, 1H), 5.18 (d, J=6.8Hz, 1H), 
4.35 (J=6.9Hz, 1H), 4.23 (q. J=7.2Hz, 2H), 3.84 (s, 1H), 3.74 (s, 3H), 1.47 (s, 3H), 
1.31 (t, q=7.2Hz, 3H) 13C NMR (125 MHz, CDCl3) δ 169.3, 168.6, 135.1, 121.1, 
91.7, 67.7, 62.2, 53.4, 53.1, 22.0, 18.1, 13.9. 
5.4.7. Procedure for preparation of N-tosyl indole glyoxal 94 
To a solution of indole 46 (20mmol) in toluene 20mL was added Bu4NHSO4 
(1.4mmol) , 50% aqueous KOH solution (25 mL) and purified tosyl chloride solution 
(26mmol in 50mL toluene), The mixture was stirred at r.t. for 3h. Aqueous layer was 
then separated from organic layer, which was washed with water (2×20mL). 
Combined aqueous layer was then extracted with DCM (2×20mL). Combined organic 
layer was dried over MgSO4, filtered and concentrated under reduced pressure. The 
crude material was then purified by recrystalization with 95% EtOH to afford N-tosyl 
indole 92. 
Into the suspension of AlCl3 (123.0mmol) in 150mL dry DCM was added acetic 
anhydride (68.0mmol) during 10min. The solution of 92 in 30mL dry DCM was 
added into the mixture portionally. The resulting solution was stirred at r.t. for 16h. 
The reaction mixture was then poured into a separatory funnel with ¾ full of ice. 
Organic layer was separated, and then washed with sat.NaHCO3 aqueous solution and 
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brine. Resulting DCM solution was dried over MgSO4, filtered, and concentrated 
under reduced pressure. Crude material 93 was purified by recrystalization with 
MeOH.  
3-acyl indole 93 (17.0mmol) was dissolved in 80mL dioxane. 1.5 equivalent of 
SeO2 and 2mL water were added in one portion. The reaction mixture was heated at 
reflux for 16h, which was then filtered through Celite when still warm. Filtrate was 
diluted with DCM, and then washed with water (2×100mL). Resulting organic 
solution was dried over MgSO4, filtered, and concentrated under reduced pressure. 
Crude material was further purified by silica flash column chromatography 
(EtOAc:hexanes=1:2) to afford 94 as a mixture of desired aldehyde and its hydrate.  
5.4.8. Procedure for formation of 96 and 97 
Allylamine 21 (1.0mmmol) and N-tosyl indole glyoxal 94 (1.0mmol) were 
stirred in 2mL THF at r.t. for 0.5h. Into the solution was next added AgOAc/PPh3 (0.1 
mmol) (stirred for 1h at r.t. in 2mL THF), Et3N (1.0 mmol), and dipolarophile 55 or 
62 (0.5mmol). The mixture was stirred at r.t. for 2.5h, which was then diluted with 
DCM. The organic solution was washed with sat. NH4Cl aqueous solution (2×20mL). 
The aqueous layer was then extracted with DCM (2×20mL). Combined organic layers 
was dried over anhydrous MgSO4, then filtered and concentrated under reduced 
pressure to collect crude material, which were then purified by silica flash column 
chromatography (EtOAc:hexanes=1:3) to afford 96 or 97. 
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96. 72% as a pale-white solid. 1H NMR (500 MHz, CDCl3) δ 9.49 (s, 1H), 8.45 (s, 
1H), 7.98 (d, J=8.1Hz, 2H), 7.93 (d, J=8.1Hz, 2H), 7.52 (d, J=9.4Hz, 2H), 7.37 (m, 
1H), 7.31 (m, 3H), 6.84 (d, J=8.0Hz, 2H), 5.82 (ddd, J=7.6, 10.4, 17.8Hz, 1H), 5.40 
(d, J=15.5Hz, 1H), 5.34 (d, J=10.4Hz, 1H), 4.85 (s, 2H), 3.89 (d, J=7.6Hz, 1H), 2.38 
(s, 3H), 2.00 (s, 3H), 1.77 (s, 3H) 13C NMR (125 MHz, CDCl3) δ 201.5, 191.3, 146.4, 
145.2, 136.1, 134.7, 134.6, 133.8, 132.2, 130.5, 129.7, 128.4, 127.6, 127.5, 126.1, 
125.0, 123.5, 120.1, 119.4, 113.8, 73.2, 67.9, 64.7, 59.8, 21.8, 21.4, 15.5. 
 
97. 65% as a light yellow solid. 1H NMR (500 MHz, CDCl3) δ 8.48 (s, 1H), 7.94 (m, 
4H), 7.41 (d, J=8.3Hz, 2H), 7.37 (m, 1H), 7.33 (d, J=8.3Hz, 2H), 7.28 (m, 1H), 6.74 
(d, J=8.1Hz, 2H), 5.74 (ddd, J=7.5, 10.4, 17.4Hz, 1H), 5.25 (d, J=17.0Hz, 1H), 5.19 
(d, J=10.4Hz, 1H), 4.87 (d, J=8.4Hz, 1H), 4.85 (d, J=8.4Hz, 1H), 3.71 (m, 4H), 2.37 
(s, 3H), 1.99 (s, 3H), 1.86 (s, 3H) 13C NMR (125 MHz, CDCl3) δ 191.4, 173.2, 146.4, 
144.9, 136.4, 134.8, 134.6, 134.1, 133.8, 130.5, 129.5, 128.3, 127.5, 126.0, 124.9, 
123.1, 119.7, 118.3, 113.2, 73.9, 71.1, 65.0, 57.7, 52.6, 21.8, 21.4, 18.4. 
5.4.9. Procedure for formation of 102 and 103 
Allylamine 21 (0.5mmmol) and N-tosyl indole glyoxal 94 (0.5mmol) were 
stirred in 4mL THF at r.t. for 0.5h, which was then dropwisely added over 3h into the 
mixture of AgOAc/PPh3 (0.1 mmol), Et3N (1.0 mmol), and methacrolein or methyl 
methacrylate (5.0mmol) in 2mL toluene. The resulting mixture was stirred at r.t. for 
24h before diluted with DCM. The organic solution was washed with sat. NH4Cl 
aqueous solution (2×20mL). The aqueous layer was then extracted with DCM 
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(2×20mL). Combined organic layers was dried over anhydrous MgSO4, then filtered 
and concentrated under reduced pressure to collect crude material, which were then 
purified by silica flash column chromatography (EtOAc:hexanes=1:5) to afford 102 
or 103. 
N
O
NTs
CO2Me
 
102. 45% as light yellow foam. 1H NMR (500 MHz, CDCl3) δ 9.06 (s, 1H), 8.41 
(m,1H), 7.95 (m,1H), 7.86 (d, J=8.4Hz, 2H), 7.38 (m, 2H), 7.29 (d, J=8.3Hz, 2H), 
5.81 (ddd, J=7.2, 10.3, 17.3Hz, 1H), 5.38 (d, J=17.1Hz, 1H), 5.30 (d, J=10.4Hz, 1H), 
4.78 (d, J=7.2Hz, 1H), 3.68 (dd, J=2.0, 18.0Hz, 1H), 3.68 (s, 3H), 2.88 (dd, J=1.1, 
18.0Hz, 1H), 2.37 (s, 3H), 1.48 (s, 3H) 13C NMR (125 MHz, CDCl3) δ 184.7, 174.4, 
173.7, 146.1, 136.9, 134.8, 134.6, 133.9, 130.4, 128.5, 127.5, 125.9, 125.1, 123.1, 
118.3, 118.2, 113.3, 85.5, 52.6, 52.2, 45.9, 24.1, 21.8. 
 
103. 46% as light yellow foam. 1H NMR (500 MHz, CDCl3) δ 9.52 (s, 1H), 9.03 (s, 
1H), 8.37 (m, 1H), 7.92 (m, 1H), 7.82 (d, J=8.4Hz, 2H), 7.35 (m,2H), 7.25 (d, 
J=8.3Hz, 2H), 5.81 (ddd, J=7.4, 10.3, 17.2Hz, 1H), 5.41 (dt, J=1.3, 18.4Hz, 1H), 5.34 
(dt, J=1.1, 11.4Hz, 1H), 4.81 (d, J=7.3Hz, 1H), 3.54 (dd, J=2.2, 18.2Hz, 1H), 2.78 
(dd, J=1.6, 18.2Hz, 1H), 2.33 (s, 3H), 1.37 (s, 3H) 13C NMR (125 MHz, CDCl3) δ 
202.3, 184.2, 173.3., 146.1, 136.9, 134.7, 134.6, 133.2, 130.4, 128.5, 127.5, 125.9, 
125.2, 123.1, 119.1, 118.1, 113.3, 85.1, 55.2, 42.9, 21.8, 20.7. 
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5.4.10. Procedures for synthesis toward 108’ and 109’ 
Prenylamine 25 (0.5mmmol) and N-tosyl indole glyoxal 94 (0.5mmol) were 
stirred in 4mL THF at r.t. for 0.5h, which was then dropwisely added over 3h into the 
mixture of AgOAc/PPh3 (0.1 mmol), Et3N (1.0 mmol), and methacrolein (5.0mmol) 
in 2mL toluene. The resulting mixture was stirred at r.t. for 24h before diluted with 
DCM. The organic solution was washed with sat. NH4Cl aqueous solution (2×20mL). 
The aqueous layer was then extracted with DCM (2×20mL). Combined organic layers 
was dried over anhydrous MgSO4, then filtered and concentrated under reduced 
pressure to collect crude material, which were then purified by silica flash column 
chromatography (EtOAc:hexanes=1:5) to afford 105’. 
 
105’. 45% as a light yellow foam. 1H NMR (500 MHz, CDCl3) δ 9.52 (s, 1H), 9.03 (s, 
1H), 8.40 (m, 1H), 7.93 (m, 1H), 7.86 (d, J=8.4Hz, 2H), 7.38 (m, 2H), 7.29 (d, 
J=8.5Hz, 2H), 5.11 (dd, J=1.3, 9.9Hz, 1H), 4.98 (dt, J=1.3, 9.9Hz, 1H), 3.60 (dd, 
J=2.2, 18.2Hz, 1H), 2.78 (dd, J=0.8, 18.2Hz, 1H), 2.38 (s, 3H), 1.87 (s, 3H), 1.82 (s, 
3H), 1.37 (s, 3H) 13C NMR (125 MHz, CDCl3) δ 202.0, 184.5, 172.3, 145.9, 138.2, 
136.7, 134.6, 134.4, 130.2, 128.3, 127.3, 125.7, 124.9, 122.9, 120.1, 117.9, 113.1, 
81.2, 55.2, 42.7, 25.9, 21.7, 21.2, 18.9. 
2H-pyrrole 105’ was dissolved in 10mL MeOH. Into the solution was added 4 
equivalent of KOH in one portion. The reaction was stirred at 0 °C for 0.5 h, then r.t. 
for 2.5h. Resulting mixture was poured into sat. NH4Cl aqueous solution (20mL), and 
then extracted with DCM. Organic layer was next washed with water and brine, dried 
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over MgSO4, filtered and concentrated under reduced pressure. Crude material was 
purified with silica column chromatography (EtOAc:hexanes=1:4 to 1:3, 1% Et3N) to 
afford 106’. 
 
106’. 58% as a yellow solid. . 1H NMR (500 MHz, CDCl3) δ 9.54 (s, 1H), 8.74 (b.p. 
1H), 8.63 (d, J=3.2Hz, 1H), 8.51 (m, 1H), 7.44 (m, 1H), 7.34 (m, 2H), 5.05 (dd, J=1.2, 
10.2Hz, 1H), 5.02 (dt, J=1.3, 10.2Hz, 1H), 3.62 (dd, J=2.1, 18.2Hz, 1H), 2.88 (dd, 
J=0.9, 18.2Hz, 1H), 1.83 (d, J=1.2Hz, 3H), 1.80 (d, J=1.2Hz, 3H), 1.39 (s, 3H). 13C 
NMR (125 MHz, CDCl3) δ 202.4, 184.1, 173.4, 138.0, 136.3, 135.9, 126.3, 124.0, 
123.1, 122.5, 120.4, 115.2, 111.4, 81.2, 55.2, 43.1, 25.8, 21.0, 18.8.  
Into stirring suspension of MePPh3Br (0.4mmol) in 2mL THF under N2 was 
added dropwisely KHMDS (0.3mmol) at 0 °C. The mixture was then warmed up to r.t. 
and stirred for another 1 hour before cooled back down to 0 °C. The solution of 106’ 
(0.17mmol) in 3mL THF was added dropwisely into the solution of ylide. The 
resulting mixture was warmed up to r.t. and stirred overnight, which was then diluted 
by diethyl ether, and washed with sat. NH4Cl aqueous solution (2×20mL). Aqueous 
layer was then extracted by Et2O (2×20mL). Combined organic layer was dried over 
MgSO4, filtered, and concentrated under reduced pressure. The crude material was 
then purified by silica flash column chromatography (EtOAc:hexanes=1:5 to 1:3, 1% 
Et3N) to afford desired product 107’.  
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107’. 85% as an off-white solid. 1H NMR (500 MHz, CDCl3) δ 8.79 (b.p. 1H), 8.55 
(d, J=3.1Hz, 1H), 8.45 (d, J=7.7Hz, 1H), 7.35 (d, J=7.8Hz, 1H), 7.28 (m, 2H), 5.82 
(dd, J=10.4, 17.7Hz, 1H), 5.00 (m, 2H), 4.97 (d, J=4.5Hz, 1H), 4.72 (d, J=10.0Hz, 
1H), 3.12 (dd, J=1.4, 17.5Hz, 1H), 2.79 (J=1.2, 17.5Hz, 1H), 1.76 (s, 6H), 1.23 (s, 
3H) 13C NMR (125 MHz, CDCl3) δ 185.1, 174.6, 142.2, 136.3, 136.0, 135.9., 126.4, 
123.9, 123.0, 122.6, 122.1, 115.3, 112.4, 111.3, 80.9, 47.9, 45.6, 26.0, 25.2, 18.6. 
Compound 107’ (0.032mmol) was dissolved into 1mL EtOH at 0 °C. Into the 
solution was added 2 equivalent of NaBH4 in one portion. The mixture was stirred at 
0 °C for 0.5h. Into the reaction mixture was then added sat. NH4Cl aqueous solution 
(10mL). The mixture was then extracted with DCM (2×10mL). Combined organic 
layer was dried over MgSO4, filtered, and concentrated under reduced pressure. Crude 
material was then purified by column chromatography (2% MeOH in DCM, 1% 
NH4OH) to afford 2 separated diastereomers 108’ and 109’. 
H
N
O
NH
 
108’. 49% as an off-white solid. 1H NMR (500 MHz, CDCl3) δ 9.37 (b.p. 1H), 8.41 
(m, 1H), 7.88 (s, 1H), 7.43 (m, 1H), 7.31 (m, 2H), 6.18 (dd, J= 10.9, 17.5Hz, 1H), 
5.15 (d, J=10.9Hz, 1H), 5.14 (d, J=9.3Hz, 1H), 5.10 (d, J=17.5Hz, 1H), 4.68 (t, 
J=8.8Hz, 1H), 3.83 (d, J=9.3Hz, 1H), 2.39 (dd, J=8.5, 12.7Hz, 1H), 1.90 (dd, J=9.0, 
12.7Hz, 1H), 1.77 (s, 3H), 1.72 (s, 3H), 1.09 (s, 3H) 13C NMR (125 MHz, CDCl3) δ 
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196.5, 142.1, 136.3, 136.2, 131.5, 125.8, 123.9, 123.2, 122.8, 122.4, 115.4, 112.8, 
111.5, 65.6, 61.2, 49.4, 45.0, 26.2, 22.2, 18.5.  
H
N
O
NH
 
109’. 49% as an off-white solid. 1H NMR (500 MHz, CDCl3) δ 8.35 (b.p. 1H), 8.32 
(s, 1H), 8.19 (m, 1H), 7.48 (m, 1H), 7.21 (m, 2H), 5.81 (dd, J=10.8, 17.5Hz, 1H), 5.00 
(d, J=9.3Hz, 1H), 4.91 (dd, J=1.4, 10.9Hz, 1H), 4.81 (dd, J=1.4, 17.5Hz, 1H), 4.60 
(dd, J=6.1, 10.0Hz, 1H), 3.55 (d, J=9.3Hz, 1H), 2.25 (dd, J=10.1, 12.8Hz, 1H), 1.87 
(dd, J=6.1, 12.8Hz, 1H), 1.70 (s, 3H), 1.67 (s, 3H), 1.13 (s, 3H) 13C NMR (125 MHz, 
CDCl3) δ 192.9, 141.0, 138.1, 136.6, 132.7, 125.7, 123.8, 122.8, 122.1, 120.9, 114.6, 
113.6, 112.1, 66.4, 61.6, 49.3, 44.1, 26.2, 23.1, 18.7.  
5.4.11. Procedures for preparation of 122 
Indole boric acid 120 (2.0mmol) and phthalimide-protected 2-bromo allylamine 
118 (1.6mmol) was added into flame-dried 100mL flask with 20mL toluene and 4mL 
EtOH. N2 was then bubbled through the solution. After 10min, Na2CO3 (4.8mmol) 
and LiCl (4.8mmol) and Pd(PPh3)4 (0.16mmol) were added sequentially into the 
solution. The reaction mixture was then warmed up to 100 °C and stirred for 1h, into 
which was next added 1.5g Na2SO4 and quenched with water. The mixture was 
extracted with DCM (2×50mL). Combined organic layer was washed with brine, 
dried over MgSO4, filtered, and concentrated under reduced pressure. The crude 
material was purified by silica flash column chromatography (100% DCM) to afford 
desired product 121.  
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121. 90% as an off-white solid. 1H NMR (500 MHz, CDCl3) δ 8.01 (d, J=8.3Hz, 1H), 
7.89 (m, 2H), 7.86 (s, 1H), 7.81 (m, 3H), 7.76 (m, 2H), 7.34 (m, 1H), 7.28 (m, 1H), 
7.20 (d, J=8.1Hz, 2H), 5.67 (s, 1H), 5.42 (s, 1H), 4.69  (s, 2H), 2.34 (s, 3H) 13C NMR 
(125 MHz, CDCl3) δ 167.9, 145.0, 135.3, 135.1, 134.6, 134.1, 132.0, 129.9, 129.0, 
127.0, 124.9, 123.5, 124.0, 123.4, 121.0, 120.3, 115.3, 42.1, 21.6. 
Compound 121 (1.24 mmol) was suspended in 6mL EtOH, in which 1 
equivalent of hydrazine hydrate was added. The reaction mixture was heated at reflux 
for 5h. 6 equivalent of 2M HCl was then added. The reaction was kept refluxing for 
an another hour, then cooled with ice-water bath. Precipitate was filtered off. The 
filtrate was concentrated and dissolved in 30mL 2M HCl. Aqueous solution was then 
washed with diethyl ether (2×20mL), basified with NaOH pallets, and extracted with 
diethyl ether (2×30mL). Organic layer was dried over MgSO4, filtered, and 
concentrated under reduced pressure. Crude material was purified by silica flash 
column chromatography (5% MeOH in EtOAc, 1% Et3N) to afford desired free amine 
product 122.  
 
122. 65% as yellow oil. 1H NMR (500 MHz, CDCl3) δ 8.03 (d, J=8.3Hz, 1H), 7.80 (d, 
J=8.4Hz, 2H), 7.76 (d, J=7.9Hz, 1H), 7.63 (s, 1H), 7.36 (m, 1H), 7.29 (m, 1H), 7.25 
(d, J=8.2Hz, 2H), 5.54 (s, 1H), 5.47 (s, 1H), 3.70 (s, 2H), 2.38 (s, 3H), 1.62 (b.p. 2H) 
 120 
13C NMR (125 MHz, CDCl3) δ 145.1, 142.0, 135.4, 135.1, 129.9, 129.4, 128.8, 124.9, 
123.6, 123.0, 122.1, 121.0, 113.8, 112.2, 46.9, 21.5. 
5.4.12. Procedures for preparation of 123 
Allylic amine 122 (0.6mmol) and ethyl glyoxylate (0.6mmol) was stirred in 
3mL toluene for 0.5h at r.t. Into the solution was next added AgOAc/PPh3 (0.12 mmol) 
(stirred for 1h at r.t. in 3mL toluene), Et3N (1.2 mmol), and methacrolein (6.0mmol). 
The mixture was stirred at r.t. for 22h, which was then diluted with DCM. The 
organic solution was washed with sat. NH4Cl aqueous solution (2×20mL). The 
aqueous layer was then extracted with DCM (2×20mL). Combined organic layers was 
dried over anhydrous MgSO4, then filtered and concentrated under reduced pressure 
to afford crude material 123.  
Unpurified cycloadduct 123 (0.45mmol) was then dissolved in 10mL EtOH, 
and cooled to 0 °C. 2 equivalent of NaBH4 was added. The mixture was stirred at 0 °C 
for 0.5h before addition of 10mL sat. NH4Cl aqueous solution and 10mL DCM. The 
mixture was then kept stirring at 0 °C for 0.5h before the organic layer was separated 
and washed with sat. NH4Cl aqueous solution (2×20mL). Combined aqueous layer 
was then washed with DCM (2×20mL). Combined organic layer was dried over 
MgSO4, filtered, and concentrated under reduced pressure. Crude material was 
purified by silica column chromatography (EtOAc:hexanes=1:2) to afford 124.  
 
124. 30% in 2 steps as light yellow foam. 1H NMR (500 MHz, CDCl3) δ 7.98 (d, 
J=8.3Hz, 1H), 7.73 (d, J=8.4Hz, 2H), 7.72 (d, J=8.4Hz, 1H), 7.56 (s, 1H), 7.32 (m, 
 121 
1H), 7.25 (m, 1H), 7.18 (d, J=8.2Hz, 2H), 5.80 (s, 1H), 5.54 (s, 1H), 4.22 (q, J=7.1Hz, 
2H), 3.96 (s, 1H), 3.93 (dd, J=6.5, 10.3 Hz, 1H), 3.45 (d, J=10.7Hz, 1H), 3.10 (b.p. 
1H), 3.01 (d, J=10.5Hz, 1H), 2.32 (dd, J=6.5, 13.4Hz, 1H), 2.00 (dd, J=10.4, 13.3Hz, 
1H), 1.29 (t, J=7.1Hz, 3H), 0.58 (s, 3H) 13C NMR (125 MHz, CDCl3) δ 173.9, 145.1, 
138.1, 135.2, 135.1, 129.9, 129.3, 126.8, 125.1, 123.8, 123.3, 123.0, 120.6, 115.4, 
113.8, 70.7, 68.7, 61.0, 56.3, 45.1, 39.1, 23.0, 21.6, 14.3. 
5.5. Procedures for decarboxylative generation of azomethine ylide and 
subsequent [3+2] dipolar cycloaddition  
Glyoxylic acid monohydrate (1.0mmol; 0.092g) was stirred for 10 minutes in 
3mL dry toluene with 0.5g 4Å molecular sieves in a flamed-dried round-bottom flask 
under N2. After the addition of homoallylic secondary amine (1.0mmol, 0.237g), the 
mixture was stirred for another 10 minutes. N-phenyl maleimide dipolarophile 
(1.0mmol; 0.173g) was finally added into the flask. Then the Dean-Stark trap was set 
up, and the temperature was raised up to 80℃. After 24 hours stirring, the crude 
material was concentrated under reduced pressure, followed by further purification by 
column chromatography using gradient solvent system of hexane and ethyl acetate 
from 10:1 to 5:1. Two diastereomers were obtained with the ratio 4:1 with the 
combined yield of 28%. (133b cannot be cleanly separated from N-phenyl maleimide.) 
 
133a 6% as off-white solid: 1H NMR (500 MHz, CDCl3) δ7.51 (m, 2H), 7.42 (m, 1H), 
7.33 (m, 7H), 7,21 (m, 4H), 7.01 (m, 2H), 5.71 (m, 1H), 5.14 (m, 2H), 4.43(d, 
J=9.6Hz, 1H), 3.90(dd, J=3.6, 10.5Hz, 1H), 3.79(d, J=14.3Hz, 1H), 3.62(dd, J=8.0, 
 122 
9.6Hz, 1H), 3.48(d, J=14.3Hz, 1H), 3.33(d, J=8.0Hz, 1H), 2.56(m, 1H), 2.11(m, 1H); 
13C NMR (125 MHz, CDCl3) δ177.7, 174.8, 137.9, 134.1, 132.0, 129.1, 128.9, 128.7, 
128.5, 128.1, 127.9, 127.7, 127.0, 126.0, 125.9, 118.3, 67.6, 59.8, 50.5, 49.5, 48.8, 
29.5. 
 
133b 24% as off-white solid: 1H NMR (500 MHz, CDCl3) δ 7.42 (m, 6H), 7.34 (m, 
8H), 7.17 (m, 2H), 6.05(m, 1H), 5.06(m,2H), 4.67(s, 1H), 3.82(d, J=14.6Hz, 1H), 
3.70(t, J=8.2Hz, 1H), 3.53(m, 2H), 3.14(d, J=14.6Hz, 1H), 2.49(t, J=6.4Hz, 2H); 13C 
NMR (125 MHz, CDCl3) δ177.7, 174.8, 137.9, 134.1, 132.0, 129.1, 128.9, 128.7, 
128.5, 128.1, 127.9, 127.7, 127.0, 126.0, 125.9, 118.3, 67.6, 59.8, 50.5, 49.5, 48.8, 
29.5. 
5.6. General Procedures of [3+2] dipolar cycloaddition with aqueous 
formaldehyde: 
Into the round bottom flash was added AgOAc (0.1 mmol) and PPh3 (0.1 mmol) 
and 3 mL THF. The mixture was stirred at r.t. for 1 h before sequential addition of 
amino acid esters 132 or 133 (1.0 mmol), aqueous formaldehyde (0.08 mL, 1.0 mmol), 
Et3N (2.0 mmol) and N-phenyl maleimide (1.5 mmol) or dimethyl maleate (1.5 
mmol). The mixture was left stirring at r.t. for 24 h. After filtration and concentration 
under reduced pressure, the crude materials were then purified by silica flash column 
chromatography (EtOAc:hexanes=1:1) to afford cycloadducts 134-136.  
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134. 87% as a light yellow solid. 1H NMR (500 MHz, CDCl3) δ 7.43 (m, 2H), 7.35 (m, 
1H), 7.23 (m, 2H), 5.79 (m, 1H), 5.17 (m, 2H), 4.22 (q, J=7.2Hz, 2H), 3.64 (dd, J=2.1, 
12.4Hz, 1H), 3.48 (td, J=2.2, 8.2Hz, 1H), 3.31 (m, 2H), 2.78 (dd, J=6.9, 14.1Hz, 1H), 
2.46 (dd, J=7.3, 14.1Hz, 1H), 1.28 (t, J=7.2Hz, 3H) 13C NMR (125 MHz, CDCl3) δ 
177.4, 175.0, 171.3, 132.5, 131.7, 129.2, 128.7, 126.5, 119.4, 73.4, 62.2, 55.0, 48.6, 
47.6, 40.1, 14.0.  
 
135. 78% as a white solid. 1H NMR (500 MHz, CDCl3) δ 7.43 (m, 2H), 7.36 (m, 1H), 
7.28 (m, 2H), 7.23 (m, 5H), 3.77 (s, 3H), 3.64 (d, J=12.0Hz, 1H), 3.47 (qd, J=2.1, 
8.2Hz, 1H), 3.42 (m, 3H), 2.99 (d, J=13.8Hz, 1H), 2.56 (bp, 1H) 13C NMR (125 MHz, 
CDCl3) δ 177.3, 175.0, 171.6, 135.7, 131.7, 130.2, 129.2, 128.8, 128.4, 127.2, 126.4, 
74.5, 55.3, 52.7, 48.5, 47.1, 40.9. 
 
136. 87% as yellow oil. 1H NMR (500 MHz, CDCl3) δ 7.22 (m, 5H), 3.64 (s, 3H), 
3.62 (s, 6H), 3.47 (dd, J=8.6, 10.0Hz, 1H), 3.30 (d, J=8.1Hz, 1H), 3.19 (dd, J=7.9, 
10.0Hz, 1H), 3.13 (m, 1H), 3.11 (d, J=13.0Hz, 1H), 2.89 (d, J=13.0, 1H) 13C NMR 
(125 MHz, CDCl3) δ 173.2, 172.0, 171.9, 135.9, 130.2, 128.0, 127.0, 74.1, 54.7, 52.2, 
52.0, 51.9, 48.1, 47.2, 45.6. 
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5.7. Procedures for CSA-catalyzed [3+2] dipolar cycloaddition 
Preparation of 143: Into a flame-dried flash with 0.12 g molecular sieves was 
added 2-aryl homoallylic amine 142 (1.0 mmol) and ethyl glyoxylate (1.0 mmol), and 
3mL dry acetonitrile. The solution was stirred for 10 min at r.t. Then N-phenyl 
maleimide (1.5 mmol) and CSA (0.2 mmol) were added into the reaction mixture. The 
mixture was stirred at 50 °C under N2 for 48 hours. The reaction was then cooled to 
r.t., and diluted with DCM. The organic layer was washed with sat. NaHCO3 
(2x15mL). Aqeous layer was then extracted with DCM (2x15mL). Combined DCM 
layers was dried over MgSO4 followed by filtration and evaporation under reduced 
pressure to afford crude material, which was then purified by silica column 
chromatography (EtOAc:hexanes=1:4 to 1:2 with 1% Et3N) to obtain cycloadduct 143 
in 52% yield. Characterizations of 143 by NMR matched with the spectra of the same 
compound in the reference.35 
Preparation of 145: Into a flame-dried flash with 0.12 g molecular sieves was 
added 0.75mL 1M solution of homoallylic amine 140 in toluene (0.75 mmol), ethyl 
glyoxylate (0.5 mmol), 3mL dry acetonitrile. The mixture was stirred for 10 min at r.t. 
Then N-phenyl maleimide (0.75 mmol) and CSA (0.075mmol) were added into the 
reaction mixture. The mixture was stirred at 50 °C under N2 for 48 hours. The 
reaction was then cooled to r.t., and diluted with DCM. The organic layer was washed 
with sat. NaHCO3 (2x15mL). Aqeous layer was then extracted with DCM (2x15mL). 
Combined DCM layers was dried over MgSO4 followed by filtration and evaporation 
under reduced pressure to afford crude material, which was then purified by silica 
column chromatography (EtOAc:hexanes=1:2 with 1% Et3N) to obtain cycloadduct 
145. (145 cannot be cleanly separated from N-phenyl maleimide.) 
 125 
 
145. 18% as a yellow solid; 1H NMR (500 MHz, CDCl3) δ 7.46 (m, 3H), 7.39 (m, 2H), 
5.84 (td, J=7.0, 17.2Hz, 1H), 5.19 (m, 2H), 4.29 (m, 5H), 3.75 (dd, J=7.8, 8.4Hz, 1H), 
3.45 (d, J=7.8Hz, 1H), 2.84 (dd, J=7.4, 14.2Hz, 1H), 2.43 (dd, J=6.6, 14.2Hz, 1H), 
1.34 (t, J=7.2Hz, 3H), 1.32 (t, J=7.1Hz, 3H) 13C NMR (125 MHz, CDCl3) δ 174.2, 
174.0, 170.2, 169.2, 132.3, 129.2, 128.9, 126.5, 119.3, 73.2, 62.3, 62.2, 62.1, 56.0, 
50.4, 41.2, 14.0, 13.9.  
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Figure A.  1. The 500 MHz 1H-NMR spectrum of compound 4 in CDCl3 
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Figure A. 2. The 125 MHz 13C-NMR spectrum of compound 4 in CDCl3 
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Figure A. 3. The 500 MHz 1H-NMR spectrum of compound 5 in CDCl3 
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Figure A.  4. The 125 MHz 13C-NMR spectrum of compound 5 in CDCl3 
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Figure A. 5. The 500 MHz 1H-NMR spectrum of compound 6 in CDCl3 
 132
ppm (f1)
050100150200
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A. 6. The 125 MHz 13C-NMR spectrum of compound 6 in CDCl3 
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Figure A. 7. The 500 MHz 1H-NMR spectrum of compound 7 in CDCl3 
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Figure A. 8. The 125 MHz 13C-NMR spectrum of compound 7 in CDCl3 
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Figure A. 9. The 500 MHz 1H-NMR spectrum of compound 8 in CDCl3 
 136
ppm (f1)
050100150200
Figure A. 10. The 125 MHz 13C-NMR spectrum of compound 8 in CDCl3 
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Figure A. 11. The 500 MHz 1H-NMR spectrum of compound 9 in CDCl3 
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Figure A. 12. The 125 MHz 13C-NMR spectrum of compound 9 in CDCl3 
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Figure A. 13. The 500 MHz 1H-NMR spectrum of compound 10 in CDCl3 
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Figure A. 14. The 125 MHz 13C-NMR spectrum of compound 10 in CDCl3 
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Figure A. 15. The 500 MHz 1H-NMR spectrum of compound 11 in CDCl3 
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Figure A. 16. The 125 MHz 13C-NMR spectrum of compound 11 in CDCl3 
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Figure A. 17. The 500 MHz 1H-NMR spectrum of compound 12 in CDCl3 
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Figure A. 18. The 125 MHz 13C-NMR spectrum of compound 12 in CDCl3 
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Figure A. 19. The 500 MHz 1H-NMR spectrum of compound 13 in CDCl3 
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Figure A. 20. The 125 MHz 13C-NMR spectrum of compound 13 in CDCl3 
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Figure A. 21. The 500 MHz 1H-NMR spectrum of compound 14 in CDCl3 
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Figure A. 22. The 125 MHz 13C-NMR spectrum of compound 14 in CDCl3 
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Figure A. 23. The 500 MHz 1H-NMR spectrum of compound 15 in CDCl3 
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Figure A. 24. The 125 MHz 13C-NMR spectrum of compound 15 in CDCl3 
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Figure A. 25. The 500 MHz 1H-NMR spectrum of compound 17 in CDCl3 
 152
           
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A. 26. The 125 MHz 13C-NMR spectrum of compound 17 in CDCl3 
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Figure A. 27. The 500 MHz 1H-NMR spectrum of compound 18a in CDCl3 
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Figure A. 28. The 125 MHz 13C-NMR spectrum of compound 18a in CDCl3 
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Figure A. 29. The 500 MHz 1H-NMR spectrum of compound 18b in CDCl3 
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Figure A. 30. The 125 MHz 13C-NMR spectrum of compound 18b in CDCl3 
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Figure A. 31. The 500 MHz 1H-NMR spectrum of compound 27 in CDCl3 
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Figure A. 32. The 125 MHz 13C-NMR spectrum of compound 27 in CDCl3 
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Figure A. 33. The 500 MHz 1H-NMR spectrum of compound 28 in CDCl3 
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Figure A. 34. The 125 MHz 13C-NMR spectrum of compound 28 in CDCl3 
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Figure A. 35. The 500 MHz 1H-NMR spectrum of compound 29 in CDCl3 
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Figure A. 36. The 125 MHz 13C-NMR spectrum of compound 29 in CDCl3 
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Figure A. 37. The 500 MHz 1H-NMR spectrum of compound 30 in CDCl3 
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Figure A. 38. The 125 MHz 13C-NMR spectrum of compound 30 in CDCl3 
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Figure A. 39. The 500 MHz 1H-NMR spectrum of compound 31 in CDCl3 
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Figure A. 40. The 125 MHz 13C-NMR spectrum of compound 31 in CDCl3 
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Figure A. 41. The 500 MHz 1H-NMR spectrum of compound 32 in DMSO-d6 
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Figure A. 42. The 125 MHz 13C-NMR spectrum of compound 32 in DMSO-d6 
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Figure A. 43. The 500 MHz 1H-NMR spectrum of compound 33 in DMSO-d6 
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Figure A. 44. The 125 MHz 13C-NMR spectrum of compound 33 in DMSO-d6 
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Figure A. 45. The 500 MHz 1H-NMR spectrum of compound 34 in DMSO-d6 
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Figure A. 46. The 125 MHz 13C-NMR spectrum of compound 34 in DMSO-d6 
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Figure A. 47. The 500 MHz 1H-NMR spectrum of compound 35 in DMSO-d6 
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Figure A. 48. The 125 MHz 13C-NMR spectrum of compound 35 in DMSO-d6 
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Figure A. 49. The 500 MHz 1H-NMR spectrum of compound 36 in DMSO-d6 
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Figure A. 50. The 125 MHz 13C-NMR spectrum of compound 36 in DMSO-d6 
 177
ppm (f1)
0.05.0
1
.32
1
.30
1
.36
1
.66
1
.19
3
.56
6
.20
1
.25
1
.15
1
.60
2
.33
1
.07
3
.37
1
.73
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A. 51. The 500 MHz 1H-NMR spectrum of compound 37 in CDCl3 
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Figure A. 52. The 125 MHz 13C-NMR spectrum of compound 37 in CDCl3 
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Figure A. 53. The 500 MHz 1H-NMR spectrum of compound 38 in DMSO-d6 
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Figure A. 54. The 125 MHz 13C-NMR spectrum of compound 38 in DMSO-d6 
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Figure A. 55. The 500 MHz 1H-NMR spectrum of compound 65 in CDCl3 
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Figure A. 56. The 125 MHz 13C-NMR spectrum of compound 65 in CDCl3 
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Figure A. 57. The 500 MHz 1H-NMR spectrum of compound 70 in CDCl3 
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Figure A. 58. The 500 MHz 1H-NMR spectrum of compound 71 in CDCl3 
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Figure A. 59. The 500 MHz 1H-NMR spectrum of compound 72 in CDCl3 
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Figure A. 60. The 125 MHz 13C-NMR spectrum of compound 72 in CDCl3 
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Figure A. 61. The 500 MHz 1H-NMR spectrum of compound 73&74 in CDCl3 
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Figure A. 62. The 125 MHz 13C-NMR spectrum of compound 73&74 in CDCl3 
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Figure A. 63. The 500 MHz 1H-NMR spectrum of compound 75 in CDCl3 
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Figure A. 64. The 125 MHz 13C-NMR spectrum of compound 75 in CDCl3 
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Figure A. 65. The 500 MHz 1H-NMR spectrum of compound 76 in CDCl3 
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Figure A. 66. The 125 MHz 13C-NMR spectrum of compound 76 in CDCl3 
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Figure A. 67. The 500 MHz 1H-NMR spectrum of compound 77 in CDCl3 
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Figure A. 68. The 125 MHz 13C-NMR spectrum of compound 77 in CDCl3 
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Figure A. 69. The 500 MHz 1H-NMR spectrum of compound 78 in CDCl3 
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Figure A. 70. The 125 MHz 13C-NMR spectrum of compound 78 in CDCl3 
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Figure A. 71. The 500 MHz 1H-NMR spectrum of compound 86 in CDCl3 
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Figure A. 72. The 125 MHz 13C-NMR spectrum of compound 86 in CDCl3 
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Figure A. 73. The 500 MHz 1H-NMR spectrum of compound 96 in CDCl3 
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Figure A. 74. The 125 MHz 13C-NMR spectrum of compound 96 in CDCl3 
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Figure A.  75. The 500 MHz 1H-NMR spectrum of compound 97 in CDCl3 
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Figure A. 76. The 125 MHz 13C-NMR spectrum of compound 97 in CDCl3 
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Figure A. 77. The 500 MHz 1H-NMR spectrum of compound 102’ in CDCl3 
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Figure A. 78. The 125 MHz 13C-NMR spectrum of compound 102’ in CDCl3 
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Figure A.  79. The 500 MHz 1H-NMR spectrum of compound 103’ in CDCl3 
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Figure A. 80. The 125 MHz 13C-NMR spectrum of compound 103’ in CDCl3 
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Figure A. 81. The 500 MHz 1H-NMR spectrum of compound 105’ in CDCl3 
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Figure A. 82. The 125 MHz 13C-NMR spectrum of compound 105’ in CDCl3 
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Figure A.  83. The 500 MHz 1H-NMR spectrum of compound 106’ in CDCl3 
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Figure A. 84. The 125 MHz 13C-NMR spectrum of compound 106’ in CDCl3 
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Figure A. 85. The 500 MHz 1H-NMR spectrum of compound 107’ in CDCl3 
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Figure A. 86. The 125 MHz 13C-NMR spectrum of compound 107’ in CDCl3 
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Figure A. 87. The 500 MHz 1H-NMR spectrum of compound 108’ in CDCl3 
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Figure A.  88. The 125 MHz 13C-NMR spectrum of compound 108’ in CDCl3 
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Figure A. 89. The 500 MHz 1H-NMR spectrum of compound 109’ in CDCl3 
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Figure A. 90. The 125 MHz 13C-NMR spectrum of compound 109’ in CDCl3 
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Figure A. 91. The 500 MHz 1H-NMR spectrum of compound 121 in CDCl3 
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Figure A. 92. The 125 MHz 13C-NMR spectrum of compound 121 in CDCl3 
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Figure A. 93. The 500 MHz 1H-NMR spectrum of compound 122 in CDCl3 
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Figure A. 94. The 125 MHz 13C-NMR spectrum of compound 122 in CDCl3 
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Figure A. 78. The 500 MHz 1H-NMR spectrum of compound 124 in CDCl3 
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Figure A. 96. The 125 MHz 13C-NMR spectrum of compound 124 in CDCl3 
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Figure A. 97. The 500 MHz 1H-NMR spectrum of compound 133a in CDCl3 
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Figure A. 98. The 125 MHz 13C-NMR spectrum of compound 133a in CDCl3 
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Figure A. 99. The 500 MHz 1H-NMR spectrum of compound 133b in CDCl3 
 226
             
N
Bn
N
O O
Ph
133b
Figure A. 100. The 125 MHz 13C-NMR spectrum of compound 133b in CDCl3 
 227
 
 
             
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure A. 101. The 500 MHz 1H-NMR spectrum of compound 136 in CDCl3 
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Figure A. 102. The 125 MHz 13C-NMR spectrum of compound 136 in CDCl3 
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Figure A. 103. The 500 MHz 1H-NMR spectrum of compound 137 in CDCl3 
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Figure A. 104. The 125 MHz 13C-NMR spectrum of compound 137 in CDCl3 
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Figure A. 105. The 500 MHz 1H-NMR spectrum of compound 138 in CDCl3 
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Figure A. 106. The 125 MHz 13C-NMR spectrum of compound 138 in CDCl3 
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Figure A. 107. The 500 MHz 1H-NMR spectrum of compound 145 in CDCl3 
 234
              
N
H
N CO2Et
O O
Ph
EtO2C
145
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A. 108. The 125 MHz 13C-NMR spectrum of compound 145 in CDCl3 
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          Figure A. 109.  The 2D-TOCSY NMR spectrum of compound 98 in CDCl3 
 236
                  Figure A. 110. The 2D-COSY NMR spectrum of compound 103 in CDCl3 
 237
Figure A. 111. The 1D-NOE NMR spectrum of compound 103 in CDCl3 
 238
Figure A. 112.  The 2D-COSY NMR spectrum of compound 105’ in CDCl3 
 239
Figure A. 113. The 1D-NOE NMR spectrum of compound 105’ in CDCl3 
 240
       Figure A. 114.  The 2D-COSY NMR spectrum of compound 108’ in CDCl3 
 241
Figure A. 115.  The 2D-COSY NMR spectrum of compound 109’ in CDCl3 
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          Figure A. 116. The 2D-COSY NMR spectrum of compound 124 in CDCl3 
 243
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
          Figure A. 117.  The 2D-HMQC NMR spectrum of compound 124 in CDCl3 
 244
 
 
 
 
 
 
 
 
 
            Figure A.  79.  The 2D-HMBC NMR spectrum of compound 124 in CDCl3 
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